STMicroelectronics (STM) 20-F 23 Feb 23 2022 FY Annual report (foreign) Financial data

Document and Entity Information

Document and Entity Information	12 Months Ended
	Dec. 31, 2022 shares
Document Information [Line Items]
Document Type	20-F
Amendment Flag	false
Document Period End Date	Dec. 31, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Trading Symbol	STM
Entity Registrant Name	STMicroelectronics N.V.
Entity Central Index Key	0000932787
Current Fiscal Year End Date	--12-31
Entity File Number	1-13546
Entity Incorporation, State or Country Code	P7
Entity Address, Address Line One	WTC Schiphol Airport
Entity Address, Address Line Two	Schiphol Boulevard 265
Entity Address, City or Town	Schiphol
Entity Address, Country	NL
Entity Address, Postal Zip Code	1118 BH
Document Annual Report	true
Document Transition Report	false
Document Shell Company Report	false
Document Registration Statement	false
Document Accounting Standard	U.S. GAAP
Entity Well-known Seasoned Issuer	Yes
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding	903,865,763
Title of 12(b) Security	Common shares, nominal value €1.04 per share
Security Exchange Name	NYSE
ICFR Auditor Attestation Flag	true
Auditor Name	Ernst & Young AG
Auditor Firm ID	1460
Auditor Location	Geneva, Switzerland
Business Contact
Document Information [Line Items]
Entity Address, Address Line One	39, Chemin du Champ des Filles
Entity Address, Address Line Two	Plan-Les-Ouates
Entity Address, City or Town	Geneva
Entity Address, Country	CH
Entity Address, Postal Zip Code	1228
Contact Personnel Name	Jean-Marc Chery
City Area Code	22
Local Phone Number	41 22 929 29 29
Contact Personnel Fax Number	41 22 929 29 88

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Net revenues	$ 16,128	$ 12,761	$ 10,219
Cost of sales	(8,493)	(7,435)	(6,430)
Gross profit	7,635	5,326	3,789
Selling, general and administrative	(1,454)	(1,323)	(1,109)
Research and development	(1,901)	(1,723)	(1,548)
Other income and expenses, net	159	141	202
Impairment, restructuring charges and other related closure costs		(2)	(11)
Operating income	4,439	2,419	1,323
Interest income (expense), net	58	(29)	(20)
Other components of pension benefit costs	(11)	(10)	(12)
Income (loss) on equity-method investments			2
Loss on financial instruments, net		(43)	(26)
Income before income taxes and noncontrolling interest	4,486	2,337	1,267
Income tax expense	(520)	(331)	(159)
Net income	3,966	2,006	1,108
Net income attributable to noncontrolling interest	(6)	(6)	(2)
Net income attributable to parent company stockholders	$ 3,960	$ 2,000	$ 1,106
Earnings per share (Basic) attributable to parent company stockholders	$ 4.37	$ 2.21	$ 1.24
Earnings per share (Diluted) attributable to parent company stockholders	$ 4.19	$ 2.16	$ 1.20
Net Sales [Member]
Net revenues	$ 16,083	$ 12,729	$ 10,181
Other Revenues [Member]
Net revenues	$ 45	$ 32	$ 38

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 3,966	$ 2,006	$ 1,108
Other comprehensive income (loss), net of tax:
Currency translation adjustments arising during the period	(148)	(189)	203
Foreign currency translation adjustments	(148)	(189)	203
Net unrealized gains (losses) on securities arising during the period	(14)	(1)
Net unrealized gains (losses) on securities	(14)	(1)
Net unrealized gains (losses) on derivatives arising during the period	(108)	(79)	56
Reclassification adjustment for (gains) losses included in net income	170	(16)
Net unrealized gains (losses) on derivatives	62	(95)	56
Net gains (losses) on defined benefit pension plans arising during the period	64	57	(12)
Amortization of prior service cost included in net periodic pension cost	1	1	1
Defined benefit pension plans	65	58	(11)
Other comprehensive income (loss), net of tax	(35)	(227)	248
Comprehensive income (loss)	3,931	1,779	1,356
Less: comprehensive income (loss) attributable to noncontrolling interest	7	6	2
Comprehensive income (loss) attributable to the Company's stockholders	$ 3,924	$ 1,773	$ 1,354

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 3,258	$ 3,225
Short-term deposits	581	291
Marketable securities	679
Trade accounts receivable, net	1,970	1,759
Inventories	2,583	1,972
Other current assets	734	581
Total current assets	9,805	7,828
Goodwill	297	313
Other intangible assets, net	405	438
Property, plant and equipment, net	8,201	5,660
Non-current deferred tax assets	602	652
Long-term investments	11	10
Other non-current assets	661	639
Total non-current assets	10,177	7,712
Total assets	19,982	15,540
Current liabilities:
Short-term debt	175	143
Trade accounts payable	2,122	1,582
Other payables and accrued liabilities	1,385	1,101
Dividends payable to stockholders	60	55
Accrued income tax	95	68
Total current liabilities	3,837	2,949
Long-term debt	2,542	2,396
Post-employment benefit obligations	331	442
Long-term deferred tax liabilities	60	64
Other long-term liabilities	454	416
Total non-current liabilities	3,387	3,318
Total liabilities	7,224	6,267
Commitment and contingencies
Parent company stockholders' equity
Common stock (preferred stock: 540,000,000 shares authorized, not issued; common stock: Euro 1.04 par value, 1,200,000,000 shares authorized, 911,281,920 shares issued, 903,865,763 shares outstanding as of December 31, 2022)	1,157	1,157
Additional paid-in capital	2,631	2,533
Retained earnings	8,713	5,223
Accumulated other comprehensive income	460	496
Treasury stock	(268)	(200)
Total parent company stockholders' equity	12,693	9,209
Noncontrolling interest	65	64
Total equity	12,758	9,273
Total liabilities and equity	$ 19,982	$ 15,540

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - € / shares	Dec. 31, 2022	Dec. 31, 2021
Statement Of Financial Position [Abstract]
Preferred stock, shares authorized	540,000,000
Preferred stock, shares issued	0	0
Common stock, nominal value	€ 1.04
Common stock, shares authorized	1,200,000,000
Common stock, shares issued	911,281,920	911,276,920
Common stock, shares outstanding	903,865,763	906,518,057

Consolidated Statements of Equi

Consolidated Statements of Equity - USD ($) $ in Millions	Total	Transition Effect of Update in Accounting Standard [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Additional Paid-In Capital [Member] Transition Effect of Update in Accounting Standard [Member]	Treasury Stock [Member]	Retained Earnings [Member]	Retained Earnings [Member] Transition Effect of Update in Accounting Standard [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Noncontrolling Interest [Member]
Beginning Balance at Dec. 31, 2019	$ 7,111		$ 1,157	$ 2,992		$ (328)	$ 2,747		$ 475	$ 68
Repurchase of common stock	(125)					(125)
Issuance of senior convertible bonds	184			184
Settlement of senior convertible bonds	(11)			(269)		258
Stock-based compensation expense	155			155		102	(102)
Comprehensive income (loss):
Net income	1,108						1,106			2
Other comprehensive income (loss), net of tax	248								248
Comprehensive income (loss)	1,356
Dividends to noncontrolling interest	(12)									(12)
Dividends	(152)						(152)
Ending Balance at Dec. 31, 2020	8,506		1,157	3,062		(93)	3,599		723	58
Repurchase of common stock	(485)					(485)
Settlement of senior convertible bonds	(530)			(750)		220
Stock-based compensation expense	221			221		158	(158)
Comprehensive income (loss):
Net income	2,006						2,000			6
Other comprehensive income (loss), net of tax	(227)								(227)
Comprehensive income (loss)	1,779
Dividends	(218)						(218)
Ending Balance at Dec. 31, 2021	9,273	$ (92)	1,157	2,533	$ (117)	(200)	5,223	$ 25	496	64
Repurchase of common stock	(346)					(346)
Stock-based compensation expense	215			215		278	(278)
Comprehensive income (loss):
Net income	3,966						3,960			6
Other comprehensive income (loss), net of tax	(35)								(36)	1
Comprehensive income (loss)	3,931
Dividends to noncontrolling interest	(6)									(6)
Dividends	(217)						(217)
Ending Balance at Dec. 31, 2022	$ 12,758		$ 1,157	$ 2,631		$ (268)	$ 8,713		$ 460	$ 65

Consolidated Statements of Eq_2

Consolidated Statements of Equity (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Common Stock [Member]
Dividends, per share	$ 0.24	$ 0.24	$ 0.168

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income	$ 3,966	$ 2,006	$ 1,108
Items to reconcile net income and cash flows from operating activities:
Depreciation and amortization	1,216	1,045	923
Interest and amortization of issuance costs on convertible bonds	1	36	44
Interest on settled convertible bonds		(40)	(41)
Loss on financial instruments, net		43	26
Non-cash stock-based compensation	215	221	155
Other non-cash items	(69)	(153)	(130)
Deferred income tax	3	45	(8)
Income on equity-method investments			(2)
Impairment, restructuring charges and other related closure costs, net of cash payments		2	(3)
Changes in assets and liabilities:
Trade receivables, net	(231)	(307)	(72)
Inventories	(650)	(188)	(84)
Trade payables	240	95	161
Other assets and liabilities, net	511	255	16
Net cash from operating activities	5,202	3,060	2,093
Cash flows used in investing activities:
Payment for purchase of tangible assets	(3,528)	(1,830)	(1,283)
Proceeds from sale of tangible assets	4	2	4
Payment for purchase of marketable securities	(687)
Proceeds from matured marketable securities		132
Net proceeds from (investment in) short-term deposits	(293)	290	(577)
Payment for purchase of intangible assets	(87)	(97)	(75)
Net payment for financial assets		(17)
Proceeds from sale of financial assets		2
Proceeds from sale of equity investments			1
Payment for business acquisitions, net of cash acquired			(113)
Net cash used in investing activities	(4,591)	(1,518)	(2,043)
Cash flows from (used in) financing activities:
Proceeds from long-term debt	200	788	4
Net proceeds from issuance of convertible bonds			1,567
Repayment of issued convertible bonds		(1,223)	(709)
Repayment of long-term debt	(134)	(134)	(184)
Repurchase of common stock	(346)	(485)	(125)
Dividends paid to stockholders	(212)	(205)	(168)
Dividends paid to noncontrolling interest	(6)	(6)	(6)
Payment of withholding tax on vested shares	(44)	(49)	(31)
Payment for deferred consideration on business acquisitions	(25)
Net cash from (used in) financing activities	(567)	(1,314)	348
Effect of changes in exchange rates	(11)	(9)	1
Net cash increase	33	219	399
Cash, cash equivalents and restricted cash at beginning of the period	3,225	3,006	2,607
Cash and cash equivalents at end of the period	3,258	3,225	3,006
Supplemental cash information:
Interest paid	2	2	7
Income tax paid	$ 416	$ 279	$ 138

The Company

The Company	12 Months Ended
	Dec. 31, 2022
Organization Consolidation And Presentation Of Financial Statements [Abstract]
The Company	1. THE COMPANY STMicroelectronics N.V. (the “Company”) is registered in the Netherlands with its corporate legal seat in Amsterdam, the Netherlands, and its corporate headquarters located in Geneva, Switzerland. The Company is a global semiconductor company that designs, develops, manufactures and markets a broad range of products, including discrete and general purpose components, application-specific integrated circuits (“ASICs”), full-custom devices and semi-custom devices and application-specific standard products (“ASSPs”) for analog, digital and mixed-signal applications. In addition, the Company participates in the manufacturing value chain of smartcard products, which includes the production and sale of both silicon chips and smartcards.

Accounting Policies

Accounting Policies	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Accounting Policies	2. ACCOUNTING POLICIES The accounting policies of the Company conform to accounting principles generally accepted in the United States of America (“U.S. GAAP”) . 2.1 Basis of presentation and consolidation The Company's consolidated financial statements include the assets, liabilities, results of operations and cash flows of its wholly-owned and majority-owned subsidiaries, after elimination of intercompany transactions and balances. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases. The Company assesses each investment in equity securities to determine whether the investee is a Variable Interest Entity (“VIE”). The Company consolidates the VIEs for which the Company is determined to be the primary beneficiary. The primary beneficiary of a VIE is the party that: (i) has the power to direct the most significant activities of the VIE and (ii) is obligated to absorb losses or has the rights to receive returns that would be considered significant to the VIE. Assets, liabilities, and the noncontrolling interest of newly consolidated VIEs are initially measured at fair value in the same manner as if the consolidation resulted from a business combination. When the Company owns some, but not all, of the voting stock of a consolidated entity, the shares held by third parties represent a noncontrolling interest . . . 2.2 Use of estimates The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions . • • • • • • assessment of the Company’s long-lived assets economic useful lives, • • • • The Company bases the estimates and assumptions on historical experience and on various other factors such as market trends, market information used by market participants and the latest available business plans that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. While the Company regularly evaluates its estimates and assumptions, the actual results experienced by the Company could differ materially and adversely from those estimates . 2.3 Foreign currency The U.S. dollar is the reporting currency of the Company . . . The functional currency of each subsidiary of the Company is either the local currency or the U.S. dollar, depending on the basis of the economic environment in which each subsidiary operates. Foreign currency transactions, including operations in local currency when the U.S. dollar is the functional currency, are measured into the functional currency using the prevailing exchange rate . For consolidation purposes, the results and financial position of the subsidiaries whose functional currency is different from the U.S. dollar are translated into the reporting currency as follows: (a) (b) (c) 2.4 Cash and cash equivalents Cash and cash equivalents include cash on hand, deposits held at call with external financial institutions and other short-term highly liquid investments with original maturities of three months or less. They are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates . Short-term deposits representing cash equivalent with original maturity beyond three months are reported as current assets in the line “Short-term deposits” of the consolidated balance sheets. 2.5 Trade accounts receivable Trade accounts receivable are amounts due from customers for goods sold and services rendered to third parties in the ordinary course of business . In the event of transfers of receivables such as factoring, the Company derecognizes the receivables only to the extent that the Company has surrendered control over the receivables in exchange for a consideration other than beneficial interest in the transferred receivables . 2.6 Inventories Inventories are stated at the lower of cost and net realizable value. Actual cost is based on an adjusted standard cost, which approximates cost on a first-in, first-out basis for all categories of inventory (raw materials, work-in-process, finished products). Actual cost is therefore dependent on the Company’s manufacturing performance and cost is based on the normal utilization of its production capacity. In case of underutilization of manufacturing facilities, the costs associated with unused capacity are not included in the valuation of inventories but charged directly to cost of sales. Net realizable value is based upon the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company performs, on a continuous basis, write-offs of inventories, which have the characteristics of slow-moving, old production dates and technical obsolescence. The Company evaluates its inventory to identify obsolete or slow-selling items, as well as inventory that is not of saleable quality and records a specific reserve if the Company estimates the inventory will eventually become obsolete. Reserve for obsolescence is estimated for excess uncommitted inventory based on historical sales data, order backlog and production plans . 2.7 Income taxes Income tax for the period comprises current and deferred income tax. Current income tax represents the income tax expected to be paid or the tax benefit expected to be received related to the current year taxable profit and loss in each tax jurisdiction. Deferred income tax is recognized, using the liability method, for all temporary differences arising between the tax bases of assets and liabilities and their carrying amount in the consolidated financial statements. Deferred tax liabilities are not recognized on the initial recognition of goodwill as a result of a business combination. Deferred income tax is determined using tax rates and laws that are enacted at the balance sheet date and are expected to apply when the related deferred income tax asset is realized or the deferred income tax liability is settled. The effect on deferred tax assets and liabilities from changes in tax laws and tax rates is recognized on the line “Income tax expense” in the consolidated statements of income in the period in which the law is enacted. Deferred income tax assets are recognized in full but the Company assesses whether future taxable profit will be available against which temporary differences can be utilized. A valuation allowance is provided for deferred tax assets when management considers it is more likely than not that they will not be realized. The Company recognizes a deferred tax liability on undistributed earnings of subsidiaries when there is a presumption that taxable earnings will be remitted to the parent. A deferred tax asset is recognized on compensation for the grant of stock awards to the extent that such charge constitutes a temporary difference in the subsidiaries’ local tax jurisdictions. Changes in the stock price do not result in any adjustments to the deferred tax asset prior to vesting. At each reporting date, the Company assesses all significant income tax positions in all tax jurisdictions to determine any uncertain tax positions. The Company uses a two-step process for the evaluation of uncertain tax positions. The first step consists in assessing whether the tax benefit must be recognized. The second step consists in measuring the amount of tax benefit to be recognized on each uncertain tax position. In step 1 (recognition), the Company assesses whether a tax position, based solely on its technical merits, is more likely than not to be sustained upon examination. Only tax positions with a sustainability threshold higher than 50 50 Company accrues for interest and penalties on uncertain tax liabilities reported on the consolidated balance sheets. Interests and penalties are classified as components of income tax expense in the consolidated statements of income . 2. 8 Business combinations and goodwill The acquisition method of accounting is applied to all business combinations. The identifiable assets acquired, liabilities assumed, and equity instruments issued are measured at acquisition date fair value. Any contingent consideration is recorded at acquisition date fair value and remeasured at each reporting date. Acquisition-related transaction costs and restructuring costs related to the acquired business are expensed as incurred. Acquired in-process research and development (“IPR&D”) is capitalized and recorded as an intangible asset at acquisition date, subject to impairment testing until the research or development is completed. The excess of the consideration transferred over the acquisition-date fair value of the identifiable assets acquired and liabilities assumed, net of related deferred tax impacts, is recorded as goodwill. In case of a bargain purchase, the Company reassesses whether it has correctly identified all of the assets acquired and all of the liabilities assumed, the noncontrolling interest in the acquiree, if any, the Company’s previously held equity interest in the acquiree, if any, and the consideration transferred. If after this review, a bargain purchase is still indicated, it is recognized in earnings attributable to parent company stockholders. The purchase of additional interests in a partially owned subsidiary is treated as an equity transaction as well as all transactions concerning the sale of subsidiary stock or the issuance of stock by the partially owned subsidiary, assuming there is no change in control of the subsidiary. In the case of a sale of subsidiary shares, whereby the Company no longer maintains control of the subsidiary, the Company recognizes a gain or loss in earnings. Goodwill is carried at cost less accumulated impairment losses, if any. Goodwill is not amortized but is tested for impairment at least annually, and more frequently whenever events or changes in circumstances indicate that the carrying amount of goodwill may not be recoverable. Goodwill subject to potential impairment is tested at the reporting unit level. The impairment test determines whether the fair value of each reporting unit under which goodwill is allocated is lower than the total carrying amount of relevant net assets allocated to such reporting unit, including its allocated goodwill. The Company records an impairment loss on goodwill when a reporting unit’s carrying value exceeds its fair value. Significant management judgments and estimates are used in forecasting the future discounted cash flows associated with the reporting unit, including: the applicable industry’s sales volume forecast and selling price evolution, the reporting unit’s market penetration and its revenues evolution, the market acceptance of certain new technologies and products, the relevant cost structure, the discount rates applied using a weighted average cost of capital and the perpetuity rates used in calculating cash flow terminal values. 2. 9 Intangible assets with definite useful lives Intangible assets subject to amortization include intangible assets purchased from third parties recorded at cost and intangible assets acquired in business combinations initially recorded at fair value. Amortization begins when the intangible asset is available for its intended use. Amortization reflects the pattern in which the asset’s economic benefits are consumed, which usually consists in applying the straight-line method to allocate the cost of the intangible assets over their estimated useful lives. The carrying value of intangible assets with definite useful lives is evaluated whenever changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized for the amount by which the asset’s carrying amount exceeds its fair value. The Company evaluates the remaining useful life of an intangible asset at each reporting date to determine whether events and circumstances warrant a revision to the remaining period of amortization Technologies and licenses Separately acquired technologies and licenses are recorded at historical cost. Technologies and licenses acquired in a business combination are initially recognized at acquisition date fair value. Technologies and licenses have a useful life which usually ranges from 3 to 8 years Computer software Separately acquired computer software is recorded at historical cost. Costs associated with maintaining computer software programs are expensed as incurred and reported as “Cost of sales”, “Selling, general and administrative”, or “Research and development” in the consolidated statements of income according to their intended use. The capitalization of costs for internally generated software developed by the Company for its internal use begins when the preliminary project stage is completed and when the Company, implicitly or explicitly, authorizes and commits to funding a computer software project. It must be probable that the project will be completed and will be used to perform the function intended. Amortization of computer software begins when the software is available for its intended use and is calculated using the straight-line method over the estimated useful life, which does not excee d 4 years . 2.1 0 Property, plant and equipment Property, plant and equipment are stated at historical cost, net of accumulated depreciation and any impairment losses. Property, plant and equipment acquired in a business combination are initially recognized at acquisition date fair value. Land is not depreciated. Depreciation on fixed assets is computed using the straight-line method over their estimated useful lives, as follows : Buildings 33 years Facilities and leasehold improvements 5-10 years Machinery and equipment 2-10 years Computer and R&D equipment 3-6 years Other 2-5 years Property, plant and equipment are periodically reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or a group of assets may not be recoverable. Several impairment indicators exist for making this assessment, such as: restructuring plans, significant changes in the technology, market, economic or legal environment in which the Company operates, available evidence of obsolescence of the asset, or indication that its economic performance is, or will be, worse than expected. In determining the recoverability of assets to be held and used, the Company initially assesses whether the carrying value of the tangible assets or group of assets exceeds the undiscounted cash flows associated with these assets. If exceeded, the Company then evaluates whether an impairment charge is required by determining if the asset’s carrying value also exceeds its fair value. This fair value is normally estimated by the Company based on independent market appraisals or the sum of discounted future cash flows, using market assumptions such as the utilization of the Company’s fabrication facilities and the ability to upgrade such facilities, change in the selling price and the adoption of new technologies. The Company also evaluates, and adjusts if appropriate, the assets’ useful lives When property, plant and equipment are retired or otherwise disposed of, the net book value of the assets is removed from the Company’s books. Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are included in “Other income and expenses, net” in the consolidated statements of income . The Company did not hold any significant assets held for sale as of December 31, 2022 and December 31, 2021. 2.1 1 Leases A lease contract is a contract, or part of a contract, that conveys the right to control the use of an identified asset for a period of time in exchange for consideration. If a lease is identified, classification between finance or operating is determined at lease commencement. Most leases entered by the Company are operating leases. Operating lease liabilities are recognized at the present value of the future lease payments at the lease commencement date. The rate implicit in the lease should be used as a discount rate whenever that rate is readily determinable. In most cases, this rate is not readily determinable and therefore, the Company Right-of-use assets are included in the line “Property, plant and equipment, net” of the consolidated balance sheet. Operating lease liabilities due within one year are included in the line “Other payables and accrued liabilities”, while noncurrent operating lease liabilities are included in the line “Other long-term liabilities” of the Company’s consolidated balance sheets. Operating lease expenses are recognized in the consolidated statements of income, on a straight-line basis over the lease period and reported as “Cost of sales”, “Selling, general and administrative”, or “Research and development”, according to the intended use of the leased asset . Finance lease liabilities due within one year are included in the line “Short-term debt”, while noncurrent finance lease liabilities are included in the line “Long-term debt” of the Company’s consolidated balance sheets. Right-of-use assets for finance leases are depreciated on a straight-line basis since the lease commencement date over the lease period or the estimated useful life of the leased asset in case of transfer of ownership or purchase option that is reasonably certain to be exercised. The depreciation expense is reported as “Cost of sales”, “Selling, general and administrative”, or “Research and development”, according to the intended use of the leased asset . Certain lease contracts contain options to extend the lease. On these contracts, t commencement date only. Additionally, lease contracts with a sum of lease payments not exceeding$5,000 are The right-of-use asset is a nonmonetary asset while the lease liability is a monetary liability. When accounting for a lease that is denominated in a foreign currency, the lease liability is remeasured using the current exchange rate, while the right-of-use asset is measured using the historical exchange rate as of the commencement date. The Company does not separate lease and non-lease components and instead accounts for each separate lease component and the non-lease components associated with that lease component as a single lease component. Variable lease payments that depend on an index or a rate are included in the lease payments and are measured using the prevailing index or rate at the measurement date. Changes to index and rate-based variable lease payments are recognized in earnings in the period of the change . 2.1 2 Loss contingencies In determining loss contingencies, the Company considers the likelihood of the incurrence of a liability as well as the ability to reasonably estimate the amount of such loss or liability. An estimated loss from a loss contingency is accrued when information available indicates that it is probable that a liability has been incurred at the date of the consolidated financial statements and when the amount of the loss can be reasonably estimated . 2.1 3 Long-term debt (a) Convertible debt The Company adopted on January 1, 2022 the new guidance on distinguishing liabilities from equity by applying the modified retrospective approach, with the impact upon transition recorded in retained earnings for instruments outstanding as of the adoption date. Prior to the new guidance adoption, the Company evaluated, at initial recognition of a convertible debt, the different components and features of the hybrid instruments and determined whether certain elements were embedded derivative instruments which required bifurcation. Components of convertible debt instruments that may be settled in cash upon conversion based on a net-share settlement basis were accounted for separately as long-term debt and equity when the conversion feature of the convertible bonds constituted an embedded equity instrument. When an equity instrument was identified, proceeds from issuance were allocated between debt and equity by measuring first the liability component and then determining the equity component as a residual amount. The liability component was measured as the fair value of a similar non-convertible debt, which resulted in the recognition of a debt discount. In subsequent periods, the Company amortized the debt discount through earnings in the line “Interest income (expense), net” of the consolidated statements of income, using the effective interest method, based on the contractual maturity of the debt. The equity component, reported on the line “Additional paid-in capital” of the consolidated statement of equity, was not remeasured. Deferred taxes were recognized on the difference between the carrying amount of the liability component and its tax basis . difference between the carrying amount of the debt at the settlement date and the fair value of the debt component was recorded in earnings as a loss on debt extinguishment and reported in the line “Loss on financial instruments, net” of the consolidated statements of income. The liability component was measured as the fair value of a similar non-convertible debt prior to settlement. The reacquired equity component was recorded in equity and reported on the line “Additional paid-in capital” of the consolidated statement of equity . The new accounting guidance adopted on January 1, 2022 has eliminated the cash conversion model in ASC 470-20 applicable to the convertible debt issued by the Company, which required separate accounting for embedded conversion features. At initial recognition, total cash proceeds received at issuance are reported as financial debt and no equity conversion instrument is recorded separately in equity. Impact of the new guidance upon adoption is further described in Note 2.25. Debt issuance costs are reported as a deduction of debt. They are subsequently amortized through earnings on the line “Interest income (expense), net” of the consolidated statements of income, using the effective interest rate method . (b) Bank loans Bank loans and non-convertible senior bonds are recognized at the amount of cash proceeds received, net of debt issuance costs incurred. They are subsequently reported at amortized cost; any difference between the proceeds (net of debt issuance costs) and the principal amount is recognized through earnings on the line “Interest income (expense), net” of the consolidated statements of income over the period of the borrowings using the effective interest method . 2.1 4 Employee benefits (a) Pension obligations The Company sponsors various pension schemes for its employees. These schemes conform to local regulations and practices in the countries in which the Company operates. Such plans include both defined benefit and defined contribution plans. For defined benefit pension plans, the liability recognized in the consolidated balance sheets is the present value of the defined benefit obligation at the balance sheet date less the fair value of plan assets. The overfunded or underfunded status of the defined benefit plans are calculated as the difference between plan assets and the projected benefit obligations. Estimates are used in determining the assumptions incorporated in the calculation of the pension obligations, which is supported by input from independent actuaries. Actuarial gains and losses arising from changes in actuarial assumptions are recognized in “Accumulated other comprehensive income (loss)” in the consolidated statements of equity and are charged or credited to earnings over the employees’ expected average remaining working lives. Past service costs are recognized in “Accumulated other comprehensive income (loss)” in the consolidated statements of equity and are amortized on a straight-line basis over the vesting period. The net periodic benefit cost of the year is determined based on the assumptions used at the end of the previous year. Past service costs are recognized in earnings on the line “Other components of pension benefit costs” of the consolidated statements of income if the changes to the pension scheme are not conditional on the employees remaining in service for a specified period (the vesting period) . For defined contribution pension plans, the Company pays contributions to publicly or privately administered pension insurance plans on a mandatory, contractual or voluntary basis. The Company has no further payment obligations once the contributions have been paid. The contributions are recognized as employee benefit expense when they are due. Prepaid contributions are recognized as an asset to the extent that a cash refund or a reduction in the future payments is available . The service cost component of net periodic benefit costs is presented in the same income statement line as other employee compensation costs arising from services rendered during the period. The other components of the net periodic benefit cost are presented separately, outside operating income, on the line “Other components of pension benefit costs” of the consolidated statements of income. These elements include: interest cost; expected return on plan assets; amortization of transition (asset) obligation; amortization of prior service cost; amortization of net (gain) loss; (gain) loss recognized due to curtailment or settlement and; cost of special termination benefits . ( b ) Termination benefits Termination benefits are payable when an employee is involuntarily terminated, or whenever an employee accepts voluntary termination in exchange for termination benefits. For the accounting treatment and timing recognition of involuntary termination benefits, the Company distinguishes between one-time termination benefit arrangements and ongoing termination benefit arrangements. A one-time termination benefit arrangement is established by a termination plan and applies to a specified termination event. One-time involuntary termination benefits are recognized as a liability when the termination plan meets certain criteria and has been communicated to employees. If employees are required to render future service in order to receive these one-time termination benefits, the liability is recognized ratably over the future service period. Termination benefits other than one-time termination benefits are termination benefits for which the communication criterion is not met but that are committed to by management, or termination obligations that are not specifically determined in a new and single plan. These termination benefits are all legal, contractual and past practice termination obligations to be paid to employees in case of involuntary termination. These termination benefits are accrued for when commitment creates a present obligation to others for the benefits expected to be paid, when it is probable that employees will be entitled to the benefits and the amount can be reasonably estimated . In case of special termination benefits related to voluntary redundancy programs, the Company recognizes a provision for voluntary termination benefits at the date on which the employee irrevocably accepts the offer and the amount can be reasonably estimated . (c) Profit-sharing and bonus plans The Company recognizes a liability and an expense for bonuses and profit-sharing plans when a contractual obligation exists or where there is a past practice that has created a present obligation (d) Other long-term employee benefits The Company provides long-term employee benefits such as seniority awards in certain countries. The entitlement to these benefits is usually conditional on the employee completing a minimum service period. The expected costs of these benefits are accrued over the period of employment. Actuarial gains and losses arising from changes in actuarial assumptions are charged or credited to earnings in the period of the revised estimate. These obligations are valued annually with the assistance of independent qualified actuaries (e) Share-based compensation The Company accounts for stock-based compensation for all stock-based awards granted to senior executives and selected employees, including awards that vest upon the satisfaction of a service condition and awards that vest upon the satisfaction of both a service condition and a performance condition. Both equity awards vest over a three-year measures the cost of the awards based on the grant-date fair value of the awards, reflecting the market price of the underlying shares at the date of the grant, reduced by the present value of the dividends expected to be paid on the shares during the requisite service period. That cost is recognized using graded vesting over the period during which an employee is required to provide service in exchange for the award or the requisite service period. The compensation cost is recorded through earnings with the corresponding amount reported in equity, under “Additional paid-in capital” of the consolidated statements of equity. The compensation cost is calculated based on the number of awards expected to vest, net of an estimated number of awards to be forfeited due to the employees failing to satisfy the service condition or one or more performance conditions. By the end of the vesting period, compensation is recognized only for the awards that ultimately vest. Liabilities for the Company’s portion of payroll taxes are recognized at vesting, which is the event triggering the payment of the social contributions in most of the Company’s local tax jurisdictions. Employee-related social charges are measured based on the intrinsic value of the share and recorded at vesting 2.1 5 Share capital Ordinary shares are classified as “Common stock” within equity on the consolidated balance sheets. Incremental costs directly attributable to the issuance of new shares are shown in equity as a deduction, net of tax, from the proceeds received. Where the Company purchases its own equity share capital (treasury stock), the consideration paid, including any directly attributable incremental costs (net of income taxes), is deducted from parent company stockholders’ equity until the shares are cancelled, reissued, or disposed of. 2.1 6 Comprehensive income (loss) Comprehensive income (loss) is defined as the change in equity of a business during a period except those changes resulting from investment by and distributions to stockholders. In the consolidated financial statements, Other comprehensive income (loss) and “Accumulated other comprehensive income” primarily consists of foreign currency translation adjustments, unrealized gains (losses) on debt securities classified as available-for-sale, unrealized gains (losses) on derivatives designated as cash flow hedge and the accounting for defined benefit plans as described in Note 2.14, net of tax 2.1 7 Revenue recognition Arrangements with customers are considered contracts if all the following criteria are met: (a) parties have approved the contract and are committed to perform their respective obligations; (b) each party’s rights regarding the goods or services to be transferred can be identified; (c) payment terms for the goods or services to be transferred can be identified; (d) the contract has commercial substance and (e) collectability of substantially all of the consideration is probable. The Company recognizes revenue from products sold to a customer, including distributors, when it satisfies a performance obligation by transferring control over a product to the customer. In certain circumstances, the Company may enter into agreements that concern principally revenues from services, where the performance obligation is satisfied over time. The objective when allocating the transaction price is to allocate the transaction price to each performance obligation (or distinct good or service) in an amount that depicts the amount of consideration to which the Company expects to be entitled in exchange for transferring the promised goods or services to the customer. The payment terms typically range between Certain customers require the Company to hold inventory as consignment in their hubs and only purchase inventory when they require it. Revenue for sales of such inventory is recognized when, at the customer’s option, the products are withdrawn from the consignment and the Company satisfies a performance obligation by transferring control over a product to the customer Consistent with standard business practice in the semiconductor industry, price protection is granted to distribution customers on thei

Short-Term Deposits and Marketa

Short-Term Deposits and Marketable Securities	12 Months Ended
	Dec. 31, 2022
Investments Debt And Equity Securities [Abstract]
Short-Term Deposits and Marketable Securities	3. SHORT-TERM DEPOSITS AND MARKETABLE SECURITIES To optimize the return yield on its short-term investments, the Company invested $581 million of available cash in short-term deposits as of December 31, 2022, compared to $291 million as of December 31, 2021. These short-term deposits represent liquid assets with original maturity beyond three months and no significant risk of changes in fair value. Changes in the fair value of marketable securities are detailed in the tables below: December 31, 2021 Purchase Accretion Proceeds at maturity Change in fair value included in OCI* December 31, 2022 U.S. Treasury debt securities — 687 8 — (16 ) 679 Total — 687 8 — (16 ) 679 * Other Comprehensive Income December 31, 2020 Purchase Accretion Proceeds at maturity Change in fair value included in OCI* December 31, 2021 U.S. Treasury debt securities 133 — — (132 ) (1 ) — Total 133 — — (132 ) (1 ) — * Other Comprehensive Income In 2022, the Company invested Marketable securities totaling $750 million at principal amount were transferred to financial institutions as part of short-term securities lending transactions, in compliance with corporate policies. The Company, acting as the securities lender, does not hold any collateral in this unsecured securities lending transaction. The Company retains effective control on the transferred securities. The Company did not hold debt securities as of December 31, 2021.

Trade Accounts Receivable, Net

Trade Accounts Receivable, Net	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
Trade Accounts Receivable, Net	4. TRADE ACCOUNTS RECEIVABLE, NET Trade accounts receivable, net consisted of the following: December 31, December 31, 2022 2021 Trade accounts receivable 1,991 1,778 Current expected credit losses allowance ( “ ” (21 ) (19 ) Total 1,970 1,759 The Company uses a lifetime expected losses allowance for all trade receivables based on failure rates, as applied to the gross amounts of trade accounts receivable. The allowance also includes reasonable assumptions about future credit trends . . economic factors are weighted into different economic scenarios, in line with estimates and methodologies applied by other business entities, including financial institutions . On that basis, the changes in reported CECLA for the year ended December 31, 2022 are presented below: CECLA As of December 31, 2021 (19) Current-period adjustment to CECLA (2) CECLA As of December 31, 2022 (21) Adjustments to the expected credit losses allowance are reported in the line “Selling, general and administrative” in the consolidated statements of income. There were no significant write-offs in 2022, 2021 and 2020.

Inventories

Inventories	12 Months Ended
	Dec. 31, 2022
Inventory Disclosure [Abstract]
Inventories	5. INVENTORIES Inventories consisted of the following: December 31, December 31, 2022 2021 Raw materials 349 223 Work-in-process 1,490 1,235 Finished products 744 514 Total 2,583 1,972 Reserve for obsolescence is estimated for excess uncommitted inventories based on history of sales, backlog of orders and production plans.

Other Current Assets

Other Current Assets	12 Months Ended
	Dec. 31, 2022
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract]
Other Current Assets	6. OTHER CURRENT ASSETS Other current assets consisted of the following: December 31, 2022 December 31, 2021 Public funding receivables 190 296 Taxes and other government receivables 270 119 Advances and prepayments 125 118 Loans and deposits 10 8 Interest receivable 22 1 Derivative instruments 56 6 Other current assets 61 33 Total 734 581 Derivative instruments are further described in Note 27. The Company applies a current expected credit losses model on all financial assets measured at amortized cost, including deposits, loans and receivables. The major portion of other current assets to which this model applies corresponds to government receivables. Due to the existing history of zero-default on receivables originated by governments, the expected credit losses are assumed to be not significant as of December 31, 2022 and December 31, 2021. Other current assets presented in the table above within the lines “Loans and deposits” and “Other current assets” are composed of individually insignificant amounts at exposure of default. Consequently, no significant loss allowance was reported on those current assets as of December 31, 2022 and December 31, 2021. Public funding receivables are described in Note 7. Taxes and other government receivables include receivables related to value-added tax, primarily in European tax jurisdictions.

Public Funding

Public Funding	12 Months Ended
	Dec. 31, 2022
Government Assistance [Abstract]
Public Funding	7. PUBLIC FUNDING The Company receives public funding mainly from French, Italian and other European Union governmental entities. Such funding is usually provided to encourage research and innovation activities, industrialization and other local economic development. Government assistance is generally available to all companies, regardless of their ownership structure or country of incorporation. The conditions for the receipt of government funding may include restrictions on eligible expenditures, approval by European Union authorities, annual budget appropriations, compliance with European Union regulations, royalties or contingent return provisions as well as specifications regarding objectives and results. Certain specific contracts may imply compliance with extensive regulatory requirements. They may also set forth conditions relating to the funded programs, including penalties in case certain conditions are not fulfilled, or repayment obligations. The main government assistance received by the Company are classified under four general categories: funding for Research and Development (R&D), R&D and Innovation activities (RDI), funding for First Industrial Deployment activities (FID) and capital investments for pilot lines and other industrial activities. The Company also benefits from research tax credits and other tax incentives to foster research and innovation activities, together with capital investments in certain tax jurisdictions, primarily in France and Italy. These research tax credits and tax incentive schemes are further described in Note 23. French research tax credits (“Crédit Impôt Recherche”) and Italian research tax credits (“Credito d’Imposta Ricerca & Sviluppo”) are deemed to be grants in substance. The Italian research tax credit scheme ended in 2019. The French research tax credits are to be paid in cash by the taxing authorities within three years . Receivables related to public funding totaled $346 million as of December 31, 2022, of which $190 million reported on the line “Other current assets” and $156 million reported on the line “Other non-current assets”, as collection is expected beyond 12 months. Research tax credit receivables totaled $294 million and were reported on the line “Other non-current assets” of the consolidated balance sheet as of December 31, 2022. Liabilities related to public funding totaled $88 million as of December 31, 2022, of which $37 million advances from grants reported on the line “Other payables and accrued liabilities” and $51 million reported on the line “Other long-term liabilities” of the consolidated balance sheet. Long-term liabilities related to public funding included $46 million grants received mainly as part of the Nano2017 program with the French government, which is subject to a financial return and depends on future cumulative sales of a certain product group over a five-year period. Additionally, $95 million capital investment grants were reported as a reduction of Property, plant and equipment, net as of December 31, 2022. Tax incentives reducing the carrying amount of Property, plant and equipment are further described in Note 10 and in Note 23. For the year ended December 31, 2022, the Company recorded $177 million of public funding related to R&D and innovation activities, reported on the line “Other income and expenses, net” of the consolidated statement of income. The research tax credit received in France totaled $106 million and was reported as a reduction of “Research and development” in the consolidated statement of income for the year ended December 31, 2022. The Company reported as a reduction of cost of sales in the consolidated statement of income for the year ended December 31, 2022 a total $59 million amount related to capital investment and industrialization funding programs. The impact on depreciation expense of tax incentives received in certain tax jurisdictions and reducing the carrying amount of “Property, plant and equipment, net”, are further described in Note 10 and in Note 23.

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2022
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill	8. GOODWILL Goodwill allocated to reportable segments as of December 31, 2022 and 2021 and changes in the carrying amount of goodwill during the years ended December 31, 2022 and 2021 are as follows: ADG AMS MDG Total December 31, 2020 91 2 237 330 Measurement period adjustment — — 1 1 Foreign currency translation (8) — (10) (18) December 31, 2021 83 2 228 313 Measurement period adjustment — — — — Foreign currency translation (9) — (7) (16) December 31, 2022 74 2 221 297 In 2022, 2021 and 2020, no impairment loss was recorded by the Company.

Other Intangible Assets, Net

Other Intangible Assets, Net	12 Months Ended
	Dec. 31, 2022
Goodwill And Intangible Assets Disclosure [Abstract]
Other Intangible Assets, Net	9. OTHER INTANGIBLE ASSETS, NET Other intangible assets, net consisted of the following: December 31, 2022 Gross Amount Accumulated Amortization Net Amount Technologies & licenses 1,064 (795 ) 269 Purchased & internally developed software 609 (514 ) 95 Technologies in progress 41 — 41 Total 1,714 (1,309 ) 405 December 31, 2021 Gross Amount Accumulated Amortization Net Amount Technologies & licenses 1,050 (746 ) 304 Purchased & internally developed software 567 (485 ) 82 Technologies in progress 52 — 52 Total 1,669 (1,231 ) 438 The line “Technologies in progress” in the table above also includes internally developed software under construction and software not ready for their intended use. Amortization expense related to intangible assets subject to amortization was $103 million, $93 million and $79 million for the years ended December 31, 2022, 2021 and 2020, respectively. Estimated future amortization expense related to intangible assets as of December 31, 2022 is as follows: Year 2023 112 2024 98 2025 72 2026 42 2027 20 Thereafter 61 Total 405 In 2022, the Company recorded a $38 million impairment loss reported in the line “Research and development” of the consolidated statements of income. The impairment loss was related to certain technologies acquired as part of one of the Company’s recent business combinations. In 2021 and 2020, the Company impaired $1 million and $4 million, respectively, of acquired licenses and technologies with no alternative future use.

Property, Plant and Equipment,

Property, Plant and Equipment, Net	12 Months Ended
	Dec. 31, 2022
Property Plant And Equipment [Abstract]
Property, Plant and Equipment, Net	10. PROPERTY, PLANT AND EQUIPMENT, NET Property, plant and equipment, net consisted of the following: December 31, 2022 Gross Amount Accumulated Depreciation Net Amount Land 83 — 83 Buildings 1,116 (563 ) 553 Facilities & leasehold improvements 3,877 (2,895 ) 982 Machinery and equipment 18,751 (14,023 ) 4,728 Computer and R&D equipment 398 (319 ) 79 Operating lease right-of-use assets 311 (118 ) 193 Finance lease right-of-use assets 57 (2 ) 55 Other tangible assets 169 (95 ) 74 Construction in progress 1,454 — 1,454 Total 26,216 (18,015 ) 8,201 December 31, 2021 Gross Amount Accumulated Depreciation Net Amount Land 84 — 84 Buildings 951 (562 ) 389 Facilities & leasehold improvements 3,490 (2,936 ) 554 Machinery and equipment 17,085 (13,786 ) 3,299 Computer and R&D equipment 395 (333 ) 62 Operating lease right-of-use assets 314 (114 ) 200 Other tangible assets 147 (97 ) 50 Construction in progress 1,022 — 1,022 Total 23,488 (17,828 ) 5,660 The line “Construction in progress” in the table above includes property, plant and equipment under construction and equipment under qualification and not ready for their intended use. In 2022, the Company transferred from construction in progress to definitive long-lived assets, approximately $650 million corresponding to assets dedicated to its new 300mm fab in Agrate, Italy, where operations started in December 2022. The depreciation charge was $1,113 million, $952 million and $844 million in 2022, 2021 and 2020, respectively. Tax incentives and capital investment funding reported as a reduction of capital expenditures totaled $25 million, $13 million and $10 million for the years ended December 31, 2022, 2021 and 2020, respectively . Capital investment public funding is described in Note 7. Tax incentives related to capital expenditures is further described in Note 23. For the years ended December 31, 2022, 2021 and 2020, the Company sold property, plant and equipment for cash proceeds of $4 million, $2 million and $4 million, respectively. There was no significant impairment recognized for the years ended December 31, 2022, 2021 and 2020.

Leases

Leases	12 Months Ended
	Dec. 31, 2021
Lessee Disclosure [Abstract]
Leases	11. LEASES The Company leases land, buildings, cars and certain equipment (including IT equipment) which have remaining lease terms between less than one year and 47 years. Operating and finance leases consisted of the following: December 31, 2022 December 31, 2021 Right-of-use assets Operating leases 193 200 Finance Leases 55 — Total right-of-use assets 248 200 Lease liabilities Current 59 55 Operating leases 52 55 Finance Leases 7 — Non-current 191 148 Operating leases 141 148 Finance Leases 50 — Total lease liabilities 250 203 Maturities of operating lease liabilities are as follows: Operating Leases Finance Leases December 31, 2022 2023 57 8 65 2024 40 5 45 2025 27 5 32 2026 19 5 24 2027 12 28 40 Thereafter 86 23 109 Total future undiscounted cash outflows 241 74 315 Effect of discounting (48 ) (17 ) (65 ) Total operating lease liabilities 193 57 250 Operating and finance lease terms and discount rates are as follows: December 31, 2022 December 31, 2021 Weighted average remaining lease term (in years) – operating leases 9.46 9.38 Weighted average remaining lease term (in years) – finance leases 9.89 — Weighted average discount rate – operating lease 3.12 % 2.69 % Weighted average discount rate – finance lease 3.86 % — Operating and finance lease cost and cash paid are as follows: 2022 2021 Operating lease cost 62 68 Finance lease cost Amortization of right-of-use assets 2 — Interest 1 — Operating lease cash paid 63 67 Finance lease cash paid — — Right-of-use assets obtained in exchange for new operating lease liabilities are as follows: 2022 2021 Operating leases 60 80 Finance leases 55 —

Long-Term Investments

Long-Term Investments	12 Months Ended
	Dec. 31, 2022
Investments Debt And Equity Securities [Abstract]
Long-Term Investments	12. LONG-TERM INVESTMENTS December 31, 2022 December 31, 2021 Long-term investments 11 10 Total 11 10 Long-term investments are equity securities with no readily determinable fair value for which the Company has elected to apply the cost method as a measurement alternative. It includes principally the Company’s investment in DNP Photomask Europe S.p.A (“DNP”). The Company has identified DNP as a VIE but has determined that it is not the primary beneficiary. The significant activities of DNP revolve around creation of masks and development of high level mask technology. The Company does not have the power to direct these activities. The Company’s current maximum exposure to losses as a result of its involvement with DNP is limited to its investment. The Company has not provided additional financial support to DNP in 2022 and 2021 and has no current requirement or intent to provide further financial support to DNP.

Other Non-Current Assets

Other Non-Current Assets	12 Months Ended
	Dec. 31, 2022
Investments All Other Investments [Abstract]
Other Non-Current Assets	13. OTHER NON-CURRENT ASSETS Other non-current assets consisted of the following: December 31, December 31, 2022 2021 Equity securities 26 29 Receivables from government agencies 156 124 French research tax credit receivable 294 376 Defined benefit plans 9 15 Prepayments and deposits to third parties 107 21 Derivative instruments 13 — Other non-current assets 56 74 Total 661 639 Long-term receivables from government agencies, including the French research tax credit scheme, which is considered to be, in substance, public funding, are described in Note 7. Prepayments and deposits to third parties include receivables related to long-term supply agreements involving purchase of raw materials, capacity commitments, cloud-hosting arrangements, and other services. In 2022 and 2021, and 2020, the Company entered into factoring transactions to accelerate the realization in cash of certain long-term receivables . The major portion of other non-current assets to which the expected credit loss model applies are long-term State receivables . . .

Other Payables and Accrued Liab

Other Payables and Accrued Liabilities	12 Months Ended
	Dec. 31, 2022
Payables And Accruals [Abstract]
Other Payables and Accrued Liabilities	14. OTHER PAYABLES AND ACCRUED LIABILITIES Other payables and accrued liabilities consisted of the following: December 31, 2022 December 31, 2021 Employee related liabilities 599 536 Employee compensated absences 196 181 Taxes other than income taxes 68 58 Advances from customers 225 25 Advances from grants 37 34 Derivative instruments 35 43 Defined benefit and contribution plans 39 34 Royalties 32 29 Current operating lease liabilities 52 55 Deferred and contingent consideration on business combinations — 27 Others 102 79 Total 1,385 1,101 Derivative instruments are further described in Note 27. Defined benefit and defined contribution plans and other long-term employee benefits are further described in Note 16. Lease liabilities are described in Note 11. In 2022, the Company paid $25 million of deferred and contingent consideration related to business acquisitions. Liabilities related to public funding are described in Note 7. Advances from customers are primarily related to multi-annual capacity reservation and volume commitment agreements signed in 2022 with certain customers. Some of these arrangements include take-or-pay clauses, according to which the Company is entitled to receive the full amount of the contractual committed fees in case of non-compliant orders from those customers. Certain agreements include penalties in case the Company is not able to fulfill its contractual obligations. No significant provision for those penalties was reported on the consolidated balance sheet as of December 31, 2022.

Long-Term Debt

Long-Term Debt	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Long-Term Debt	15. LONG-TERM DEBT Long-term debt consisted of the following: December 31, December 31, 2022 2021 Funding program loans from European Investment Bank ("EIB"): 2.67% due 2028, floating interest rate at Euribor + 0.589% 163 202 1.20% 0.564% 183 222 1.31% 0.583% 322 379 0.89% 0.660% 159 187 Credit Facility from Cassa Depositi e Prestiti SpA ("CDP") 3.15% 0.690% 120 156 1.85% 0.550% 107 — 2.15% 0.850% 107 — Dual tranche senior unsecured convertible bonds Zero-coupon, due 2025 (Tranche A) 748 713 Zero-coupon, due 2027 (Tranche B) 747 674 Finance leases: 3.86% 38 — 3.78% 19 — Other funding program loans: 0.32% 4 6 Total long-term debt 2,717 2,539 Less current portion (175 ) (143 ) Total long-term debt, less current portion 2,542 2,396 Long-term debt is denominated in the following currencies: December 31, 2022 December 31, 2021 U.S. dollar 1,495 1,387 Euro 1,222 1,152 Total 2,717 2,539 On August 4, 2020, the Company issued a $1.5 billion principal amount of dual tranche senior unsecured convertible bonds (Tranche A and Tranche B for $750 million each tranche), due 2025 and 2027, respectively . . . . . On January 1, 2022, the Company adopted the new guidance on distinguishing liabilities from equity to simplify an issuer’s accounting for convertible instruments by eliminating the cash conversion and beneficial conversion feature models in ASC 470-20. The Company adopted the new guidance by applying the modified retrospective method on instruments outstanding at transition date. These instruments correspond solely to the dual-tranche senior unsecured convertible bonds issued on August 4, 2020, which are convertible instruments with cash conversion features in the scope of the new guidance . Under previous guidance, proceeds were allocated between debt and equity by measuring first the liability component and then determining the equity component as a residual amount. The fair value of the liability component at initial recognition totaled $1,362 million before the allocation of issuance costs and deferred tax effect. An amount of $215 million, before the allocation of $1 million issuance costs and a $30 million deferred tax effect, was recorded in equity as the value of the conversion features of the instruments. Under the new guidance, the Company is no longer required to separately present in equity the cash conversion features embedded in the convertible bonds. Instead, the convertible bonds are wholly accounted for as debt and thus, are stated at principal amount less unamortized debt issuance costs. The new guidance does not affect the separation model for embedded conversion features of convertible debt instruments issued with substantial premium, for which the premium is required to be recorded as additional paid-in capital. The premium received by the Company upon issuance of the convertible bonds remains therefore in equity and amounts to $77 million, net of the corresponding deferred tax effect. The impact upon adoption on the Company’s consolidated financial statements was a $107 million increase in Long-term debt, to reflect the convertible debt at its $1,500 million nominal value, less $6 million of unamortized debt issuance costs, and a $15 million decrease in Long-term deferred tax liabilities, with a corresponding $92 million decrease in equity (composed of a $117 million decrease in Additional paid-in capital and a $25 million increase in Retained earnings). As of December 31, 2022, the Company stock price did not exceed the conversion prices of the dual-tranche senior unsecured convertible bonds issued on August 4, 2020. On July 3, 2017, the Company issued a $1.5 billion principal amount of dual tranche senior unsecured convertible bonds (Tranche A and Tranche B for $750 million each tranche), due 2022 and 2024, respectively . . . . . . . The call option available to the Company for the early redemption of Tranche A was exercised in July 2020 . The call option available to the Company for the early redemption of Tranche B was exercised in July 2021. As a consequence, bondholders exercised their conversion rights on the full Tranche B. Each conversion exercised by the bondholders followed the process defined in the original terms and conditions of the convertible bonds, which determined the actual consideration to be transferred to bondholders upon each conversion. Out of the 3,750 bonds composing Tranche B, the Company elected to settle 1,238 bonds on a net-share basis for a total consideration of $479 million, through the payment of the $248 million nominal value in cash and the delivery of approximately 5.8 million treasury shares. The remaining 2,512 bonds were settled on a full cash basis for a total consideration of $1,015 million. The Company allocated the total consideration transferred between debt and equity by measuring at fair value the liability component of Tranche B prior to settlement, then determining the equity component as a residual amount. The liability component was measured at fair value based on a discount rate adjustment technique (income approach), which corresponded to a Level 3 fair value hierarchy measurement and consisted in calculating the present value of cash flows using an average estimated discount rate of 1.1%, which approximated current market rates for similar bonds that have no conversion rights. The fair value of the liability component as measured prior to extinguishment was $689 million for the full Tranche B, which generated a loss amounting to $44 million, in addition to $1 million write-off of unamortized debt issuance costs, reported on the line “Loss on financial instruments, net” in the consolidated statement of income for the year ended December 31, 2021. Aggregate future maturities of total long-term debt (including current portion) at principal amount are as follows: December 31, 2022 2023 175 2024 172 2025 922 2026 172 2027 908 Thereafter 373 Total 2,722 The difference between the total aggregated future maturities in the preceding table and the total carrying amount of long-term debt is due to unamortized issuance costs on the dual tranche senior unsecured convertible bonds. Credit facilities The Company’s long-term debt contained standard conditions but does not impose minimum financial ratios The EIB Loans are comprised of three long-term amortizing credit facilities as part of R&D funding programs. The first one, signed in August 2017, is a €500 million loan in relation to R&D and capital expenditures in the European Union for the years 2017 and 2018. The entire amount was fully drawn in Euros corresponding to $346 million outstanding as of December 31, 2022. The second one, signed in 2020, is a €500 million credit facility agreement with EIB to support R&D and capital expenditure programs in Italy and France. The amount was fully drawn in Euros representing $481 million outstanding as of December 31, 2022. In 2022, the Company signed a third long-term amortizing credit facility with EIB of €600 million, out of which, no amount had been drawn as of December 31, 2022. The CDP loans are comprised of two long-term credit facilities. The first, signed in 2021, is a €150 million loan, fully drawn in Euros, of which $120 million were outstanding as of December 31, 2022. The second one, signed in 2022, is a €200 million loan, fully drawn in Euros, of which $214 million was outstanding as of December 31, 2022.

Post-Employment and Other Long-

Post-Employment and Other Long-Term Employees Benefits	12 Months Ended
	Dec. 31, 2022
Compensation And Retirement Disclosure [Abstract]
Post-Employment and Other Long-Term Employees Benefits	16. POST-EMPLOYMENT AND OTHER LONG-TERM EMPLOYEES BENEFITS The Company and its subsidiaries have a number of defined benefit pension plans, mainly unfunded, and other long-term employees’ benefits covering employees in various countries. The defined benefit plans provide pension benefits based on years of service and employee compensation levels. The other long-term employees’ plans provide benefits due during the employees’ period of service after certain seniority levels. The Company uses December 31 as measurement date for its plans. Eligibility is generally determined in accordance with local statutory requirements. For Italian termination indemnity plan (“TFR”), generated before July 1, 2007, the Company measures the vested benefits to which Italian employees are entitled as if the amounts were immediately due as of December 31, 2022, in compliance with U.S. GAAP guidance on determining vested benefit obligations for defined benefit pension plans. The changes in benefit obligation and plan assets were as follows: Pension Benefits Other Long-Term Benefits December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021 Change in benefit obligation: Benefit obligation at beginning of year 1,165 1,216 94 101 Service cost 33 36 17 13 Interest cost 27 21 1 1 Employee contributions 4 4 — — Benefits paid (22 ) (25 ) (6 ) (5 ) Effect of settlement (14 ) (8 ) — — Business combination — 3 — — Actuarial (gain) loss (260 ) (48 ) (15 ) — Foreign currency translation and other adjustments (47 ) (34 ) (5 ) (16 ) Benefit obligation at end of year 886 1,165 86 94 Change in plan assets: Plan assets at fair value at beginning of year 743 718 — — Return on plan assets (157 ) 32 — — Employer contributions 25 17 — — Employee contributions 4 4 — — Benefits paid (9 ) (12 ) — — Effect of settlement (14 ) (8 ) — — Business combination — 2 — — Foreign currency translation and other adjustments (25 ) (10 ) — — Plan assets at fair value at end of year 567 743 — — Funded status (319 ) (422 ) (86 ) (94 ) The actuarial gains in 2022 were primarily due to an increase in discount rates applied against future expected benefit payments and resulted in a decrease of the benefit obligation mainly for the plans located in France, in the United States and Switzerland. The actuarial gains in 2021 were primarily due to an increase in discount rates applied against future expected benefit payments and resulted in a decrease of the benefit obligation mainly for the plans located in France, in the United Kingdom and in the United States. Net amount recognized in the consolidated balance sheets consisted of the following: Pension Benefits Other Long-Term Benefits December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021 Non-current assets 9 15 — — Current liabilities (11 ) (11 ) (5 ) (4 ) Long-term liabilities (317 ) (426 ) (81 ) (90 ) Net amount recognized (319 ) (422 ) (86 ) (94 ) Pension plans net assets are reported in the Company’s consolidated balance sheets in the line “Other non-current assets” while current and non-current liability positions are reported in the lines “Other payables and accrued liabilities” and “Post-employment benefit obligations” respectively. Other long-term benefits current and non-current net liability positions are reported in our consolidated balance sheets in the lines “Other payables and accrued liabilities” and “Other long-term liabilities” respectively. The components of accumulated other comprehensive loss (income) before tax effects were as follows: Actuarial (gains)/losses Prior service cost Total Accumulated other comprehensive loss as of December 31, 2020 216 3 219 Net amount generated/arising in current year (56 ) — (56 ) Amortization (12 ) (1 ) (13 ) Foreign currency translation adjustment (6 ) — (6 ) Accumulated other comprehensive loss as of December 31, 2021 142 2 144 Net amount generated/arising in current year (84 ) — (84 ) Amortization (3 ) (1 ) (4 ) Foreign currency translation adjustment (10 ) — (10 ) Accumulated other comprehensive loss as of December 31, 2022 45 1 46 The accumulated benefit obligations were as follows: Pension Benefits Other Long-Term Benefits December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021 Accumulated benefit obligations 778 1,004 25 79 For pension plans and other long-term benefits with accumulated benefit obligations in excess of plan assets, the accumulated benefit obligation and fair value of plan assets were $409 million and $139 million, respectively, as of December 31, 2022 and $528 million and $134 million, respectively, as of December 31, 2021. For pension plans with projected benefit obligations in excess of plan assets, the benefit obligation and fair value of plan assets were $839 million and $427 million, respectively, as of December 31, 2022 and $1,030 million and $499 million, respectively, as of December 31, 2021. The components of the net periodic benefit cost included the following: Pension Benefits Other Long-term Benefits Year ended December 31, 2022 Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2022 Year ended December 31, 2021 Year ended December 31, 2020 Service cost 33 36 31 17 13 11 Interest cost 27 21 21 1 1 1 Expected return on plan assets (23 ) (24 ) (23 ) — — — Amortization of actuarial net loss (gain) 6 12 12 (14 ) — 3 Amortization of prior service cost 1 1 1 — — — Effect of settlement — — 1 — — — Net periodic benefit cost 44 46 43 4 14 15 Pension benefits components other than service cost, recognized outside of Operating income in “Other components of pension benefit costs” in the Company’s consolidated statements of income, were $11 million, $10 million and $12 million in the years ended December 31, 2022, 2021 and 2020, respectively. The weighted average assumptions used in the determination of the benefit obligation and the plan assets for the pension plans and the other long-term benefits were as follows: Assumptions 2022 2021 Discount rate 4.18 % 1.84 % Salary increase rate 2.31 % 2.27 % Expected long-term rate of return on funds for the pension expense of the following year 2.66 % 3.19 % The weighted average assumptions used in the determination of the net periodic benefit cost for the pension plans and the other long-term benefits were as follows: Assumptions 2022 2021 2020 Discount rate 1.84 % 1.45 % 1.95 % Salary increase rate 2.27 % 2.43 % 2.48 % Expected long-term rate of return on funds for the pension expense of the year 3.19 % 3.44 % 4.04 % The discount rate was determined by reference to market yields on high quality long-term corporate bonds applicable to the respective country of each plan, with terms consistent with the terms of the benefit obligations. In developing the expected long-term rate of return on assets, the Company modelled the expected long-term rates of return for broad categories of investments held by the plan against a number of various potential economic scenarios. The Company’s pension plan asset allocation as of December 31, 2022 and December 31, 2021 is as follows: Percentage of Plan Assets as of December 31, Asset Category 2022 2021 Cash and cash equivalents 1 % 1 % Equity securities 17 % 17 % Government debt securities 10 % 12 % Corporate debt securities 21 % 22 % Investments in funds (a) 16 % 21 % Real estate 1 % 1 % Other (mainly insurance assets – contracts and reserves) 34 % 26 % Total 100 % 100 % (a) As of December 31, 2022, investments in funds were composed of commingled and multi-strategy funds invested in diversified portfolios of fixed income ( 79 % % As of December 31, 2022, the Company’s plan asset allocation was in line with the targets set for each plan. The Company’s detailed pension plan asset allocation including the fair-value measurements of those plan assets as of December 31, 2022 is as follows: Total Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Cash and cash equivalents 4 4 — — Equity securities 95 1 94 — Government debt securities 59 — 59 — Corporate debt securities 120 — 98 22 Investment funds 87 1 86 — Real estate 6 — 6 — Other (mainly insurance assets – contracts and reserves) 194 — 38 156 TOTAL 565 6 381 178 The Company’s detailed pension plan asset allocation including the fair-value measurements of those plan assets as of December 31, 2021 is as follows: Total Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Cash and cash equivalents 5 5 — — Equity securities 130 2 128 — Government debt securities 87 — 87 — Corporate debt securities 164 — 139 25 Investment funds 156 1 155 — Real estate 10 — 10 — Other (mainly insurance assets – contracts and reserves) 191 — 49 142 TOTAL 743 8 568 167 The fair value of insurance contracts is based on the value of the assets held by the provider. The approach is consistent with prior years. For plan assets measured at fair value using significant unobservable inputs (Level 3), the reconciliation between January 1, 2022 and December 31, 2022 is presented as follows: Fair Value Measurements using Significant Unobservable Inputs (Level 3) January 1, 2022 167 Contributions (employer and employee) 21 Net benefit payments (a) 9 Settlements (14 ) Foreign currency translation adjustment (5 ) December 31, 2022 178 ( a ) For plan assets measured at fair value using significant unobservable inputs (Level 3), the reconciliation between January 1, 2021 and December 31, 2021 is presented as follows: Fair Value Measurements using Significant Unobservable Inputs (Level 3) January 1, 2021 162 Contributions (employer and employee) 15 Actual return on plan assets 2 Net benefit payments (a) 1 Settlements (8 ) Foreign currency translation adjustment (5 ) December 31, 2021 167 ( a ) The Company’s investment strategy for its pension plans is to optimize the long-term investment return on plan assets in relation to the liability structure to maintain an acceptable level of risk while minimizing the cost of providing pension benefits and maintaining adequate funding levels in accordance with applicable rules in each jurisdiction. The Company’s practice is to periodically conduct a review of its asset allocation strategy, in such a way that the asset allocation is in line with the targeted asset allocation within reasonable boundaries. The Company’s asset portfolios are managed in such a way as to achieve adapted diversity. The Company does not manage any assets internally. After considering the funded status of the Company’s defined benefit plans, movements in the discount rate, investment performance and related tax consequences, the Company may choose to make contributions to its pension plans in any given year in excess of required amounts. The Company’s contributions to plan assets were $25 million in 2022 and $17 million in 2021 and the Company expects to contribute $30 million to plan assets in 2023. The Company’s estimated future benefit payments as of December 31, 2022 are as follows: Years Pension Benefits Other Long-term Benefits 2023 41 5 2024 46 6 2025 57 9 2026 70 8 2027 51 9 From 2028 to 2032 319 43 The Company has certain defined contribution plans, which accrue benefits for employees on a pro-rata basis during their employment period based on their individual salaries. The Company’s accrued benefits related to defined contribution pension plans for $24 million as of December 31, 2022 and $23 million as of December 31, 2021. The annual cost of these plans amounted to approximately $100 million in 2022, $101 million in 2021 and $91 million in 2020.

Other Long-Term Liabilities

Other Long-Term Liabilities	12 Months Ended
	Dec. 31, 2022
Other Liabilities Noncurrent [Abstract]
Other Long-Term Liabilities	17. OTHER LONG-TERM LIABILITIES Other long-term liabilities consisted of the following: December 31, 2022 December 31, 2021 Non-current operating lease liabilities 141 148 Contingent consideration on business combinations 31 70 Other long-term employee benefits 81 90 Long-term liabilities related to public funding 51 44 Long-term advances from customers 73 — Derivative instruments 4 — Others 73 64 Total 454 416 Lease liabilities are described in Note 11. Deferred and contingent consideration related to business acquisitions are further described in Note 27. Other long-term employee benefits are described in Note 16. Long-term liabilities related to public funding are described in Note 7. Advances from customers are described in Note 14 and Note 19. Derivative instruments are described in Note 27. Other long-term liabilities also include individually not significant amounts as of December 31, 2022 and December 31, 2021, presented cumulatively in the line “Others”.

Shareholders' Equity

Shareholders' Equity	12 Months Ended
	Dec. 31, 2022
Federal Home Loan Banks [Abstract]
Shareholders' Equity	1 8 . SHAREHOLDERS’ EQUITY 1 8 .1 Outstanding shares The authorized share capital of the Company is Euro 1,810 million consisting of 1,200,000,000 common shares and 540,000,000 preference shares, each with a nominal value of €1.04. As of December 31, 2022, the number of shares of common stock issued was 911,281,920 shares (911,276,920 as of December 31, 2021). As of December 31, 2022, the number of shares of common stock outstanding was 903,865,763 (906,518,057 as of December 31, 2021). 1 8 .2 Preference shares The 540,000,000 preference shares, when issued, will entitle a holder to full voting rights and to a preferential right to dividends and distributions upon liquidation. The Company is a party to an option agreement regarding the preference shares with Stichting Continuïteit ST (the “Stichting”), entered into on January 22, 2007, with a duration of ten years, which agreement was extended for another ten years in October 2016. The Managing Board and Supervisory Board, along with the board of the Stichting, have declared that they are jointly of the opinion that the Stichting is independent of the Company. The option agreement provides for the issuance of up to a maximum 540,000,000 preference shares. Any such shares would be issued to the Stichting upon its request and in its sole discretion and upon payment of at least 25% of the par value of the preference shares to be issued. The shares would be issuable in the event of actions which the board of the Stichting determines would be contrary to the Company’s interests, shareholders and other stakeholders and which in the event of a creeping acquisition or offer for the Company’s common shares are not supported by the Company’s Managing Board and Supervisory Board. The preference shares may remain outstanding for no longer than two years. The effect of the preference shares may be to deter potential acquirers from effecting an unsolicited acquisition resulting in a change of control as well as to create a level-playing field in the event actions which are considered to be hostile by the Company’s Managing Board and Supervisory Board, as described above, occur and which the board of the Stichting determines to be contrary to the Company’s interests , shareholders and other stakeholders. There were no preference shares issued as of December 31, 2022 and December 31, 2021 respectively. 1 8 .3 Treasury stock As of December 31, 2022, the Company owned 7,416,157 shares classified as treasury stock in the consolidated statement of equity compared to 4,758,863 shares as of December 31, 2021. The treasury shares have been originally designated for allocation under the Company’s share-based remuneration programs. As of December 31, 2022, 74,520,215 of these treasury shares were transferred to employees under the Company’s share-based remuneration programs, of which 6,587,002 during the year ended December 31, 2022. On July 1, 2021, the Company announced the launch of a share buy-back program of up to $1,040 million to be executed within a three-year 1 8 .4 Unvested share awards for the Supervisory Board On an annual basis and until the year 2012, the Compensation Committee (on behalf of the Supervisory Board and with its approval) used to grant stock-based awards (options to acquire common shares of the Company) to the members and professionals of the Supervisory Board (“The Supervisory Board Plan”). The awards were granted at the nominal value of the share of €1.04 (exercise price of the option). The options granted under the Supervisory Board Plan vested and became exercisable immediately, while the shares resulting from these awards vested and therefore became available for trade evenly over three years (one third every year), with no market, performance or service conditions. At the Company’s AGM held on June 21, 2013, it was resolved to abolish and terminate the stock-based compensation for the Supervisory Board members and professionals. The table below summarizes grants under the outstanding stock award plans, as authorized by the Compensation Committee: Year of grant Options granted Options waived at grant 2011 172,500 (30,000 ) 2012 180,000 (22,500 ) Since 2013 No options granted A summary of the options’ activity by plan for the years ended December 31, 2022 and December 31, 2021 is presented below: Year of grant Outstanding as of December 31, 2020 Exercised Expired / Cancelled Outstanding as of December 31, 2021 Exercised Expired / Cancelled Outstanding as of December 31, 2022 2011 7,500 (7,500 ) — — — — — 2012 50,000 (30,000 ) — 20,000 (5,000 ) (15,000 ) — The total intrinsic value of options exercised during the year 2022 were not significant, compared to $2 million in 2021 and $2 million in 2020. The total intrinsic value of options outstanding was $1 million as of December 31, 2021. 1 8 .5 Unvested share awards for the employees On an annual basis, the Compensation Committee (on behalf of the Supervisory Board and with its approval) grants stock-based awards to the senior executives and selected employees (the “Employee Plan”). The awards are granted for services under the Employee Plan . There are two types of unvested shares: (1) shares granted to employees, which are subject only to service conditions and vest over the requisite service period, and (2) shares granted to senior executives, whose vesting is subject to performance conditions . For plans 2019 and 2020, the performance conditions consisted of two external targets (sales evolution and operating income compared to a basket of competitors) weighting for two thirds of the total number of awards granted and of one internal target (return on net assets compared to the previous period), weighting for one third of the total number of awards granted. For plans 2021 and 2022, the performance conditions consisted of two external targets (sales evolution and operating income compared to a basket of competitors) weighting for two thirds of the total number of awards granted and of one internal target (Company’s sustainability and diversity performance), weighting for one third of the total number of awards granted. Stock awards usually vest over a three-year The table below summarizes grants under the outstanding stock award plans in 2022, as authorized by the Compensation Committee: Date of grant Plan name Number of shares granted Number of shares waived Number of shares lost on performance conditions May 23, 2019 2019 CEO Special Bonus 34,960 — — July 24, 2019 2019 Employee Plan 7,752,940 — (1,161,966 ) December 26, 2019 2019 Employee Plan 246,750 — (17,013 ) June 17, 2020 2020 CEO Special Bonus 16,000 — — July 23, 2020 2020 Employee Plan 7,437,580 — — December 24, 2020 2020 Employee Plan 562,350 — — July 28, 2021 2021 Employee Plan 6,327,205 — (920,263 ) December 21, 2021 2021 Employee Plan 213,270 — (60,483 ) July 27, 2022 2022 Employee Plan 6,243,670 — (*) December 22, 2022 2022 Employee Plan 287,675 — (*) (*) As of the date of issuance of these consolidated financial statements, a final decision by the Compensation Committee of the Supervisory Board on the achievement of the performance conditions had not been made yet. A summary of the unvested share activity by plan for the year ended December 31, 2022 is presented below: Unvested Shares Unvested as at December 31, 2021 Granted Forfeited / waived Cancelled on failed vesting conditions Vested Unvested as at December 31, 2022 2019 CEO Special Bonus 11,652 — — — (11,652 ) — 2019 Employee Plan 2,356,399 — (10,988 ) — (2,345,411 ) — 2020 CEO Special Bonus 10,667 — — — (5,333 ) 5,334 2020 Employee Plan 5,325,666 — (52,350 ) — (2,492,520 ) 2,780,796 2021 Employee Plan 6,497,505 — (65,958 ) (980,746 ) (1,751,287 ) 3,699,514 2022 Employee Plan — 6,531,345 (34,820 ) — — 6,496,525 Total 14,201,889 6,531,345 (164,116 ) (980,746 ) (6,606,203 ) 12,982,169 The grant date fair value of unvested shares granted to the CEO under the 2019 CEO Special Bonus Plan was $14.97, which was based on the market price of the shares at the date of the grant. The grant date weighted average fair value of unvested shares granted to employees under the 2019 Employee Plan was $19.28. On March 25, 2020, the Compensation Committee approved the statement that with respect to the shares subject to performance conditions, two performance conditions were fully met. Consequently, the compensation expense recorded on the 2019 Employee Plan reflects the statement that – for the portion of shares subject to performance conditions – two thirds The grant date fair value of unvested shares granted to the CEO under the 2020 CEO Special Bonus Plan was $26.64, which was based on the market price of the shares at the date of the grant. The grant date weighted average fair value of unvested shares granted to employees under the 2020 Employee Plan was $30.17. On March 24, 2021, the Compensation Committee approved the statement that with respect to the shares subject to performance conditions, all three performance conditions were fully met. Consequently, the compensation expense recorded on the 2020 Employee Plan reflects the statement that – for the portion of shares subject to performance conditions – 100% The grant date weighted average fair value of unvested shares granted to employees under the 2021 Employee Plan was $39.20. On March 23, 2022, the Compensation Committee approved the statement that with respect to the shares subject to performance conditions, two performance conditions were fully met. Consequently, the compensation expense recorded on the 2021 Employee Plan reflects the statement that – for the portion of shares subject to performance conditions – two thirds The grant date weighted average fair value of unvested shares granted to employees under the 2022 Employee Plan was $35.92. Moreover, for the portion of the shares subject to performance conditions (2,705,521 shares) the Company estimated the number of awards expected to vest by assessing the probability of achieving the performance conditions. As of the date of issuance of these consolidated financial statements, a final determination by the Compensation Committee of the Supervisory Board of the achievement of the performance conditions had not been made yet by the Compensation Committee of the Supervisory Board. The Company estimated that 100% of the awards subject to performance conditions are expected to vest. Consequently, the compensation expense recorded for the 2022 Employee Plan reflects the vesting of the 100% of the awards granted with performance conditions, subject to the service condition being met. The assumption of the expected number of awards to be vested upon achievement of the performance conditions is subject to changes based on the final measurement of the conditions, which is expected to occur in the first half of 2023. The following table illustrates the classification of pre-payroll tax and social contribution stock-based compensation expense included in the consolidated statements of income for the years ended December 31, 2022, 2021 and 2020: December 31, 2022 December 31, 2021 December 31, 2020 Cost of sales 34 34 25 R&D 69 70 51 SG&A 112 117 79 Total pre-payroll tax and social contribution compensation 215 221 155 The grant date fair value of the shares that vested in 2022 was $189 million compared to $181 million in 2021 and $141 million in 2020. Stock-based compensation, excluding payroll tax and social contribution, capitalized as part of inventory was $11 million as of December 31, 2022, compared to $9 million as of December 31, 2021 and $6 million as of December 31, 2020. As of December 31, 2022, there was $228 million of total unrecognized compensation cost related to the grant of unvested shares, which is expected to be recognized over a weighted average period of approximately 9 months. The total deferred income tax benefit recognized in the consolidated statements of income related to unvested share-based compensation expense amounted to $15 million, $14 million and $10 million for the years ended December 31, 2022, 2021 and 2020, respectively. 1 8 .6 Accumulated other comprehensive income (loss) attributable to parent company stockholders The table below details the changes in AOCI attributable to the company’s stockholders by component, net of tax, for the years ended December 31, 2022, 2021 and 2020: Gains (Losses) on Cash Flow Hedges Gains (Losses) on Available- For-Sale Securities Defined Benefit Pension Plan Items Foreign Currency Translation Adjustments (“CTA”) Total December 31, 2019 (3 ) 1 (223 ) 646 421 Cumulative tax impact — — 54 — 54 December 31, 2019, net of tax (3 ) 1 (169 ) 646 475 OCI before reclassifications 64 — (22 ) 203 245 Amounts reclassified from AOCI — — 14 — 14 OCI for the year ended December 31, 2020 64 — (8 ) 203 259 Cumulative tax impact (8 ) — (3 ) — (11 ) OCI for the year ended December 31, 2020, net of tax 56 — (11 ) 203 248 December 31, 2020 61 1 (231 ) 849 680 Cumulative tax impact (8 ) — 51 — 43 December 31, 2020, net of tax 53 1 (180 ) 849 723 OCI before reclassifications (90 ) (1 ) 56 (189 ) (224 ) Amounts reclassified from AOCI (19 ) — 13 — (6 ) OCI for the year ended December 31, 2021 (109 ) (1 ) 69 (189 ) (230 ) Cumulative tax impact 14 — (11 ) — 3 OCI for the year ended December 31, 2021, net of tax (95 ) (1 ) 58 (189 ) (227 ) December 31, 2021 (48 ) — (162 ) 660 450 Cumulative tax impact 6 — 40 — 46 December 31, 2021, net of tax (42 ) — (122 ) 660 496 OCI before reclassifications (126 ) (16 ) 80 (149 ) (211 ) Amounts reclassified from AOCI 197 — 4 — 201 OCI for the year ended December 31, 2022 71 (16 ) 84 (149 ) (10 ) Cumulative tax impact (9 ) 2 (19 ) — (26 ) OCI for the year ended December 31, 2022, net of tax 62 (14 ) 65 (149 ) (36 ) December 31, 2022 23 (16 ) (78 ) 511 440 Cumulative tax impact (3 ) 2 21 — 20 December 31, 2022, net of tax 20 (14 ) (57 ) 511 460 Items reclassified out of Accumulated Other Comprehensive Income for the years ended December 31, 2022, 2021, 2020 are listed in the table below: Details about AOCI components Amounts reclassified from AOCI in the year ended December 31, 2022 Amounts reclassified from AOCI in the year ended December 31, 2021 Amounts reclassified from AOCI in the year ended December 31, 2020 Affected line item in the statement where net income (loss) is presented Gains (Losses) on Cash Flow Hedges Foreign exchange derivative contracts (129 ) 15 (3 ) Cost of sales Foreign exchange derivative contracts (15 ) 1 1 Selling, general and administrative Foreign exchange derivative contracts (53 ) 3 2 Research and development 27 (3 ) — Income tax benefit (expense) (170 ) 16 — Net of tax Defined Benefit Pension Plan Items Amortization of actuarial gains (losses) (3 ) (12 ) (13 ) Other components of pension benefit costs Amortization of prior service cost (1 ) (1 ) (1 ) Other components of pension benefit costs 1 2 3 Income tax benefit (expense) (3 ) (11 ) (11 ) Net of tax Total reclassifications for the year (173 ) 5 (11 ) Attributable to noncontrolling interest — — — Attributable to the parent company stockholders (173 ) 5 (11 ) 1 8 .7 Dividends The AGM held on May 25, 2022, authorized the distribution of a cash dividend of $0.24 per outstanding share of the Company’s common stock, to be distributed in quarterly installments of $0.06 in each of the second, third and fourth quarters of 2022 and first quarter of 2023. An amount of $6 million corresponding to the remaining portion of the third installment and orresponding to the last installment The AGM held on May 27, 2021 authorized the distribution of a cash dividend of $0.24 per outstanding share of the Company’s common stock, to be distributed in quarterly installments of $0.06 in each of the second, third and fourth quarters of 2021 and first quarter of 2022. The amounts of $54 million corresponding to the first installment, $55 million corresponding to the second installment and $54 million corresponding to the third installment were paid as of December 31, 2021. An amount of $55 million corresponding to the fourth installment was paid in 2022. The AGM held on June 17, 2020 authorized the distribution of a cash dividend of $0.168 per outstanding share of the Company’s common stock, to be distributed in quarterly installments of $0.042 . $37 million corresponding to the first installment, $38 million corresponding to the second installment and $34 million corresponding to the third installment were paid as of December 31, 2020. The remaining $4 million portion of the third installment and the fourth installment of $38 million, were paid in 2021. The AGM held on May 31, 2019 authorized the distribution of a cash dividend of $0.24 per outstanding share of the Company’s common stock, to be distributed in quarterly installments of $0.06 and fourth quarters of 201 9 and first quarter of 20 20 . The amount s of $ 53 million corresponding to the first installment, $ 53 million corresponding to the second installment and $ 48 million corresponding to the third installment were paid as of December 31, 201 9 . The remaining portion of $ 6 million related to the third installment and the last installment of $ 54 million were paid in 20 20 .

Revenues

Revenues	12 Months Ended
	Dec. 31, 2022
Revenue From Contract With Customer [Abstract]
Revenues	1 9 . REVENUES 1 9 .1 Nature of goods and services The Company designs, develops, manufactures and markets a broad range of products, including discrete and standard commodity components, application-specific integrated circuits (“ASICs”), full-custom devices and semi-custom devices and application specific standard products (“ASSPs”) for analog, digital and mixed-signal applications. In addition, the Company participates in the manufacturing value chain of smartcard products, which includes the production and sale of both silicon chips and smartcards. The principal activities – separated by reportable segments – from which the Company generates its revenues are described in Note 20. Other revenues consist of license revenue, service revenue related to transferring licenses, patent royalty income, sale of scrap materials and manufacturing by-products. While the majority of the Company’s sales agreements contain standard terms and conditions, the Company may, from time to time, enter into agreements that contain multiple performance obligations or terms and conditions. Those agreements concern principally the revenues from services, where the performance obligation is satisfied over time. The objective when allocating the transaction price is to allocate the transaction price to each performance obligation (or distinct good or service) in an amount that depicts the amount of consideration to which the Company expects to be entitled in exchange for transferring the promised goods or services to the customer. 1 9 .2 Revenue recognition and disaggregation The Company recognizes revenue from products sold to a customer, including distributors, when it satisfies a performance obligation at a point in time by transferring control over a product to the customer. This usually occurs at the time of shipment. The performance obligations linked to the sale of goods contracts usually have original expected length of less than one year. The transaction price is determined based on the contract terms, adjusted for price protection, if applicable. The revenues from services are usually linked to performance obligations transferred over time and are recognized in line with the contract terms. In 2022, the Company signed several multi-annual capacity reservation and volume commitment arrangements with certain customers. These agreements constitute a binding commitment for the customers to purchase and for the Company to supply allocated commitment volumes in exchange for additional consideration. The consideration related to commitment fees is reported as revenues from sale of products as it is usually based on delivered quantities. Advances from customers received as part of those agreements are described in Note 14 and Note 17. The payment terms typically range between 30 and 90 days. The Company’s consolidated net revenues disaggregated by reportable segment are presented in Note 20. The following tables present the Company’s consolidated net revenues disaggregated by geographical region of shipment, nature and market channel: Year ended December 31, 2022 December 31, 2021 December 31, 2020 Net revenues by geographical region of shipment (1) EMEA 3,619 2,557 1,966 Americas 2,310 1,525 1,165 Asia Pacific 10,199 8,679 7,088 Total net revenues 16,128 12,761 10,219 Net revenues by nature Revenues from sale of products 15,953 12,560 10,049 Revenues from sale of services 130 169 132 Other revenues 45 32 38 Total net revenues 16,128 12,761 10,219 Net revenues by market channel (2) Original Equipment Manufacturers (“OEM”) 10,764 8,486 7,411 Distribution 5,364 4,275 2,808 Total net revenues 16,128 12,761 10,219 (1) Net revenues by geographical region of shipment are classified by location of customer invoiced or reclassified by shipment destination in line with customer demand. For example, products ordered by U.S.-based companies to be invoiced to Asia Pacific affiliates are classified as Asia Pacific revenues. Furthermore, the Company, among the different periods, may be affected by shifts in shipments from one location to another, as requested by customers. (2) Original Equipment Manufacturers (“OEM”) are the end-customers to which the Company provides direct marketing application engineering support, while Distribution refers to the distributors and representatives that the Company engages to distribute its products around the world. The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which the Company recognizes revenue at the amount to which the Company has the right to invoice for services performed. In 2022, 2021 and 2020, the Company’s largest customer, Apple represented 16.8%, 20.5% and 23.9% of consolidated net revenues, respectively, reported in the ADG, AMS and MDG segments.

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
Segment Information	20 . SEGMENT INFORMATION The Company designs, develops, manufactures and markets a broad range of products, including discrete and standard commodity components ASICs, full custom devices and semi-custom devices and ASSPs for analog, digital, and mixed-signal applications. In addition, the Company further participates in the manufacturing value chain of smartcard products, which includes the production and sale of both silicon chips and smartcards. The Company’s reportable segments are as follows: • Automotive and Discrete Group (ADG) , comprised of dedicated automotive integrated circuits (“ICs”), and discrete and power transistor products. • Analog, MEMS and Sensors Group (AMS) , comprised of analog, smart power, MEMS sensors and actuators, and optical sensing solutions. • Microcontrollers and Digital ICs Group (MDG) , comprised of general-purpose microcontrollers and microprocessors, connected security products (e.g. embedded secured elements and NFC readers), memories (e.g. serial and page EEPROM) and RF and Communications products. Effective July 1, 2022, the Low Power RF business unit was transferred from AMS (within the Analog sub-group) to MDG (within the Microcontrollers and Memories sub-group) with no significant impact on the Company’s segment reporting. Prior year periods have been adjusted accordingly. For the computation of the segments’ internal financial measurements, the Company uses certain internal rules of allocation for the costs not directly chargeable to the segments, including cost of sales, SG&A expenses and a part of R&D expenses. In compliance with the Company’s internal policies, certain costs are not allocated to the segments, but reported in “Others”. Those comprise unused capacity charges, including reduced manufacturing activity due to COVID-19 and incidents leading to power outage, impairment, restructuring charges and other related closure costs, management reorganization expenses, phase-out and start-up costs of certain manufacturing facilities, and other unallocated income (expenses) such as: strategic or special R&D programs, certain corporate-level operating expenses, patent claims and litigations, and other costs that are not allocated to product groups, as well as operating earnings of other products. In addition, depreciation and amortization expense is part of the manufacturing costs allocated to the segments and is neither identified as part of the inventory variation nor as part of the unused capacity charges; therefore, it cannot be isolated in cost of sales. Finally, public grants are allocated to the Company’s segments proportionally to the incurred expenses on the sponsored projects . Wafer costs are allocated to the segments based on actual cost. From time to time, with respect to specific technologies, wafer costs are allocated to segments based on market price. The following tables present the Company’s consolidated net revenues and consolidated operating income by reportable segment. Net revenues by reportable segment: December 31, 2022 December 31, 2021 December 31, 2020 ADG 5,969 4,350 3,284 AMS (1) 4,911 4,587 3,858 MDG (1) 5,228 3,802 3,064 Total net revenues of product segments 16,108 12,739 10,206 Others 20 22 13 Total consolidated net revenues 16,128 12,761 10,219 (1) Effective July 1, 2022, the Low Power RF business unit was transferred from AMS to MDG with no significant impact on segment reporting. Prior year periods have been adjusted accordingly. Operating income by reportable segment: December 31, 2022 December 31, 2021 December 31, 2020 ADG 1,469 512 182 AMS (1) 1,237 1,022 816 MDG (1) 1,830 908 498 Total operating income of product segments 4,536 2,442 1,496 Others (2) (97 ) (23 ) (173 ) Total consolidated operating income 4,439 2,419 1,323 (1) Effective July 1, 2022, the Low Power RF business unit was transferred from AMS to MDG with no significant impact on segment reporting. Prior year periods have been adjusted accordingly. (2) Operating income (loss) of “Others” includes items such as unused capacity charges, including reduced manufacturing activity due to COVID-19 and incidents leading to power outage, impairment, restructuring charges and other related closure costs, management reorganization costs, phase-out and start-up costs of certain manufacturing facilities, and other unallocated income (expenses) such as: strategic or special R&D programs, certain corporate-level operating expenses, patent claims and litigations, and other costs that are not allocated to product groups, as well as operating earnings of other products. The reconciliation of operating income of reportable segments to the total consolidated operating income is presented in the below table: December 31, 2022 December 31, 2021 December 31, 2020 Total operating income of reportable segments 4,536 2,442 1,496 Impairment, restructuring charges and other related closure costs — (2 ) (11 ) Start-up and phase-out costs (13 ) — — Unused capacity charges (22 ) (16 ) (153 ) Other unallocated manufacturing results (57 ) 1 (8 ) Gain on sale of non-current assets 2 3 11 Strategic and other research and development programs and other non-allocated provisions (1) (7 ) (9 ) (12 ) Total operating loss Others (97 ) (23 ) (173 ) Total consolidated operating income 4,439 2,419 1,323 (1) Includes unallocated income and expenses such as certain corporate-level operating expenses and other income (costs) that are not allocated to the product segments. The following is a summary of operations by entities located within the indicated geographic areas for 2022, 2021 and 2020. Net revenues represent sales to third parties from the country in which each subsidiary is domiciled. The Company is incorporated under Dutch law with head offices located in the Netherlands while the Company’s operational office and headquarters are located in Switzerland. Long-lived assets consist of property, plant and equipment, net. A significant portion of property, plant and equipment expenditures is attributable to front-end and back-end facilities, located in the different countries in which the Company operates. As such, the Company mainly allocates capital spending resources according to geographic areas rather than along product segment areas. Net revenues December 31, 2022 December 31, 2021 December 31, 2020 Switzerland 4,569 3,282 2,795 France 153 126 89 Italy 47 56 52 USA 1,981 1,253 976 Singapore 8,604 7,442 5,817 Japan 758 586 479 Other countries 16 16 11 Total net revenues 16,128 12,761 10,219 Property, plant and equipment, net December 31, 2022 December 31, 2021 Netherlands 2,753 1,476 France 1,774 1,154 Italy 1,683 1,469 Other European countries 161 136 USA 52 36 Singapore 880 671 Malaysia 365 221 Other countries 533 497 Total property, plant and equipment, net 8,201 5,660

Other Income and Expenses, Net

Other Income and Expenses, Net	12 Months Ended
	Dec. 31, 2022
Other Income And Expenses [Abstract]
Other Income and Expenses, Net	2 1 . OTHER INCOME AND EXPENSES, NET Other income and expenses, net consisted of the following: Year ended December 31, 2022 Year ended December 31, 2021 Year ended December 31, 2020 Public funding 177 162 231 Start-up and phase-out costs (13 ) — (8 ) Exchange gain (loss), net 15 7 8 Patent costs (8 ) (10 ) (11 ) Gain on sale of non-current assets 2 5 14 COVID-19 incremental costs (10 ) (19 ) (32 ) Other, net (4 ) (4 ) — Total 159 141 202 The Company receives public funding from governmental bodies in several jurisdictions. Public funding is further described in Note 7. Start-up costs represent costs incurred in the ramp-up phase of the Company’s newly integrated manufacturing facilities. Phase-out costs are costs incurred during the closing stage of a Company’s manufacturing facility. Exchange gains and losses, net represent the portion of exchange rate changes on transactions denominated in currencies other than an entity’s functional currency and the changes in fair value of derivative instruments which are not designated as hedges, as described in Note 27 Patent costs mainly include legal and attorney fees and payment for claims, patent pre-litigation consultancy and legal fees They are reported net of settlements, if any, which primarily include reimbursements of prior patent litigation costs COVID-19 incremental costs are mainly composed of incremental expenses primarily related to sanitary measures undertaken to protect employees.

Interest Income (Expense), Net

Interest Income (Expense), Net	12 Months Ended
	Dec. 31, 2022
Banking And Thrift Interest [Abstract]
Interest Income (Expense), Net	2 2 . INTEREST INCOME (EXPENSE), NET Interest income (expense), net consisted of the following: Year ended December 31, 2022 Year ended December 31, 2021 Year ended December 31, 2020 Income 71 13 34 Expense (13 ) (42 ) (54 ) Total 58 (29 ) (20 ) Interest income recorded in 2022 was composed of $71 million of interest income, partially offset by interest expense on borrowings and banking fees of $13 million. Interest income is related to cash and cash equivalents, short-term deposits and marketable securities held by the Company. On January 1, 2022, the Company adopted the new U.S. GAAP reporting guidance on distinguishing liabilities from equity and EPS. The new guidance was adopted by applying the modified retrospective method, under which prior year periods are not restated. Interest expense recorded in 2021 and 2020 included a charge of $34 million and $42 million respectively, related to the outstanding senior unsecured convertible bonds, mainly resulting from the non-cash accretion expense, as recorded under the previous accounting guidance. With the adoption of the new guidance, the finance cost of the convertible debt instruments outstanding at the date of adoption is limited to the amortization expense of debt issuance costs. No borrowing cost was capitalized in 2022, 2021 and 2020. Interest income on U.S. Treasury Bonds classified as available-for-sale marketable securities amounted to $1 million for the year ended December 31, 2022, $1 million for the year ended December 31, 2021 and $3 million for the year ended December 31, 2020.

Income Tax

Income Tax	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income Tax	2 3 . INCOME TAX Income (loss) before income tax is comprised of the following: Year ended December 31, 2022 Year ended December 31, 2021 Year ended December 31, 2020 Income (loss) recorded in the Netherlands (22 ) (20 ) (19 ) Income (loss) from foreign operations 4,508 2,357 1,286 Income (loss) before income tax benefit (expense) 4,486 2,337 1,267 STMicroelectronics N.V. and its subsidiaries are individually liable for income taxes in their jurisdictions. Income tax benefit (expense) is comprised of the following: Year ended December 31, 2022 Year ended December 31, 2021 Year ended December 31, 2020 The Netherlands taxes - current — — — Foreign taxes - current (510 ) (285 ) (171 ) Total current taxes (510 ) (285 ) (171 ) The Netherlands taxes - deferred — — — Foreign taxes - deferred (10 ) (46 ) 12 Total deferred taxes (10 ) (46 ) 12 Income tax expense (520 ) (331 ) (159 ) Effective tax rate 12 % 14 % 13 % The principal items comprising the differences in income taxes computed at the Netherlands statutory rate of 25.8% in 2022, 25% in 2021 and 25% in 2020, and the effective income tax rate are the following: Year ended December 31, 2022 Year ended December 31, 2021 Year ended December 31, 2020 Income tax benefit (expense) computed at statutory rate (1,158 ) (584 ) (316 ) Non-deductible and non-taxable permanent differences, net 22 4 (1 ) Valuation allowance adjustments 140 (2 ) 11 Effect on deferred taxes of changes in enacted tax rates 6 6 (5 ) Current year credits 30 39 40 Other tax and credits (51 ) (22 ) (40 ) Benefits from tax holidays 60 49 37 Net impact of changes to uncertain tax positions (12 ) (8 ) (1 ) Earnings of subsidiaries taxed at different rates 443 187 116 Income tax benefit (expense) (520 ) (331 ) (159 ) The variation on the valuation allowance is related to the assessment of the recoverability of the deferred tax assets in France, Malta and the US following the improved stability of profits of the Group. The increase in the benefit from tax holidays between 2021 and 2022 is the result of the increase in profit in the countries where tax holidays are applicable. The tax holidays represent a tax exemption period aimed to attract foreign technological investment in certain tax jurisdictions . The effect of the tax benefits, from tax holidays for countries which are profitable, on basic earnings per share was $ 0.07 , $ 0.05 and $ 0.04 for the years ended December 31, 2022, 2021 and 2020, respectively. These agreements are present in various countries and include programs that reduce up to and including 100 % of taxes in years affected by the agreements . The Company’s tax holidays expire at various dates through the year ending December 31, 2029 . In certain countries, tax holidays can be renewed depending on the Company still meeting certain conditions at the date of expiration of the current tax holidays. Component of the Net Deferred Tax Asset and Liability Deferred tax assets and liabilities consisted of the following: December 31, 2022 December 31, 2021 Tax loss carryforwards and investment credits 520 707 Less unrecognized tax benefit (25 ) (81 ) Tax loss carryforwards net of unrecognized tax benefit 495 626 Inventory valuation 42 28 Impairment and restructuring charges 4 4 Fixed asset depreciation in arrears 55 52 Increased depreciation incentives 83 128 Capitalized development costs 79 121 Receivables for government funding 121 64 Tax credits granted on past capital investments 218 213 Pension service costs 62 82 Stock awards 17 14 Operating lease liabilities 50 39 Commercial accruals 27 12 Other temporary differences 23 25 Total deferred tax assets 1,276 1,408 Valuation allowances (416 ) (576 ) Deferred tax assets, net 860 832 Accelerated fixed asset depreciation (37 ) (32 ) Acquired intangible assets (23 ) (22 ) Advances of government funding (177 ) (115 ) Operating lease right-of-use assets (50 ) (39 ) Other temporary differences (31 ) (36 ) Deferred tax liabilities (318 ) (244 ) Net deferred income tax asset 542 588 For a particular tax-paying component of the Company and within a particular tax jurisdiction, all deferred tax liabilities and assets are offset and presented as a single amount. The Company does not offset deferred tax liabilities and assets attributable to different tax-paying components or to different tax jurisdictions. A valuation allowance is provided for deferred tax assets when management considers it is more likely than not that they will not be realized. Deferred tax asset expiration As of December 31, 2022, the Company and its subsidiaries have gross deferred tax assets on tax loss carryforwards and investment credits that expire starting from 2023. December 31, Year 2022 2023 3 2024 2 2025 2 2026 2 2027 5 Thereafter 506 Total 520 The majority of the amount reported on the line “Thereafter” has no expiration date. The “Tax credits granted on past capital investments” is mainly related to a 2003 agreement granting the Company certain tax credits for capital investments purchased through the year ending December 31, 2006. Any unused tax credits granted under the agreement will be impacted yearly by a legal inflationary index (currently 2.56% per annum). The credits may be utilized depending on the Company meeting certain program criteria and have no expiration date. In addition to this agreement, starting from 2007 the Company continues to receive tax credits on the yearly capital investments, which may be used to offset that year’s tax liabilities and increases by the legal inflationary rate. However, pursuant to the inability to utilize these credits currently and in future years, the Company did not recognize any deferred tax asset on such tax allowance. As a result, there is no financial impact to the net deferred tax assets of the Company. Deferred Tax expense recognized through Other Comprehensive Income In 2022, we recognized a deferred tax expense of $26 million as a component of other comprehensive income (loss), compared to a deferred tax income of $3 million in 2021. They were related primarily to the tax effects of the recognized unfunded status on defined benefits plan. Deferred tax on undistributed Earnings from foreign subsidiaries The cumulative amount of distributable earnings related to the Company’s investments in foreign subsidiaries and corporate joint ventures was $ 7,140 6,612 . 528 308 22 Unrecognized Tax Benefits A reconciliation of 2022, 2021 and 2020 beginning and ending amounts of unrecognized tax benefits is as follows: December 31, 2022 December 31, 2021 December 31, 2020 Balance at beginning of year 118 48 48 Additions based on tax positions related to the current year 4 72 1 Additions based on acquisitions related to the current year — — — Additions for tax positions of prior years 13 1 1 Reduction for tax positions of prior years (69 ) (1 ) (2 ) Settlements (2 ) — (1 ) Foreign currency translation (3 ) (2 ) 1 Balance at end of year 61 118 48 In addition, as of December 31, 2022, $25 million of unrecognized tax benefits were classified as a reduction of deferred tax assets (as of December 31, 2021, the amount was $81 million) . It is reasonably possible that certain of the uncertain tax positions disclosed in the table above could increase or decrease within the next 12 months due to ongoing tax audits. The Company is not able to make an estimate of the range of the reasonably possible change impacting the annual effective tax rate. Additionally, the Company elected to classify accrued interest and penalties related to uncertain tax positions as components of income tax expense in the consolidated statements of income. They were less than $1 million in 2022, less than $1 million in 2021and $1 million in 2020. Accrued interest and penalties amounted to $6 million as of December 31, 2022 and $7 million as of December 31, 2021. The tax years that remain open for review in the Company’s major tax jurisdictions, including France, Italy, United States and India, are from 1997 to 2022.

Earnings per Share

Earnings per Share	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Earnings per Share	2 4 . EARNINGS PER SHARE For the years ended December 31, 2022, 2021 and 2020, earnings per share (“EPS”) was calculated as follows: Year ended December 31, 2022 Year ended December 31, 2021 Year ended December 31, 2020 Basic EPS Net income attributable to parent company as reported 3,960 2,000 1,106 Weighted average number of shares outstanding 905,606,885 904,332,429 894,578,477 Basic EPS 4.37 2.21 1.24 Diluted EPS Net income attributable to parent company as reported 3,960 2,000 1,106 add-back interest expense, net of income tax effect 2 — — Net income attributable to parent company as adjusted 3,962 2,000 1,106 Weighted average shares outstanding 905,606,885 904,332,429 894,578,477 Dilutive effect of stock awards 6,789,662 9,107,124 8,860,216 Dilutive effect of convertible bonds 33,825,000 11,402,645 16,291,279 Number of shares used in calculating diluted EPS 946,221,547 924,842,198 919,729,972 Diluted EPS 4.19 2.16 1.20 On January 1, 2022, the Company adopted the new guidance on distinguishing liabilities from equity and EPS by applying the modified retrospective method, under which prior year periods are not restated. Under the previous guidance, the Company applied the treasury stock method to determine the dilutive effect of convertible bonds as past experience, existing stated policies, and the contractual terms of the bonds provided a reasonable basis to expect that the settlement would include cash, shares, or a mix of both. With the adoption of the new guidance, the treasury stock method is no longer admitted and the application of the if-converted method is mandatory to determine the dilutive effect of convertible bonds. The senior unsecured convertible bonds issued on August 4, 2020 are consequently fully dilutive, with the total underlying shares presented in the line “Dilutive effect of convertible bonds” of the table above for the year ended December 31, 2022.

Commitments

Commitments	12 Months Ended
	Dec. 31, 2022
Commitments And Contingencies Disclosure [Abstract]
Commitments	25 . COMMITMENTS The Company’s commitments as of December 31, 2022 were as follows: In millions of U.S. dollars Total 2023 2024 2025 2026 2027 Thereafter Purchase obligations 5,554 4,556 424 287 101 62 124 of which: Equipment purchase 3,587 3,584 3 — — — — Foundry purchase 1,827 872 393 275 101 62 124 Software, design, technologies and licenses 140 100 28 12 — — — Other obligations 1,864 1,072 155 100 56 155 326 Total 7,418 5,628 579 387 157 217 450 Purchase obligations are primarily comprised of purchase commitments for equipment, for outsourced foundry wafers and for software licenses. Other obligations primarily relate to firm contractual commitments with respect to partnership and cooperation agreements and other service agreements.

Contingencies, Claims and Legal

Contingencies, Claims and Legal Proceedings	12 Months Ended
	Dec. 31, 2022
Commitments And Contingencies Disclosure [Abstract]
Contingencies, Claims and Legal Proceedings	2 6 . CONTINGENCIES, CLAIMS AND LEGAL PROCEEDINGS The Company is subject to possible loss contingencies arising in the ordinary course of business. These include but are not limited to: product liability claims and/or warranty cost on the products of the Company, contractual disputes, indemnification claims, claims for unauthorized use of third-party intellectual property, employee grievances, tax claims beyond assessed uncertain tax positions as well as claims for environmental damages. In determining loss contingencies, the Company considers the likelihood of impairing an asset or the incurrence of a liability at the date of the consolidated financial statements as well as the ability to reasonably estimate the amount of such loss. The Company records a provision for a loss contingency when information available before the consolidated financial statements are issued or are available to be issued indicates that it is probable that an asset has been impaired or a liability has been incurred at the date of the consolidated financial statements and when the amount of loss can be reasonably estimated. The Company regularly re-evaluates claims to determine whether provisions need to be readjusted based on the most current information available to the Company. Changes in these evaluations could result in an adverse material impact on the Company’s results of operations, cash flows or its financial position for the period in which they occur. The Company has received and may in the future receive communications alleging possible infringements of third-party patents or other third-party intellectual property rights. Furthermore, the Company from time to time enters into discussions regarding a broad patent cross license arrangement with other industry participants. There is no assurance that such discussions may be brought to a successful conclusion and result in the intended agreement. The Company may become involved in costly litigation brought against the Company regarding patents, mask works, copyrights, trademarks or trade secrets. In the event that the outcome of any litigation would be unfavorable to the Company, the Company may be required to take a license to third-party patents and/or other intellectual property rights at economically unfavorable terms and conditions, and possibly pay damages for prior use and/or face an injunction, all of which individually or in the aggregate could have a material adverse effect on the Company’s results of operations, cash flows, financial position and/or ability to compete. The Company has contractual commitments to various customers which could require the Company to incur costs to repair or replace defective products it supplies to such customer. The duration of these contractual commitments varies and, in certain cases, is indefinite . The Company is otherwise also involved in various lawsuits, claims, inquiries, inspections, investigations and/or proceedings incidental to its business and operations . Such matters, even if not meritorious, could result in the expenditure of significant financial or managerial resources . Any of the foregoing could have a material adverse effect on the Company’s results of operations, cash flows or its financial position. The Company regularly evaluates claims and legal proceedings together with their related probable losses to determine whether they need to be adjusted based on the current information available to the Company. There can be no assurance that its recorded reserves will be sufficient to cover the extent of its potential liabilities. Legal costs associated with claims are expensed as incurred. In the event of litigation which is adversely determined with respect to the Company’s interests, or in the event the Company needs to change its evaluation of a potential third-party claim, based on new evidence or communications, a material adverse effect could impact its operations or financial condition at the time it were to materialize. As of December 31, 2022 and 2021, respectively, provisions for estimated probable losses with respect to claims and legal proceedings were not considered material.

Financial Instruments and Risk

Financial Instruments and Risk Management	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Financial Instruments and Risk Management	2 7 . FINANCIAL INSTRUMENTS AND RISK MANAGEMENT 2 7 .1 Financial risk factors The Company is exposed to changes in financial market conditions in the normal course of business due to its operations in different foreign currencies and its ongoing investing and financing activities. The Company’s activities expose it to a variety of financial risks: market risk (including foreign exchange risk, fair value interest rate risk, cash flow interest rate risk and price risk), credit risk and liquidity risk. The Company’s overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the Company’s financial performance. The Company uses derivative financial instruments to hedge certain risk exposures. Financial risk management is carried out by a central treasury department (Corporate Treasury). Additionally, a Treasury Committee, chaired by the Chief Financial Officer, steers treasury activities and ensures compliance with corporate policies. Treasury activities are thus regulated by the Company’s policies, which define procedures, objectives and controls. The policies focus on managing financial risk in terms of exposure to market risk, credit risk and liquidity risk. Treasury controls are subject to internal audits. Most treasury activities are centralized, with any local treasury activities subject to oversight from Corporate Treasury. Corporate Treasury identifies, evaluates and hedges financial risks in close cooperation with the Company’s subsidiaries. It provides written principles for overall risk management, as well as written policies covering specific areas, such as foreign exchange risk, interest rate risk, price risk, credit risk, use of derivative financial instruments, and investments of excess liquidity. The majority of cash and cash equivalents is held in U.S. dollars and Euros and is placed with financial institutions rated at least a single “A” long-term rating from two of the major rating agencies, meaning at least A3 from Moody’s and A- from S&P and Fitch, or better. These ratings are closely and continuously monitored in order to manage exposure to the counterparty’s risk. Hedging transactions are performed only to hedge exposures deriving from operating, investing and financing activities conducted in the normal course of business. Market risk Foreign exchange risk The Company conducts its business globally in various major international currencies. As a result, the Company is exposed to adverse movements in foreign currency exchange rates, primarily regarding the Euro. Foreign exchange risk mainly arises from recognized assets and liabilities at the Company’s subsidiaries and future commercial transactions. Management has set up a policy to require the Company’s subsidiaries to hedge their entire foreign exchange risk exposure with the Company through financial instruments transacted or overseen by Corporate Treasury. Subsidiaries use forward contracts and purchased currency options to manage their foreign exchange risk arising from foreign-currency-denominated assets and liabilities. Foreign exchange risk arises when recognized assets and liabilities are denominated in a currency that is not the entity’s functional currency. These instruments do not qualify as hedging instruments for accounting purposes . Forward contracts and currency options, including collars, are also used by the Company to reduce its exposure to U.S . dollar fluctuations in Euro-denominated forecasted transactions that cover a large part of its R&D and corporate costs expenses as well as a portion of its front-end manufacturing costs of semi-finished goods . The Company also hedges through the use of currency forward contracts certain Singapore dollar-denominated manufacturing forecasted transactions . The derivative instruments used to hedge these forecasted transactions meet the criteria for designation as cash flow hedge . The hedged forecasted transactions have a high probability of occurring for hedge accounting purposes . It is the Company’s policy to have the foreign exchange exposures in all the currencies hedged month by month against the monthly standard rate. At each month end, the forecasted flows for the coming month are hedged together with the fixing of the new standard rate. For this reason, the hedging transactions will have an exchange rate very close to the standard rate at which the forecasted flows will be recorded in the following month. As such, the foreign exchange exposure of the Company, which consists of the balance sheet positions and other contractually agreed transactions, is always close to zero and any movement in the foreign exchange rates will therefore not influence the exchange effect on items of the consolidated statement of income. Any discrepancy between the forecasted values and the actual results is constantly monitored and prompt actions are taken, if needed. Derivative Instruments Not Designated as a Hedge The Company enters into foreign currency forward contracts to reduce its exposure to changes in exchange rates and the associated risk arising from the denomination of certain assets and liabilities in foreign currencies at the Company’s subsidiaries. These include receivables from international sales by various subsidiaries, payables for foreign currency-denominated purchases and certain other assets and liabilities arising from intercompany transactions. The notional amount of these financial instruments totaled $931 million, $505 million and $897 million on December 31, 2022, 2021 and 2020, respectively. The principal currencies covered at the end of the year 2022 are the Euro, Singapore dollar, the Japanese yen, the China Yuan Renminbi, the Indian rupee, the Swiss franc, the Moroccan dirham, the Malaysian ringgit, the Philippines peso, the Taiwan dollar, the South Korean won and the Swedish krona. The risk of loss associated with forward contracts is equal to the exchange rate differential from the time the contract is entered into until the time it is settled. The risk of loss associated with purchased currency options is equal to the premium paid when the option is not exercised. Foreign currency forward contracts not designated as cash flow hedge outstanding as of December 31, 2022 have remaining terms of 4 days to 188 days, maturing on average after 29 days. Derivative Instruments Designated as a Hedge To further reduce its exposure to U.S. dollar exchange rate fluctuations, the Company hedges through the use of currency forward contracts and currency options, including collars, certain Euro-denominated forecasted intercompany transactions that cover at year-end a large part of its R&D and SG&A expenses, as well as a portion of its front-end manufacturing costs of semi-finished goods within cost of sales. The Company also hedges through the use of currency forward contracts certain manufacturing transactions within cost of sales denominated in Singapore dollars. The principles regulating the hedging strategy for derivatives designated as cash flow hedge are established as follows: (i) for R&D and corporate costs, up to 80% of the total forecasted transactions; (ii) for manufacturing costs, up to 70% of the total forecasted transactions. In order to follow a dynamic hedge strategy, the Company may change the percentage of the designated hedged item within the limit of 100% of the forecasted transaction. The maximum length of time over which the Company could hedge its exposure to the variability of cash flows for forecasted transactions is 24 months. For the year ended December 31, 2022, the Company recorded an increase in cost of sales of $129 million and an increase in operating expenses of $68 million, related to the realized losses incurred on such hedged transactions. For the year ended December 31, 2021, the Company recorded a decrease in cost of sales of $15 million and a decrease in operating expenses of $4 million, related to the realized gains incurred on such hedged transactions. For the year ended December 31, 2020, the Company recorded an increase in cost of sales of $3 million and a decrease in operating expenses of $3 million, related to the realized losses and gains incurred on such hedged transactions. The notional amount of foreign currency forward contracts and currency options, including collars, designated as cash flow hedge totaled $3,192 million, $2,165 million and $1,502 million on December 31, 2022, 2021 and 2020, respectively. The forecasted transactions hedged as of December 31, 2022 were determined to have a high probability of occurring. As of December 31, 2022, $14 million of deferred gains on derivative instruments included in “Accumulated other comprehensive income (loss)” in the consolidated statements of equity were expected to be reclassified as earnings during the next 12 months based on the monthly forecasted R&D expenses, corporate costs and semi-finished manufacturing costs. Foreign currency forward contracts and collars designated as cash flow hedge outstanding as of December 31, 2022 have remaining terms of 4 days to 20 months, maturing on average after 239 days. As of December 31, 2022, the Company had the following outstanding derivative instruments that were entered into to hedge Euro-denominated and Singapore dollar-denominated forecasted transactions: In millions of Euros Notional amount for hedge on forecasted R&D and other operating expenses Notional amount for hedge on forecasted manufacturing costs Forward contracts 540 986 Currency collars 500 791 In millions of Singapore dollars Notional amount for hedge on forecasted R&D and other operating expenses Notional amount for hedge on forecasted manufacturing costs Forward contracts — 247 Cash flow and fair value interest rate risk The Company’s interest rate risk arises from long-term borrowings. Borrowings issued at variable rates expose the Company to cash flow interest rate risk. Borrowings issued at fixed rates expose the Company to fair value interest rate risk. The Company analyses its interest rate exposure on a dynamic basis. Various scenarios are simulated taking into consideration refinancing, renewal of existing positions, alternative financing and hedging. The Company invests primarily on a short-term basis and as such the Company’s liquidity is invested in floating interest rate instruments. As a consequence, the Company is exposed to interest rate risk due to potential mismatch between the return on its short-term floating interest rate investments and the portion of its long-term debt issued at fixed rate. Price risk As part of its ongoing investing activities, the Company may invest in publicly traded equity securities and be exposed to equity security price risk. In order to hedge the exposure to this market risk, the Company may enter into certain derivative hedging transactions. Information on fair value of derivative instruments and their location in the consolidated balance sheets as of December 31, 2022 and December 31, 2021 is presented in the table below: As of December 31, 2022 As of December 31, 2021 Asset Derivatives Balance sheet classification Fair value Fair value Derivatives designated as a hedge: Foreign exchange forward contracts Other current assets 37 2 Foreign exchange forward contracts Other non-current assets 8 — Currency collars Other current assets 10 1 Currency collars Other non-current assets 5 — Total derivatives designated as a hedge: 60 3 Derivatives not designated as a hedge: Foreign exchange forward contracts Other current assets 9 3 Total derivatives not designated as a hedge: 9 3 Total Derivatives 69 6 As of December 31, 2022 As of December 31, 2021 Liability Derivatives Balance sheet classification Fair value Fair value Derivatives designated as a hedge: Foreign exchange forward contracts Other payables and accrued liabilities (23 ) (29 ) Foreign exchange forward contracts Other non-current liabilities (3 ) — Currency collars Other payables and accrued liabilities (9 ) (13 ) Currency collars Other non-current liabilities (1 ) — Total derivatives designated as a hedge: (36 ) (42 ) Derivatives not designated as a hedge: Foreign exchange forward contracts Other payables and accrued liabilities (3 ) (1 ) Total derivatives not designated as a hedge: (3 ) (1 ) Total Derivatives (39 ) (43 ) The Company entered into currency collars as combinations of two options, which are reported, for accounting purposes, on a net basis. As of December 31, 2022, the fair value of these collars represented assets for a net amount of $15 million (composed of $19 million assets offset with a $4 million liability) and liabilities for a net amount of $10 million (composed of $15 million liabilities offset with a $5 million asset). In addition, the Company entered into other derivative instruments, primarily forward contracts, which are governed by standard International Swaps and Derivatives Association (“ISDA”) agreements and are compliant with Protocols of the European Market Infrastructure Regulation (“EMIR”) The effect of derivative instruments designated as cashflow hedge on the consolidated statements of income for the year ended December 31, 2022 and December 31, 2021 and on the “Accumulated other comprehensive income (loss)” (“AOCI”) as reported in the consolidated statements of equity as of December 31, 2022 and December 31, 2021 is presented in the table below: Gain (loss) deferred in OCI on derivative Location of gain (loss) Gain (loss) reclassified from OCI into earnings December 31, 2022 December 31, 2021 reclassified from OCI into earnings December 31, 2022 December 31, 2021 Foreign exchange forward contracts 14 (20 ) Cost of sales (83 ) 11 Foreign exchange forward contracts 2 (2 ) Selling, general and administrative (9 ) — Foreign exchange forward contracts 4 (9 ) Research and development (32 ) 1 Currency collars 1 (11 ) Cost of sales (46 ) 4 Currency collars 1 (1 ) Selling, general and administrative (6 ) 1 Currency collars 1 (5 ) Research and development (21 ) 2 Total 23 (48 ) (197 ) 19 No significant ineffective portion of the cash flow hedge relationships was recorded in earnings for the years ended December 31, 2022 and December 31, 2021. No amount was excluded from effectiveness measurement on foreign exchange forward contracts and collars. The effect on the consolidated statements of income for the year ended December 31, 2022 and December 31, 2021 of derivative instruments not designated as a hedge is presented in the table below: Location of gain Gain (loss) recognized in earnings (loss) recognized in earnings December 31, 2022 December 31, 2021 Foreign exchange forward contracts Other income and expenses, net 24 9 Total 24 9 The Company did not enter into any derivative containing significant credit-risk-related contingent features. Credit risk The expected credit loss and impairment methodology applied on each category of financial assets is further described in each respective note. While cash and cash equivalents are also subject to the expected credit loss model, the identified expected credit loss is deemed to be immaterial. The maximum credit risk exposure for all financial assets is their carrying amount. Credit risk is the risk that a counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial loss. Credit risk typically arises from cash and cash equivalents, contractual cash flows of debt investments carried at amortized cost, the counterparty of derivative financial instruments and deposits with banks and financial institutions, as well as credit exposure to customers, including outstanding receivables. The Company is exposed to credit risk from its operating activities (primarily for trade receivables) and from its financing activities, including deposits with banks and financial institutions, foreign exchange transactions and other financial instruments. Credit risk is managed at the Group level. The Company selects banks and/or financial institutions that operate with the group based on the criteria of long-term rating from at least two major Rating Agencies and keeping a maximum outstanding amount per instrument with each bank not to exceed 20% of the total. For derivative financial instruments, management has established limits so that, at any time, the fair value of contracts outstanding is not concentrated with any individual counterparty. The Company monitors the creditworthiness of its customers to which it grants credit terms in the normal course of business. If certain customers are independently rated, these ratings are used. Otherwise, if there is no independent rating, risk control assesses the customer’s credit quality, considering its financial position, past experience and other factors . The utilization of credit limits is regularly monitored . Sales to customers are primarily settled in cash , which mitigates credit risk . As of December 31, 2022 and 2021 , no customer represented more than 10 % of trade accounts receivable, net . Any remaining concentrations of credit risk with respect to trade receivables are limited due to the large number of customers and their dispersion across many geographic areas . The Company’s investments in instruments carried at amortized cost primarily include Liquidity risk Prudent liquidity risk management includes maintaining sufficient cash and cash equivalents, short-term deposits and marketable securities, the availability of funding from committed credit facilities and the ability to close out market positions. The Company’s objective is to maintain a significant cash position and a low debt-to-equity ratio, which ensures adequate financial flexibility. Liquidity management policy is to finance the Company’s investments with net cash from operating activities. Management monitors rolling forecasts of the Company’s liquidity reserve based on expected cash flows. 2 7 .2 Capital risk management The Company’s objectives when managing capital are to safeguard the Company’s ability to continue as a going concern in order to create sustainable value, benefits and returns for its stakeholders, as to maintain an optimal capital structure. In order to maintain or adjust its capital structure, the Company may review the amount of dividends paid to shareholders, return capital to shareholders, or issue new shares. Consistent with other peers in the industry, the Company monitors capital on the basis of the net debt-to-equity ratio. This ratio is calculated as the net financial position of the Company, defined as the difference between total cash position (cash and cash equivalents, short-term deposits, marketable securities and restricted cash, if any) and total financial debt (short-term and long-term debt), divided by total parent company stockholders’ equity. 2 7 .3 Fair value measurement The fair value of financial instruments traded in active markets is based on quoted market prices at the balance sheet date. The quoted market price used for financial assets held by the Company is the bid price. If the market for a financial asset is not active and if no observable market price is obtainable, the Company measures fair value by using significant assumptions and estimates. When measuring fair value, the Company makes maximum use of market inputs and minimizes the use of unobservable inputs. The table below details financial assets (liabilities) measured at fair value on a recurring basis as of December 31, 2022: Fair Value Measurements using December 31, 2022 Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Marketable securities – U.S. Treasury debt securities 679 679 — — Short-term deposits 581 581 — — Equity securities measured at fair value through earnings 26 26 — — Derivative assets designated as cash flow hedge 60 — 60 — Derivative assets not designated as cash flow hedge 9 — 9 — Derivative liabilities designated as cash flow hedge (36) — (36) — Derivative liabilities not designated as cash flow hedge (3) — (3) — Contingent consideration on business acquisitions (31) — — (31) Total 1,285 1,286 30 (31) The table below details financial assets (liabilities) measured at fair value on a recurring basis as of December 31, 2021: Fair Value Measurements using December 31, 2021 Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Short-term deposits 291 291 — — Equity securities measured at fair value through earnings 29 29 — — Derivative assets designated as cash flow hedge 3 — 3 — Derivative assets not designated as cash flow hedge 3 — 3 — Derivative liabilities designated as cash flow hedge (42) — (42) — Derivative liabilities not designated as cash flow hedge (1) — (1) — Contingent consideration on business acquisitions (77) — — (77) Total 206 320 (37) (77) For liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3), the reconciliation between January 1, 2022 and December 31, 2022 is presented as follows: Fair Value Measurements using Significant Unobservable Inputs (Level 3) January 1, 2022 77 Changes in fair value measurement (35) Currency translation adjustment (4) Payments made (7) December 31, 2022 31 Amount of total gains (losses) for the period included in earnings attributable to liabilities still held at the reporting date 35 Contingent consideration reported as liabilities on the consolidated balance sheet as of December 31, 2022 and December 31, 2021 is based on the probability that the milestones defining the variable components of the consideration will be achieved. In 2022, the Contingent consideration is composed of $31 million reported in the line “Other long-term liabilities” in the consolidated balance sheet as of December 31, 2022 , compared to $7 . For liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3), the reconciliation between January 1, 2021 and December 31, 2021 is presented as follows: Fair Value Measurements using Significant Unobservable Inputs (Level 3) January 1, 2021 123 Changes in fair value measurement (38) Currency translation adjustment (8) December 31, 2021 77 Amount of total gains (losses) for the period included in earnings attributable to liabilities still held at the reporting date (2) No asset (liability) was measured at fair value on a non-recurring basis using significant unobservable inputs (Level 3) as of December 31, 2022 and December 31, 2021. The Company evaluated in 2022, 2021 and 2020 for impairment the aggregate carrying amount of long-term investments for which the Company applies the cost method as a measurement alternative, as described in Note 2.22. No significant impairment charge was recorded on these investments in 2022, 2021 and 2020. The following table includes additional fair value information on financial assets and liabilities as of December 31, 2022 and 2021: 2022 2021 Level Carrying Amount Estimated Fair Value Carrying Amount Estimated Fair Value Cash equivalents (1) 1 2,996 2,996 2,883 2,883 Short-term, deposits 1 581 581 291 291 Long-term debt – Bank loans (including current portion) 2 1,165 1,165 1,152 1,152 – Finance leases (including current portion) 2 57 57 — — – Senior unsecured convertible bonds issued on August 4, 2020 (2) 1 1,495 1,561 1,387 1,975 (1) Cash equivalents primarily correspond to deposits at call with banks. ( 2 ) The carrying amount as of December 31, 2022, of the senior unsecured convertible bonds as reported above, corresponds to the nominal value of the bonds, net of $5 million unamortized debt issuance costs, in compliance with the new accounting guidance. The impact of the adoption is described in Note 2 and Note 15. The fair value represented the market price of the bonds trading on the Frankfurt Stock Exchange. The Company did not report any debt securities that were in an unrealized loss position for more than one year as of December 31, 2022 and December 31, 2021. The methodologies used to estimate fair value are as follows: Components Methodology used to estimate fair value Debt securities classified as available-for-sale Quoted market prices for identical instruments Foreign exchange forward contracts, currency options and collars Quoted market prices for similar instruments Equity securities measured at fair value through earnings Quoted market prices for identical instruments Equity securities carried at cost as a measurement alternative Valuation of the underlying investments on a new round of third-party financing or upon liquidation Long-term debt and current portion of long-term debt Future cash flows on a borrowing-by-borrowing basis and discounting these future cash flows using the Company's incremental borrowing rates for similar types of borrowing arrangements Cash and cash equivalents, short-term deposits, accounts receivable, short-term borrowings, and accounts payable The carrying amounts reflected in the consolidated financial statements are considered as reasonable estimates of fair value due to the relatively short period of time between the origination of the instruments and their expected realization.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	2 8 . RELATED PARTY TRANSACTIONS The below table summarizes transactions incurred in 2022, 2021 and 2020 with companies for which certain members of the Company’s management perform similar policymaking functions. These include, but are not limited to: Orange and Idemia France. December 31, December 31, December 31, 2022 2021 2020 Sales & other services 13 8 5 Other purchases 25 19 21 Accounts receivable 5 2 1 Accounts payable 2 — — In addition, the Company shares one member of its Supervisory Board with Cassa Depositi e Prestiti SpA (CDP). The Company holds two long-term credit facilities with CDP, which contractual financing terms are described in Note 15. The Company did not hold any significant equity-method investments as of December 31, 2022, 2021 and 2020. Consequently, the Company did not report any material transaction with this type of investees in the corresponding years. The Company made a cash contribution of $1 million for the year ended December 31, 2022 to the ST Foundation, a non-profit organization established to deliver and co-ordinate independent programs in line with its mission. A cash contribution of $0.5 million was made for each of the years ended December 31, 2021 and 2020. Certain members of the Foundation’s Board are senior members of the Company’s management.

Valuation and Qualifying Accoun

Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2022
Valuation And Qualifying Accounts [Abstract]
Valuation and Qualifying Accounts	STMICROELECTRONICS N.V. VALUATION AND QUALIFYING ACCOUNTS Valuation and qualifying accounts deducted from the related asset accounts Balance at beginning of period Translation adjustment Charged to costs and expenses Additions/ (Deductions) Balance at end of period (Currency—millions of U.S. dollars) 2022 Accounts Receivable 19 — — 2 21 Deferred Tax Assets 576 (19 ) (140 ) (1 ) 416 2021 Accounts Receivable 16 — — 3 19 Deferred Tax Assets 638 (24 ) (2 ) (36 ) 576 2020 Accounts Receivable 16 — — — 16 Deferred Tax Assets 1,534 28 (11 ) (913 ) 638

Accounting Policies (Policies)

Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Basis of presentation and consolidation	2.1 Basis of presentation and consolidation The Company's consolidated financial statements include the assets, liabilities, results of operations and cash flows of its wholly-owned and majority-owned subsidiaries, after elimination of intercompany transactions and balances. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases. The Company assesses each investment in equity securities to determine whether the investee is a Variable Interest Entity (“VIE”). The Company consolidates the VIEs for which the Company is determined to be the primary beneficiary. The primary beneficiary of a VIE is the party that: (i) has the power to direct the most significant activities of the VIE and (ii) is obligated to absorb losses or has the rights to receive returns that would be considered significant to the VIE. Assets, liabilities, and the noncontrolling interest of newly consolidated VIEs are initially measured at fair value in the same manner as if the consolidation resulted from a business combination. When the Company owns some, but not all, of the voting stock of a consolidated entity, the shares held by third parties represent a noncontrolling interest . . .
Use of estimates	2.2 Use of estimates The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions . • • • • • • assessment of the Company’s long-lived assets economic useful lives, • • • • The Company bases the estimates and assumptions on historical experience and on various other factors such as market trends, market information used by market participants and the latest available business plans that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. While the Company regularly evaluates its estimates and assumptions, the actual results experienced by the Company could differ materially and adversely from those estimates .
Foreign currency	2.3 Foreign currency The U.S. dollar is the reporting currency of the Company . . . The functional currency of each subsidiary of the Company is either the local currency or the U.S. dollar, depending on the basis of the economic environment in which each subsidiary operates. Foreign currency transactions, including operations in local currency when the U.S. dollar is the functional currency, are measured into the functional currency using the prevailing exchange rate . For consolidation purposes, the results and financial position of the subsidiaries whose functional currency is different from the U.S. dollar are translated into the reporting currency as follows: (a) (b) (c)
Cash and cash equivalents	2.4 Cash and cash equivalents Cash and cash equivalents include cash on hand, deposits held at call with external financial institutions and other short-term highly liquid investments with original maturities of three months or less. They are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates . Short-term deposits representing cash equivalent with original maturity beyond three months are reported as current assets in the line “Short-term deposits” of the consolidated balance sheets.
Trade accounts receivable	2.5 Trade accounts receivable Trade accounts receivable are amounts due from customers for goods sold and services rendered to third parties in the ordinary course of business . In the event of transfers of receivables such as factoring, the Company derecognizes the receivables only to the extent that the Company has surrendered control over the receivables in exchange for a consideration other than beneficial interest in the transferred receivables .
Inventories	2.6 Inventories Inventories are stated at the lower of cost and net realizable value. Actual cost is based on an adjusted standard cost, which approximates cost on a first-in, first-out basis for all categories of inventory (raw materials, work-in-process, finished products). Actual cost is therefore dependent on the Company’s manufacturing performance and cost is based on the normal utilization of its production capacity. In case of underutilization of manufacturing facilities, the costs associated with unused capacity are not included in the valuation of inventories but charged directly to cost of sales. Net realizable value is based upon the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company performs, on a continuous basis, write-offs of inventories, which have the characteristics of slow-moving, old production dates and technical obsolescence. The Company evaluates its inventory to identify obsolete or slow-selling items, as well as inventory that is not of saleable quality and records a specific reserve if the Company estimates the inventory will eventually become obsolete. Reserve for obsolescence is estimated for excess uncommitted inventory based on historical sales data, order backlog and production plans .
Income taxes	2.7 Income taxes Income tax for the period comprises current and deferred income tax. Current income tax represents the income tax expected to be paid or the tax benefit expected to be received related to the current year taxable profit and loss in each tax jurisdiction. Deferred income tax is recognized, using the liability method, for all temporary differences arising between the tax bases of assets and liabilities and their carrying amount in the consolidated financial statements. Deferred tax liabilities are not recognized on the initial recognition of goodwill as a result of a business combination. Deferred income tax is determined using tax rates and laws that are enacted at the balance sheet date and are expected to apply when the related deferred income tax asset is realized or the deferred income tax liability is settled. The effect on deferred tax assets and liabilities from changes in tax laws and tax rates is recognized on the line “Income tax expense” in the consolidated statements of income in the period in which the law is enacted. Deferred income tax assets are recognized in full but the Company assesses whether future taxable profit will be available against which temporary differences can be utilized. A valuation allowance is provided for deferred tax assets when management considers it is more likely than not that they will not be realized. The Company recognizes a deferred tax liability on undistributed earnings of subsidiaries when there is a presumption that taxable earnings will be remitted to the parent. A deferred tax asset is recognized on compensation for the grant of stock awards to the extent that such charge constitutes a temporary difference in the subsidiaries’ local tax jurisdictions. Changes in the stock price do not result in any adjustments to the deferred tax asset prior to vesting. At each reporting date, the Company assesses all significant income tax positions in all tax jurisdictions to determine any uncertain tax positions. The Company uses a two-step process for the evaluation of uncertain tax positions. The first step consists in assessing whether the tax benefit must be recognized. The second step consists in measuring the amount of tax benefit to be recognized on each uncertain tax position. In step 1 (recognition), the Company assesses whether a tax position, based solely on its technical merits, is more likely than not to be sustained upon examination. Only tax positions with a sustainability threshold higher than 50 50 Company accrues for interest and penalties on uncertain tax liabilities reported on the consolidated balance sheets. Interests and penalties are classified as components of income tax expense in the consolidated statements of income .
Business combinations and goodwill	2. 8 Business combinations and goodwill The acquisition method of accounting is applied to all business combinations. The identifiable assets acquired, liabilities assumed, and equity instruments issued are measured at acquisition date fair value. Any contingent consideration is recorded at acquisition date fair value and remeasured at each reporting date. Acquisition-related transaction costs and restructuring costs related to the acquired business are expensed as incurred. Acquired in-process research and development (“IPR&D”) is capitalized and recorded as an intangible asset at acquisition date, subject to impairment testing until the research or development is completed. The excess of the consideration transferred over the acquisition-date fair value of the identifiable assets acquired and liabilities assumed, net of related deferred tax impacts, is recorded as goodwill. In case of a bargain purchase, the Company reassesses whether it has correctly identified all of the assets acquired and all of the liabilities assumed, the noncontrolling interest in the acquiree, if any, the Company’s previously held equity interest in the acquiree, if any, and the consideration transferred. If after this review, a bargain purchase is still indicated, it is recognized in earnings attributable to parent company stockholders. The purchase of additional interests in a partially owned subsidiary is treated as an equity transaction as well as all transactions concerning the sale of subsidiary stock or the issuance of stock by the partially owned subsidiary, assuming there is no change in control of the subsidiary. In the case of a sale of subsidiary shares, whereby the Company no longer maintains control of the subsidiary, the Company recognizes a gain or loss in earnings. Goodwill is carried at cost less accumulated impairment losses, if any. Goodwill is not amortized but is tested for impairment at least annually, and more frequently whenever events or changes in circumstances indicate that the carrying amount of goodwill may not be recoverable. Goodwill subject to potential impairment is tested at the reporting unit level. The impairment test determines whether the fair value of each reporting unit under which goodwill is allocated is lower than the total carrying amount of relevant net assets allocated to such reporting unit, including its allocated goodwill. The Company records an impairment loss on goodwill when a reporting unit’s carrying value exceeds its fair value. Significant management judgments and estimates are used in forecasting the future discounted cash flows associated with the reporting unit, including: the applicable industry’s sales volume forecast and selling price evolution, the reporting unit’s market penetration and its revenues evolution, the market acceptance of certain new technologies and products, the relevant cost structure, the discount rates applied using a weighted average cost of capital and the perpetuity rates used in calculating cash flow terminal values.
Intangible assets with definite useful lives	2. 9 Intangible assets with definite useful lives Intangible assets subject to amortization include intangible assets purchased from third parties recorded at cost and intangible assets acquired in business combinations initially recorded at fair value. Amortization begins when the intangible asset is available for its intended use. Amortization reflects the pattern in which the asset’s economic benefits are consumed, which usually consists in applying the straight-line method to allocate the cost of the intangible assets over their estimated useful lives. The carrying value of intangible assets with definite useful lives is evaluated whenever changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized for the amount by which the asset’s carrying amount exceeds its fair value. The Company evaluates the remaining useful life of an intangible asset at each reporting date to determine whether events and circumstances warrant a revision to the remaining period of amortization Technologies and licenses Separately acquired technologies and licenses are recorded at historical cost. Technologies and licenses acquired in a business combination are initially recognized at acquisition date fair value. Technologies and licenses have a useful life which usually ranges from 3 to 8 years Computer software Separately acquired computer software is recorded at historical cost. Costs associated with maintaining computer software programs are expensed as incurred and reported as “Cost of sales”, “Selling, general and administrative”, or “Research and development” in the consolidated statements of income according to their intended use. The capitalization of costs for internally generated software developed by the Company for its internal use begins when the preliminary project stage is completed and when the Company, implicitly or explicitly, authorizes and commits to funding a computer software project. It must be probable that the project will be completed and will be used to perform the function intended. Amortization of computer software begins when the software is available for its intended use and is calculated using the straight-line method over the estimated useful life, which does not excee d 4 years .
Property, plant and equipment	2.1 0 Property, plant and equipment Property, plant and equipment are stated at historical cost, net of accumulated depreciation and any impairment losses. Property, plant and equipment acquired in a business combination are initially recognized at acquisition date fair value. Land is not depreciated. Depreciation on fixed assets is computed using the straight-line method over their estimated useful lives, as follows : Buildings 33 years Facilities and leasehold improvements 5-10 years Machinery and equipment 2-10 years Computer and R&D equipment 3-6 years Other 2-5 years Property, plant and equipment are periodically reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or a group of assets may not be recoverable. Several impairment indicators exist for making this assessment, such as: restructuring plans, significant changes in the technology, market, economic or legal environment in which the Company operates, available evidence of obsolescence of the asset, or indication that its economic performance is, or will be, worse than expected. In determining the recoverability of assets to be held and used, the Company initially assesses whether the carrying value of the tangible assets or group of assets exceeds the undiscounted cash flows associated with these assets. If exceeded, the Company then evaluates whether an impairment charge is required by determining if the asset’s carrying value also exceeds its fair value. This fair value is normally estimated by the Company based on independent market appraisals or the sum of discounted future cash flows, using market assumptions such as the utilization of the Company’s fabrication facilities and the ability to upgrade such facilities, change in the selling price and the adoption of new technologies. The Company also evaluates, and adjusts if appropriate, the assets’ useful lives When property, plant and equipment are retired or otherwise disposed of, the net book value of the assets is removed from the Company’s books. Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are included in “Other income and expenses, net” in the consolidated statements of income . The Company did not hold any significant assets held for sale as of December 31, 2022 and December 31, 2021.
Leases	2.1 1 Leases A lease contract is a contract, or part of a contract, that conveys the right to control the use of an identified asset for a period of time in exchange for consideration. If a lease is identified, classification between finance or operating is determined at lease commencement. Most leases entered by the Company are operating leases. Operating lease liabilities are recognized at the present value of the future lease payments at the lease commencement date. The rate implicit in the lease should be used as a discount rate whenever that rate is readily determinable. In most cases, this rate is not readily determinable and therefore, the Company Right-of-use assets are included in the line “Property, plant and equipment, net” of the consolidated balance sheet. Operating lease liabilities due within one year are included in the line “Other payables and accrued liabilities”, while noncurrent operating lease liabilities are included in the line “Other long-term liabilities” of the Company’s consolidated balance sheets. Operating lease expenses are recognized in the consolidated statements of income, on a straight-line basis over the lease period and reported as “Cost of sales”, “Selling, general and administrative”, or “Research and development”, according to the intended use of the leased asset . Finance lease liabilities due within one year are included in the line “Short-term debt”, while noncurrent finance lease liabilities are included in the line “Long-term debt” of the Company’s consolidated balance sheets. Right-of-use assets for finance leases are depreciated on a straight-line basis since the lease commencement date over the lease period or the estimated useful life of the leased asset in case of transfer of ownership or purchase option that is reasonably certain to be exercised. The depreciation expense is reported as “Cost of sales”, “Selling, general and administrative”, or “Research and development”, according to the intended use of the leased asset . Certain lease contracts contain options to extend the lease. On these contracts, t commencement date only. Additionally, lease contracts with a sum of lease payments not exceeding$5,000 are The right-of-use asset is a nonmonetary asset while the lease liability is a monetary liability. When accounting for a lease that is denominated in a foreign currency, the lease liability is remeasured using the current exchange rate, while the right-of-use asset is measured using the historical exchange rate as of the commencement date. The Company does not separate lease and non-lease components and instead accounts for each separate lease component and the non-lease components associated with that lease component as a single lease component. Variable lease payments that depend on an index or a rate are included in the lease payments and are measured using the prevailing index or rate at the measurement date. Changes to index and rate-based variable lease payments are recognized in earnings in the period of the change .
Loss contingencies	2.1 2 Loss contingencies In determining loss contingencies, the Company considers the likelihood of the incurrence of a liability as well as the ability to reasonably estimate the amount of such loss or liability. An estimated loss from a loss contingency is accrued when information available indicates that it is probable that a liability has been incurred at the date of the consolidated financial statements and when the amount of the loss can be reasonably estimated .
Long-term debt	2.1 3 Long-term debt (a) Convertible debt The Company adopted on January 1, 2022 the new guidance on distinguishing liabilities from equity by applying the modified retrospective approach, with the impact upon transition recorded in retained earnings for instruments outstanding as of the adoption date. Prior to the new guidance adoption, the Company evaluated, at initial recognition of a convertible debt, the different components and features of the hybrid instruments and determined whether certain elements were embedded derivative instruments which required bifurcation. Components of convertible debt instruments that may be settled in cash upon conversion based on a net-share settlement basis were accounted for separately as long-term debt and equity when the conversion feature of the convertible bonds constituted an embedded equity instrument. When an equity instrument was identified, proceeds from issuance were allocated between debt and equity by measuring first the liability component and then determining the equity component as a residual amount. The liability component was measured as the fair value of a similar non-convertible debt, which resulted in the recognition of a debt discount. In subsequent periods, the Company amortized the debt discount through earnings in the line “Interest income (expense), net” of the consolidated statements of income, using the effective interest method, based on the contractual maturity of the debt. The equity component, reported on the line “Additional paid-in capital” of the consolidated statement of equity, was not remeasured. Deferred taxes were recognized on the difference between the carrying amount of the liability component and its tax basis . difference between the carrying amount of the debt at the settlement date and the fair value of the debt component was recorded in earnings as a loss on debt extinguishment and reported in the line “Loss on financial instruments, net” of the consolidated statements of income. The liability component was measured as the fair value of a similar non-convertible debt prior to settlement. The reacquired equity component was recorded in equity and reported on the line “Additional paid-in capital” of the consolidated statement of equity . The new accounting guidance adopted on January 1, 2022 has eliminated the cash conversion model in ASC 470-20 applicable to the convertible debt issued by the Company, which required separate accounting for embedded conversion features. At initial recognition, total cash proceeds received at issuance are reported as financial debt and no equity conversion instrument is recorded separately in equity. Impact of the new guidance upon adoption is further described in Note 2.25. Debt issuance costs are reported as a deduction of debt. They are subsequently amortized through earnings on the line “Interest income (expense), net” of the consolidated statements of income, using the effective interest rate method . (b) Bank loans Bank loans and non-convertible senior bonds are recognized at the amount of cash proceeds received, net of debt issuance costs incurred. They are subsequently reported at amortized cost; any difference between the proceeds (net of debt issuance costs) and the principal amount is recognized through earnings on the line “Interest income (expense), net” of the consolidated statements of income over the period of the borrowings using the effective interest method .
Employee benefits	2.1 4 Employee benefits (a) Pension obligations The Company sponsors various pension schemes for its employees. These schemes conform to local regulations and practices in the countries in which the Company operates. Such plans include both defined benefit and defined contribution plans. For defined benefit pension plans, the liability recognized in the consolidated balance sheets is the present value of the defined benefit obligation at the balance sheet date less the fair value of plan assets. The overfunded or underfunded status of the defined benefit plans are calculated as the difference between plan assets and the projected benefit obligations. Estimates are used in determining the assumptions incorporated in the calculation of the pension obligations, which is supported by input from independent actuaries. Actuarial gains and losses arising from changes in actuarial assumptions are recognized in “Accumulated other comprehensive income (loss)” in the consolidated statements of equity and are charged or credited to earnings over the employees’ expected average remaining working lives. Past service costs are recognized in “Accumulated other comprehensive income (loss)” in the consolidated statements of equity and are amortized on a straight-line basis over the vesting period. The net periodic benefit cost of the year is determined based on the assumptions used at the end of the previous year. Past service costs are recognized in earnings on the line “Other components of pension benefit costs” of the consolidated statements of income if the changes to the pension scheme are not conditional on the employees remaining in service for a specified period (the vesting period) . For defined contribution pension plans, the Company pays contributions to publicly or privately administered pension insurance plans on a mandatory, contractual or voluntary basis. The Company has no further payment obligations once the contributions have been paid. The contributions are recognized as employee benefit expense when they are due. Prepaid contributions are recognized as an asset to the extent that a cash refund or a reduction in the future payments is available . The service cost component of net periodic benefit costs is presented in the same income statement line as other employee compensation costs arising from services rendered during the period. The other components of the net periodic benefit cost are presented separately, outside operating income, on the line “Other components of pension benefit costs” of the consolidated statements of income. These elements include: interest cost; expected return on plan assets; amortization of transition (asset) obligation; amortization of prior service cost; amortization of net (gain) loss; (gain) loss recognized due to curtailment or settlement and; cost of special termination benefits . ( b ) Termination benefits Termination benefits are payable when an employee is involuntarily terminated, or whenever an employee accepts voluntary termination in exchange for termination benefits. For the accounting treatment and timing recognition of involuntary termination benefits, the Company distinguishes between one-time termination benefit arrangements and ongoing termination benefit arrangements. A one-time termination benefit arrangement is established by a termination plan and applies to a specified termination event. One-time involuntary termination benefits are recognized as a liability when the termination plan meets certain criteria and has been communicated to employees. If employees are required to render future service in order to receive these one-time termination benefits, the liability is recognized ratably over the future service period. Termination benefits other than one-time termination benefits are termination benefits for which the communication criterion is not met but that are committed to by management, or termination obligations that are not specifically determined in a new and single plan. These termination benefits are all legal, contractual and past practice termination obligations to be paid to employees in case of involuntary termination. These termination benefits are accrued for when commitment creates a present obligation to others for the benefits expected to be paid, when it is probable that employees will be entitled to the benefits and the amount can be reasonably estimated . In case of special termination benefits related to voluntary redundancy programs, the Company recognizes a provision for voluntary termination benefits at the date on which the employee irrevocably accepts the offer and the amount can be reasonably estimated . (c) Profit-sharing and bonus plans The Company recognizes a liability and an expense for bonuses and profit-sharing plans when a contractual obligation exists or where there is a past practice that has created a present obligation (d) Other long-term employee benefits The Company provides long-term employee benefits such as seniority awards in certain countries. The entitlement to these benefits is usually conditional on the employee completing a minimum service period. The expected costs of these benefits are accrued over the period of employment. Actuarial gains and losses arising from changes in actuarial assumptions are charged or credited to earnings in the period of the revised estimate. These obligations are valued annually with the assistance of independent qualified actuaries (e) Share-based compensation The Company accounts for stock-based compensation for all stock-based awards granted to senior executives and selected employees, including awards that vest upon the satisfaction of a service condition and awards that vest upon the satisfaction of both a service condition and a performance condition. Both equity awards vest over a three-year measures the cost of the awards based on the grant-date fair value of the awards, reflecting the market price of the underlying shares at the date of the grant, reduced by the present value of the dividends expected to be paid on the shares during the requisite service period. That cost is recognized using graded vesting over the period during which an employee is required to provide service in exchange for the award or the requisite service period. The compensation cost is recorded through earnings with the corresponding amount reported in equity, under “Additional paid-in capital” of the consolidated statements of equity. The compensation cost is calculated based on the number of awards expected to vest, net of an estimated number of awards to be forfeited due to the employees failing to satisfy the service condition or one or more performance conditions. By the end of the vesting period, compensation is recognized only for the awards that ultimately vest. Liabilities for the Company’s portion of payroll taxes are recognized at vesting, which is the event triggering the payment of the social contributions in most of the Company’s local tax jurisdictions. Employee-related social charges are measured based on the intrinsic value of the share and recorded at vesting
Share capital	2.1 5 Share capital Ordinary shares are classified as “Common stock” within equity on the consolidated balance sheets. Incremental costs directly attributable to the issuance of new shares are shown in equity as a deduction, net of tax, from the proceeds received. Where the Company purchases its own equity share capital (treasury stock), the consideration paid, including any directly attributable incremental costs (net of income taxes), is deducted from parent company stockholders’ equity until the shares are cancelled, reissued, or disposed of.
Comprehensive income (loss)	2.1 6 Comprehensive income (loss) Comprehensive income (loss) is defined as the change in equity of a business during a period except those changes resulting from investment by and distributions to stockholders. In the consolidated financial statements, Other comprehensive income (loss) and “Accumulated other comprehensive income” primarily consists of foreign currency translation adjustments, unrealized gains (losses) on debt securities classified as available-for-sale, unrealized gains (losses) on derivatives designated as cash flow hedge and the accounting for defined benefit plans as described in Note 2.14, net of tax
Revenue recognition	2.1 7 Revenue recognition Arrangements with customers are considered contracts if all the following criteria are met: (a) parties have approved the contract and are committed to perform their respective obligations; (b) each party’s rights regarding the goods or services to be transferred can be identified; (c) payment terms for the goods or services to be transferred can be identified; (d) the contract has commercial substance and (e) collectability of substantially all of the consideration is probable. The Company recognizes revenue from products sold to a customer, including distributors, when it satisfies a performance obligation by transferring control over a product to the customer. In certain circumstances, the Company may enter into agreements that concern principally revenues from services, where the performance obligation is satisfied over time. The objective when allocating the transaction price is to allocate the transaction price to each performance obligation (or distinct good or service) in an amount that depicts the amount of consideration to which the Company expects to be entitled in exchange for transferring the promised goods or services to the customer. The payment terms typically range between Certain customers require the Company to hold inventory as consignment in their hubs and only purchase inventory when they require it. Revenue for sales of such inventory is recognized when, at the customer’s option, the products are withdrawn from the consignment and the Company satisfies a performance obligation by transferring control over a product to the customer Consistent with standard business practice in the semiconductor industry, price protection is granted to distribution customers on their existing inventory of the Company’s products to compensate them for changes in market prices. The Company accrues a provision for price protection based on a rolling historical price trend computed monthly as a percentage of gross distributor sales. This historical price trend represents differences in recent months between the invoiced price and the final price to the distributor, adjusted to accommodate a significant change in the selling price. The short outstanding inventory time, visibility into the inventory product pricing and long distributor pricing history have enabled the Company to reliably estimate price protection provisions at period-end. The Company records the accrued amounts as a deduction of “Net sales” in the consolidated The Company’s customers occasionally return the Company’s products for technical reasons. The Company’s . . . deduction of “Net sales” in the consolidated statements of income, using historical and current conditions to form a reasonable estimate of future returns The Company records a provision for warranty costs as a charge against “Cost of sales” in the consolidated statements of income, based on historical trends of warranty costs incurred as a percentage of sales, which management has determined to be a reasonable estimate of the probable losses to be incurred for warranty claims in a period. Any potential warranty claims are subject to the Company’s determination that the Company is at fault for damages, and such claims usually must be submitted within a short period of time following the date of sale . This warranty is given in lieu of all other warranties, conditions or terms expressed or implied by statute or common law . The Company’s contractual terms and conditions typically limit its liability to the sales value of the products which gave rise to the claims . The Company’s insurance policy relating to product liability covers third-party physical damages and bodily injury, indirect financial damages as well as immaterial non-consequential damages caused by defective products. In addition to product sales, the Company enters into arrangements with customers consisting in transferring licenses or related to license services. The revenue generated from these arrangements are reported on the line “Other revenues” of the consolidated statements of income. Other revenues also include patent royalty income, sale of scrap materials and manufacturing by-products
Public funding	2. 1 8 Public funding The Company receives funding mainly from governmental agencies and income is recognized when all contractual conditions for receipt of these funds are fulfilled. The Company’s primary sources for government funding are French, Italian and other country governmental entities. Such funding is generally provided to encourage research, development and other innovation activities, industrialization and local economic development. The conditions to receive government funding may include eligibility restrictions, approval by the European Union authorities, annual budget appropriations, compliance with European Commission regulations, as well as specifications regarding objectives and results. Certain specific contracts include obligations to maintain a minimum level of employment and investment during a certain period. There could be penalties if these objectives are not fulfilled. Other contracts contain penalties for late deliveries or for breach of contract, which may result in repayment obligations. Funding related to these contracts is recorded when the conditions required by the contracts are met. The Company’s funding programs are classified under two general categories: funding for research, development and other innovative activities, and capital investments Funding for research, development and innovative activities is the most common form of funding that the Company receives. This public funding is recorded as “Other income and expenses, net” in the consolidated statements of income. The funding is recognized ratably as the related costs are incurred once the agreement with the respective governmental agency has been signed and all applicable conditions are met French research tax credits (“Crédit Impôt Recherche”) and Italian research tax credits (“Credito d’Imposta Ricerca & Sviluppo”) are deemed to be grants in substance. The French research tax credits are to be paid in cash by the taxing authorities within in case they are not deducted from income tax payable during this period of time. The Italian tax credits are compensated against payroll-related social charges. French and Italian tax credits are reported as a reduction of “Research and development” in the consolidated statements of income Capital investment funding is recorded as a reduction of “Property, plant and equipment, net” and is recognized in the Company’s consolidated statements of income by offsetting the depreciation charges of the funded assets during their useful lives. The Company also receives capital funding in Italy, which can be recovered through the reduction of various governmental liabilities, including income tax, value-added tax and employee-related social charges Funding receivables are reported as non-current assets unless cash settlement features of the receivables evidence that collection is expected within one year. Long-term receivables that do not present any tax attribute or legal restriction are reflected in the consolidated balance sheets at their net present value when the discounting effect is deemed to be significant
Research and development	2. 19 Research and development Research and development expenses include costs incurred by the Company, the Company’s share of costs incurred by other research and development interest groups, and costs associated with co-development contracts. Research and development expenses do not include marketing design center costs, which are accounted for as “Selling, general and administrative” in the consolidated statements of income and process engineering, pre-production or process transfer costs which are recorded as “Cost of sales” in the consolidated statements of income. Research and development costs are expensed as incurred. The amortization expense recognized on technologies and licenses purchased by the Company from third parties to facilitate the Company’s research and development activities is reported as “Research and development” in the consolidated statements of income
Advertising costs	2.2 0 Advertising costs Advertising costs are expensed as incurred and are recorded as “Selling, general and administrative” in the consolidated statements of income . 14
Start-up and phase-out costs	2.2 1 Start-up and phase-out costs Start-up costs represent costs incurred in the ramp-up phase of the Company's newly integrated manufacturing facilities. The costs of phase-outs are associated with the latest stages of facilities closure when the relevant production volumes become immaterial. Start-up costs and phase-out costs are included in the line Other income and expenses, net of the consolidated statements of income
Investments in equity securities	2.2 2 Investments in equity securities Investments in equity securities that have readily determinable fair values and for which the Company does not have the ability to exercise significant influence are classified as equity securities measured at fair value through earnings. Changes in the fair value of these securities are reported in the consolidated statements of income within “Other income and expenses, net” when these instruments are held within the Company’s operating activities. Gains and losses arising from changes in the fair value of securities not related to operating activities are presented in the consolidated statements of income as non-operating elements within “Gain (loss) on financial instruments, net” in the period in which they arise For investments in equity securities without readily determinable fair values and for which the Company does not have the ability to exercise significant influence, the Company has elected to apply the cost method as a measurement alternative. Under the cost method of accounting, investments are carried at historical cost, less impairment, adjusted for subsequent observable price changes. An impairment loss is recorded when there are identified events or changes in circumstances that may have a significant adverse effect on the value of the investment. Loss is immediately recorded in the consolidated statements of income on the line “Gain (loss) on financial instruments, net” and is based on the Company’s assessment of any significant and sustained reductions in the investment’s value. Gains and losses on investments sold are determined on the specific identification method and are recorded as non-operating element in the line “Gain (loss) on financial instruments, net” of the consolidated statements of income when the transaction is not related to operating activities The fair values of quoted equity securities are based on current market prices. If the market for a financial asset is not active and if no observable market price is obtainable, the Company measures fair value by using assumptions and estimates. In measuring fair value, the Company makes maximum use of market inputs and minimizes the use of unobservable inputs The Company did not hold any material equity securities as of December 31, 2022 and December 31, 2021.
Investments in debt securities	2.2 3 Investments in debt securities Debt securities are included in current assets when they represent investments of funds available for current operations or when management intends to dispose of the securities within twelve months of the balance sheet date . Changes in fair value of debt securities classified as available-for-sale are recognized as a component of “Other comprehensive income (loss)” in the consolidated statements of comprehensive income. The Company assesses at each balance sheet date whether there is objective evidence that a debt security or group of debt securities is impaired. An unrealized impairment loss exists when the fair value of the instrument declines below its amortized cost basis. An impairment loss is recognized in earnings, through a direct reduction of the value of the asset, when the Company intends to sell the debt security or when it is more likely than not that the Company will be required to sell the instrument before recovery of the amortized cost basis . Moreover, an impairment loss is recognized in earnings through a credit loss allowance for any portion of the unrealized impairment loss resulting from a credit loss. Impairment losses recognized in the consolidated statements of income are not reversed through earnings . The fair values of quoted debt securities are based on current market prices. If the market for a financial asset is not active and if no observable market price is obtainable, the Company measures fair value by using assumptions and estimates. In measuring fair value, the Company makes maximum use of market inputs and minimizes the use of unobservable inputs The Company did not hold any debt securities classified as held-to-maturity or for which the Company would have elected to apply the fair value option
Derivative financial instruments and hedging activities	2.2 4 Derivative financial instruments and hedging activities Derivative financial instruments are initially recognized on the date a derivative contract is entered into and are subsequently measured at fair value. The method of recognizing the gain or loss resulting from the derivative instrument depends on whether the derivative is designated as a hedging instrument, and if so, the nature of the hedge transaction. The Company has designated certain derivatives as hedges of a particular risk associated with a highly probable forecasted transaction (cash flow hedge). The Company documents, at inception of the transaction, the relationship between hedging instruments and hedged items, as well as its risk management objectives and strategy for undertaking various hedging transactions. The Company also documents its assessment, both at hedge inception and on an ongoing basis, of whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in cash flows of hedged items. Derivative instruments that are not designated as hedges are measured at fair value through earnings . Cash Flow Hedge As part of its ongoing operating, investing and financing activities, the Company enters into certain derivative transactions that may be designated and may qualify as hedging instruments. To reduce its exposure to U.S. dollar exchange rate fluctuations, the Company hedges certain Euro-denominated forecasted transactions that cover at reporting date a large part of its research and development, and selling, general and administrative expenses as well as a portion of its front-end manufacturing costs of semi-finished goods within cost of sales through the use of currency forward contracts and currency options, including collars. The Company also hedges through the use of currency forward contracts certain Singapore dollar-denominated manufacturing forecasted transactions. The derivative instruments are designated and qualify for cash flow hedge at inception of the contract and on an ongoing basis over the duration of the hedge relationship. They are reflected at their fair value as “Other current assets” or “Other payables and accrued liabilities” in the consolidated balance sheets. The criteria for designating a derivative as a hedge include the instrument’s effectiveness in risk reduction and a one-to-one matching of the derivative instrument to its underlying transaction with the critical terms of the hedging instrument matching the terms of the hedged forecasted transaction. This enables the Company to conclude that changes in cash flows attributable to the risk being hedged are expected to be substantially offset by the hedging instruments. For derivative instruments designated as cash flow hedge, the change in fair value for the effective portion of the hedge is reported as a component of “Other comprehensive income (loss)” in the consolidated statements of comprehensive income and is reclassified into earnings in the same period in which the hedged transaction affects earnings, and within the same consolidated statements of income line as the hedged transaction. For these derivatives, ineffectiveness appears if the cumulative gain or loss on the derivative hedging instrument exceeds the cumulative change in the expected future cash flows on the hedged transaction. Effectiveness on transactions hedged through purchased options is measured on the full fair value of the option, including time value . Derivative financial instruments not designated as a hedge The Company conducts its business on a global basis in various major international currencies. As a result, the Company is exposed to adverse movements in foreign currency exchange rates. The Company enters into foreign currency forward contracts and currency options to reduce its exposure to changes in exchange rates and the associated risk arising from the denomination of certain assets and liabilities in foreign currencies at the Company's subsidiaries. Financial instruments not designated as a hedge are classified as current assets when they are expected to be realized within twelve months of the balance sheet date. Marked-to-market gains or losses arising from changes in the fair value of these instruments are reported in the consolidated statements of income within “Other income and expenses, net” in the period in which they arise, since the transactions for these instruments occur within the Company’s operating activities .
Recent accounting pronouncements	2.2 5 Recent accounting pronouncements (a) Accounting pronouncements effective in 2022 In August 2020, the FASB issued new guidance on distinguishing liabilities from equity and EPS, to simplify an issuer’s accounting for convertible instruments by eliminating the cash conversion and beneficial conversion feature models in ASC 470-20 that require separate accounting for embedded conversion features. The guidance also simplifies the settlement assessment that issuers perform to determine whether a contract in their own equity qualifies for equity classification. Finally, the guidance requires entities to use in the calculation of the diluted EPS the if-converted method for all convertible instruments and to include the effect of share settlement for instruments that may be settled in cash or shares. The new guidance was effective for public companies for annual periods beginning after December 15, 2021, with early adoption permitted in fiscal years beginning after December 15, 2020. The guidance could be adopted either on a full retrospective basis or by applying the modified retrospective approach, with the impact upon transition recorded in retained earnings for existing instruments outstanding as of the adoption date. The guidance became effective for the Company on January 1, 2022. The Company adopted the new guidance by applying the modified retrospective method on instruments outstanding at transition date. These instruments correspond solely to the dual-tranche senior unsecured convertible bonds issued on August 4, 2020, which are convertible instruments with cash conversion features in the scope of the new guidance . In November 2021, the FASB issued new guidance on disclosures about government assistance, to increase the transparency in reporting government assistance, including the disclosure of (1) the types of assistance, (2) an entity’s accounting for the assistance, and (3) the effect of the assistance on an entity’s financial statements. The new guidance was effective for public companies for annual periods beginning after December 15, 2021, with early adoption permitted in fiscal years beginning after December 15, 2020. The guidance became effective for the Company on January 1, 2022, with no significant impact on its annual disclosures. Relevant disclosures are included in Note 7. (b) Accounting pronouncements expected to impact the Company’s operations that are not yet effective and have not been early adopted by the Company The Company’s financial statements and operations are not expected to be significantly impacted by any accounting pronouncements that are not yet effective and not early adopted by the Company.

Accounting Policies (Tables)

Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Schedule of Property, Plant and Equipment Useful Lives	Land is not depreciated. Depreciation on fixed assets is computed using the straight-line method over their estimated useful lives, as follows : Buildings 33 years Facilities and leasehold improvements 5-10 years Machinery and equipment 2-10 years Computer and R&D equipment 3-6 years Other 2-5 years

Short-Term Deposits and Marke_2

Short-Term Deposits and Marketable Securities (Tables)	12 Months Ended
	Dec. 31, 2022
Investments Debt And Equity Securities [Abstract]
Changes in Value of Marketable Securities Reported in Current Assets on Consolidated Balance Sheets	To optimize the return yield on its short-term investments, the Company invested $581 million of available cash in short-term deposits as of December 31, 2022, compared to $291 million as of December 31, 2021. These short-term deposits represent liquid assets with original maturity beyond three months and no significant risk of changes in fair value. Changes in the fair value of marketable securities are detailed in the tables below: December 31, 2021 Purchase Accretion Proceeds at maturity Change in fair value included in OCI* December 31, 2022 U.S. Treasury debt securities — 687 8 — (16 ) 679 Total — 687 8 — (16 ) 679 * Other Comprehensive Income December 31, 2020 Purchase Accretion Proceeds at maturity Change in fair value included in OCI* December 31, 2021 U.S. Treasury debt securities 133 — — (132 ) (1 ) — Total 133 — — (132 ) (1 ) — * Other Comprehensive Income

Trade Accounts Receivable, Net

Trade Accounts Receivable, Net (Tables)	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
Trade Accounts Receivable, Net	Trade accounts receivable, net consisted of the following: December 31, December 31, 2022 2021 Trade accounts receivable 1,991 1,778 Current expected credit losses allowance ( “ ” (21 ) (19 ) Total 1,970 1,759
Schedule of Changes in Reported CECLA	On that basis, the changes in reported CECLA for the year ended December 31, 2022 are presented below: CECLA As of December 31, 2021 (19) Current-period adjustment to CECLA (2) CECLA As of December 31, 2022 (21)

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2022
Inventory Disclosure [Abstract]
Inventories	Inventories consisted of the following: December 31, December 31, 2022 2021 Raw materials 349 223 Work-in-process 1,490 1,235 Finished products 744 514 Total 2,583 1,972

Other Current Assets (Tables)

Other Current Assets (Tables)	12 Months Ended
	Dec. 31, 2022
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract]
Other Current Assets	Other current assets consisted of the following: December 31, 2022 December 31, 2021 Public funding receivables 190 296 Taxes and other government receivables 270 119 Advances and prepayments 125 118 Loans and deposits 10 8 Interest receivable 22 1 Derivative instruments 56 6 Other current assets 61 33 Total 734 581

Goodwill (Tables)

Goodwill (Tables)	12 Months Ended
	Dec. 31, 2022
Goodwill And Intangible Assets Disclosure [Abstract]
Changes in Carrying Amount of Goodwill	Goodwill allocated to reportable segments as of December 31, 2022 and 2021 and changes in the carrying amount of goodwill during the years ended December 31, 2022 and 2021 are as follows: ADG AMS MDG Total December 31, 2020 91 2 237 330 Measurement period adjustment — — 1 1 Foreign currency translation (8) — (10) (18) December 31, 2021 83 2 228 313 Measurement period adjustment — — — — Foreign currency translation (9) — (7) (16) December 31, 2022 74 2 221 297

Other Intangible Assets, Net (T

Other Intangible Assets, Net (Tables)	12 Months Ended
	Dec. 31, 2022
Goodwill And Intangible Assets Disclosure [Abstract]
Other Intangible Assets, Net	Other intangible assets, net consisted of the following: December 31, 2022 Gross Amount Accumulated Amortization Net Amount Technologies & licenses 1,064 (795 ) 269 Purchased & internally developed software 609 (514 ) 95 Technologies in progress 41 — 41 Total 1,714 (1,309 ) 405 December 31, 2021 Gross Amount Accumulated Amortization Net Amount Technologies & licenses 1,050 (746 ) 304 Purchased & internally developed software 567 (485 ) 82 Technologies in progress 52 — 52 Total 1,669 (1,231 ) 438
Estimated Future Amortization Expense Related to Intangible Assets	Estimated future amortization expense related to intangible assets as of December 31, 2022 is as follows: Year 2023 112 2024 98 2025 72 2026 42 2027 20 Thereafter 61 Total 405

Property, Plant and Equipment_2

Property, Plant and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2022
Property Plant And Equipment [Abstract]
Property, Plant and Equipment, Net	Property, plant and equipment, net consisted of the following: December 31, 2022 Gross Amount Accumulated Depreciation Net Amount Land 83 — 83 Buildings 1,116 (563 ) 553 Facilities & leasehold improvements 3,877 (2,895 ) 982 Machinery and equipment 18,751 (14,023 ) 4,728 Computer and R&D equipment 398 (319 ) 79 Operating lease right-of-use assets 311 (118 ) 193 Finance lease right-of-use assets 57 (2 ) 55 Other tangible assets 169 (95 ) 74 Construction in progress 1,454 — 1,454 Total 26,216 (18,015 ) 8,201 December 31, 2021 Gross Amount Accumulated Depreciation Net Amount Land 84 — 84 Buildings 951 (562 ) 389 Facilities & leasehold improvements 3,490 (2,936 ) 554 Machinery and equipment 17,085 (13,786 ) 3,299 Computer and R&D equipment 395 (333 ) 62 Operating lease right-of-use assets 314 (114 ) 200 Other tangible assets 147 (97 ) 50 Construction in progress 1,022 — 1,022 Total 23,488 (17,828 ) 5,660

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2021
Lessee Disclosure [Abstract]
Schedule of Lessee Operating and Finance Leases	Operating and finance leases consisted of the following: December 31, 2022 December 31, 2021 Right-of-use assets Operating leases 193 200 Finance Leases 55 — Total right-of-use assets 248 200 Lease liabilities Current 59 55 Operating leases 52 55 Finance Leases 7 — Non-current 191 148 Operating leases 141 148 Finance Leases 50 — Total lease liabilities 250 203
Lessee Operating and Finance Lease Liability Maturity	Maturities of operating lease liabilities are as follows: Operating Leases Finance Leases December 31, 2022 2023 57 8 65 2024 40 5 45 2025 27 5 32 2026 19 5 24 2027 12 28 40 Thereafter 86 23 109 Total future undiscounted cash outflows 241 74 315 Effect of discounting (48 ) (17 ) (65 ) Total operating lease liabilities 193 57 250
Schedule of Operating and Finance Lease Term and Discount Rate	Operating and finance lease terms and discount rates are as follows: December 31, 2022 December 31, 2021 Weighted average remaining lease term (in years) – operating leases 9.46 9.38 Weighted average remaining lease term (in years) – finance leases 9.89 — Weighted average discount rate – operating lease 3.12 % 2.69 % Weighted average discount rate – finance lease 3.86 % —
Schedule of Operating and Finance Lease Cost and Cash Paid	Operating and finance lease cost and cash paid are as follows: 2022 2021 Operating lease cost 62 68 Finance lease cost Amortization of right-of-use assets 2 — Interest 1 — Operating lease cash paid 63 67 Finance lease cash paid — —
Schedule of Right of Use Assets Obtained in Exchange for Operating Lease and Finance Liabilities	Right-of-use assets obtained in exchange for new operating lease liabilities are as follows: 2022 2021 Operating leases 60 80 Finance leases 55 —

Long-Term Investments (Tables)

Long-Term Investments (Tables)	12 Months Ended
	Dec. 31, 2022
Investments Debt And Equity Securities [Abstract]
Long-Term Investments	December 31, 2022 December 31, 2021 Long-term investments 11 10 Total 11 10

Other Non-Current Assets (Table

Other Non-Current Assets (Tables)	12 Months Ended
	Dec. 31, 2022
Investments All Other Investments [Abstract]
Other Non-Current Assets	Other non-current assets consisted of the following: December 31, December 31, 2022 2021 Equity securities 26 29 Receivables from government agencies 156 124 French research tax credit receivable 294 376 Defined benefit plans 9 15 Prepayments and deposits to third parties 107 21 Derivative instruments 13 — Other non-current assets 56 74 Total 661 639

Other Payables and Accrued Li_2

Other Payables and Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2022
Payables And Accruals [Abstract]
Other Payables and Accrued Liabilities	Other payables and accrued liabilities consisted of the following: December 31, 2022 December 31, 2021 Employee related liabilities 599 536 Employee compensated absences 196 181 Taxes other than income taxes 68 58 Advances from customers 225 25 Advances from grants 37 34 Derivative instruments 35 43 Defined benefit and contribution plans 39 34 Royalties 32 29 Current operating lease liabilities 52 55 Deferred and contingent consideration on business combinations — 27 Others 102 79 Total 1,385 1,101

Long-Term Debt (Tables)

Long-Term Debt (Tables)	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Long-Term Debt	Long-term debt consisted of the following: December 31, December 31, 2022 2021 Funding program loans from European Investment Bank ("EIB"): 2.67% due 2028, floating interest rate at Euribor + 0.589% 163 202 1.20% 0.564% 183 222 1.31% 0.583% 322 379 0.89% 0.660% 159 187 Credit Facility from Cassa Depositi e Prestiti SpA ("CDP") 3.15% 0.690% 120 156 1.85% 0.550% 107 — 2.15% 0.850% 107 — Dual tranche senior unsecured convertible bonds Zero-coupon, due 2025 (Tranche A) 748 713 Zero-coupon, due 2027 (Tranche B) 747 674 Finance leases: 3.86% 38 — 3.78% 19 — Other funding program loans: 0.32% 4 6 Total long-term debt 2,717 2,539 Less current portion (175 ) (143 ) Total long-term debt, less current portion 2,542 2,396
Long-Term Debt Denominated by Currencies	Long-term debt is denominated in the following currencies: December 31, 2022 December 31, 2021 U.S. dollar 1,495 1,387 Euro 1,222 1,152 Total 2,717 2,539
Total Long-Term Debt Outstanding Maturities	Aggregate future maturities of total long-term debt (including current portion) at principal amount are as follows: December 31, 2022 2023 175 2024 172 2025 922 2026 172 2027 908 Thereafter 373 Total 2,722

Post-Employment and Other Lon_2

Post-Employment and Other Long-Term Employees Benefits (Tables)	12 Months Ended
	Dec. 31, 2022
Compensation And Retirement Disclosure [Abstract]
Changes in Benefit Obligation and Plan Assets	The changes in benefit obligation and plan assets were as follows: Pension Benefits Other Long-Term Benefits December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021 Change in benefit obligation: Benefit obligation at beginning of year 1,165 1,216 94 101 Service cost 33 36 17 13 Interest cost 27 21 1 1 Employee contributions 4 4 — — Benefits paid (22 ) (25 ) (6 ) (5 ) Effect of settlement (14 ) (8 ) — — Business combination — 3 — — Actuarial (gain) loss (260 ) (48 ) (15 ) — Foreign currency translation and other adjustments (47 ) (34 ) (5 ) (16 ) Benefit obligation at end of year 886 1,165 86 94 Change in plan assets: Plan assets at fair value at beginning of year 743 718 — — Return on plan assets (157 ) 32 — — Employer contributions 25 17 — — Employee contributions 4 4 — — Benefits paid (9 ) (12 ) — — Effect of settlement (14 ) (8 ) — — Business combination — 2 — — Foreign currency translation and other adjustments (25 ) (10 ) — — Plan assets at fair value at end of year 567 743 — — Funded status (319 ) (422 ) (86 ) (94 ) Net amount recognized in the consolidated balance sheets consisted of the following: Pension Benefits Other Long-Term Benefits December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021 Non-current assets 9 15 — — Current liabilities (11 ) (11 ) (5 ) (4 ) Long-term liabilities (317 ) (426 ) (81 ) (90 ) Net amount recognized (319 ) (422 ) (86 ) (94 )
Accumulated Other Comprehensive Income (Loss) Before Tax Effects	The components of accumulated other comprehensive loss (income) before tax effects were as follows: Actuarial (gains)/losses Prior service cost Total Accumulated other comprehensive loss as of December 31, 2020 216 3 219 Net amount generated/arising in current year (56 ) — (56 ) Amortization (12 ) (1 ) (13 ) Foreign currency translation adjustment (6 ) — (6 ) Accumulated other comprehensive loss as of December 31, 2021 142 2 144 Net amount generated/arising in current year (84 ) — (84 ) Amortization (3 ) (1 ) (4 ) Foreign currency translation adjustment (10 ) — (10 ) Accumulated other comprehensive loss as of December 31, 2022 45 1 46
Schedule of Accumulated Benefit Obligations	The accumulated benefit obligations were as follows: Pension Benefits Other Long-Term Benefits December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021 Accumulated benefit obligations 778 1,004 25 79
Components of Net Periodic Benefit Cost	The components of the net periodic benefit cost included the following: Pension Benefits Other Long-term Benefits Year ended December 31, 2022 Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2022 Year ended December 31, 2021 Year ended December 31, 2020 Service cost 33 36 31 17 13 11 Interest cost 27 21 21 1 1 1 Expected return on plan assets (23 ) (24 ) (23 ) — — — Amortization of actuarial net loss (gain) 6 12 12 (14 ) — 3 Amortization of prior service cost 1 1 1 — — — Effect of settlement — — 1 — — — Net periodic benefit cost 44 46 43 4 14 15
Weighted Average Assumptions Used in Determination of Benefit Obligation and Plan Assets	The weighted average assumptions used in the determination of the benefit obligation and the plan assets for the pension plans and the other long-term benefits were as follows: Assumptions 2022 2021 Discount rate 4.18 % 1.84 % Salary increase rate 2.31 % 2.27 % Expected long-term rate of return on funds for the pension expense of the following year 2.66 % 3.19 % The weighted average assumptions used in the determination of the net periodic benefit cost for the pension plans and the other long-term benefits were as follows: Assumptions 2022 2021 2020 Discount rate 1.84 % 1.45 % 1.95 % Salary increase rate 2.27 % 2.43 % 2.48 % Expected long-term rate of return on funds for the pension expense of the year 3.19 % 3.44 % 4.04 %
Pension Plan Asset Allocation	The Company’s pension plan asset allocation as of December 31, 2022 and December 31, 2021 is as follows: Percentage of Plan Assets as of December 31, Asset Category 2022 2021 Cash and cash equivalents 1 % 1 % Equity securities 17 % 17 % Government debt securities 10 % 12 % Corporate debt securities 21 % 22 % Investments in funds (a) 16 % 21 % Real estate 1 % 1 % Other (mainly insurance assets – contracts and reserves) 34 % 26 % Total 100 % 100 % (a) As of December 31, 2022, investments in funds were composed of commingled and multi-strategy funds invested in diversified portfolios of fixed income ( 79 % %
Pension Plan Asset Allocation Including Fair-Value Measurements	The Company’s detailed pension plan asset allocation including the fair-value measurements of those plan assets as of December 31, 2022 is as follows: Total Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Cash and cash equivalents 4 4 — — Equity securities 95 1 94 — Government debt securities 59 — 59 — Corporate debt securities 120 — 98 22 Investment funds 87 1 86 — Real estate 6 — 6 — Other (mainly insurance assets – contracts and reserves) 194 — 38 156 TOTAL 565 6 381 178 The Company’s detailed pension plan asset allocation including the fair-value measurements of those plan assets as of December 31, 2021 is as follows: Total Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Cash and cash equivalents 5 5 — — Equity securities 130 2 128 — Government debt securities 87 — 87 — Corporate debt securities 164 — 139 25 Investment funds 156 1 155 — Real estate 10 — 10 — Other (mainly insurance assets – contracts and reserves) 191 — 49 142 TOTAL 743 8 568 167
Reconciliation for Plan Assets Measured at Fair Value Using Unobservable Inputs (Level 3)	For plan assets measured at fair value using significant unobservable inputs (Level 3), the reconciliation between January 1, 2022 and December 31, 2022 is presented as follows: Fair Value Measurements using Significant Unobservable Inputs (Level 3) January 1, 2022 167 Contributions (employer and employee) 21 Net benefit payments (a) 9 Settlements (14 ) Foreign currency translation adjustment (5 ) December 31, 2022 178 ( a ) For plan assets measured at fair value using significant unobservable inputs (Level 3), the reconciliation between January 1, 2021 and December 31, 2021 is presented as follows: Fair Value Measurements using Significant Unobservable Inputs (Level 3) January 1, 2021 162 Contributions (employer and employee) 15 Actual return on plan assets 2 Net benefit payments (a) 1 Settlements (8 ) Foreign currency translation adjustment (5 ) December 31, 2021 167 ( a )
Estimated Future Benefit Payments	The Company’s estimated future benefit payments as of December 31, 2022 are as follows: Years Pension Benefits Other Long-term Benefits 2023 41 5 2024 46 6 2025 57 9 2026 70 8 2027 51 9 From 2028 to 2032 319 43

Other Long-Term Liabilities (Ta

Other Long-Term Liabilities (Tables)	12 Months Ended
	Dec. 31, 2022
Other Liabilities Noncurrent [Abstract]
Summary of Other Long-Term Liabilities	Other long-term liabilities consisted of the following: December 31, 2022 December 31, 2021 Non-current operating lease liabilities 141 148 Contingent consideration on business combinations 31 70 Other long-term employee benefits 81 90 Long-term liabilities related to public funding 51 44 Long-term advances from customers 73 — Derivative instruments 4 — Others 73 64 Total 454 416

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2022
Classification of Pre-Payroll Tax and Social Contribution Stock-Based Compensation Expense Included in Consolidated Statements of Income	The following table illustrates the classification of pre-payroll tax and social contribution stock-based compensation expense included in the consolidated statements of income for the years ended December 31, 2022, 2021 and 2020: December 31, 2022 December 31, 2021 December 31, 2020 Cost of sales 34 34 25 R&D 69 70 51 SG&A 112 117 79 Total pre-payroll tax and social contribution compensation 215 221 155
Changes in AOCI Attributable to Stockholders	The table below details the changes in AOCI attributable to the company’s stockholders by component, net of tax, for the years ended December 31, 2022, 2021 and 2020: Gains (Losses) on Cash Flow Hedges Gains (Losses) on Available- For-Sale Securities Defined Benefit Pension Plan Items Foreign Currency Translation Adjustments (“CTA”) Total December 31, 2019 (3 ) 1 (223 ) 646 421 Cumulative tax impact — — 54 — 54 December 31, 2019, net of tax (3 ) 1 (169 ) 646 475 OCI before reclassifications 64 — (22 ) 203 245 Amounts reclassified from AOCI — — 14 — 14 OCI for the year ended December 31, 2020 64 — (8 ) 203 259 Cumulative tax impact (8 ) — (3 ) — (11 ) OCI for the year ended December 31, 2020, net of tax 56 — (11 ) 203 248 December 31, 2020 61 1 (231 ) 849 680 Cumulative tax impact (8 ) — 51 — 43 December 31, 2020, net of tax 53 1 (180 ) 849 723 OCI before reclassifications (90 ) (1 ) 56 (189 ) (224 ) Amounts reclassified from AOCI (19 ) — 13 — (6 ) OCI for the year ended December 31, 2021 (109 ) (1 ) 69 (189 ) (230 ) Cumulative tax impact 14 — (11 ) — 3 OCI for the year ended December 31, 2021, net of tax (95 ) (1 ) 58 (189 ) (227 ) December 31, 2021 (48 ) — (162 ) 660 450 Cumulative tax impact 6 — 40 — 46 December 31, 2021, net of tax (42 ) — (122 ) 660 496 OCI before reclassifications (126 ) (16 ) 80 (149 ) (211 ) Amounts reclassified from AOCI 197 — 4 — 201 OCI for the year ended December 31, 2022 71 (16 ) 84 (149 ) (10 ) Cumulative tax impact (9 ) 2 (19 ) — (26 ) OCI for the year ended December 31, 2022, net of tax 62 (14 ) 65 (149 ) (36 ) December 31, 2022 23 (16 ) (78 ) 511 440 Cumulative tax impact (3 ) 2 21 — 20 December 31, 2022, net of tax 20 (14 ) (57 ) 511 460
Schedule of Items Reclassified Out of Accumulated Other Comprehensive Income	Items reclassified out of Accumulated Other Comprehensive Income for the years ended December 31, 2022, 2021, 2020 are listed in the table below: Details about AOCI components Amounts reclassified from AOCI in the year ended December 31, 2022 Amounts reclassified from AOCI in the year ended December 31, 2021 Amounts reclassified from AOCI in the year ended December 31, 2020 Affected line item in the statement where net income (loss) is presented Gains (Losses) on Cash Flow Hedges Foreign exchange derivative contracts (129 ) 15 (3 ) Cost of sales Foreign exchange derivative contracts (15 ) 1 1 Selling, general and administrative Foreign exchange derivative contracts (53 ) 3 2 Research and development 27 (3 ) — Income tax benefit (expense) (170 ) 16 — Net of tax Defined Benefit Pension Plan Items Amortization of actuarial gains (losses) (3 ) (12 ) (13 ) Other components of pension benefit costs Amortization of prior service cost (1 ) (1 ) (1 ) Other components of pension benefit costs 1 2 3 Income tax benefit (expense) (3 ) (11 ) (11 ) Net of tax Total reclassifications for the year (173 ) 5 (11 ) Attributable to noncontrolling interest — — — Attributable to the parent company stockholders (173 ) 5 (11 )
Supervisory Board [Member]
Summary of Grants Under Outstanding Stock Award Plans	The table below summarizes grants under the outstanding stock award plans, as authorized by the Compensation Committee: Year of grant Options granted Options waived at grant 2011 172,500 (30,000 ) 2012 180,000 (22,500 ) Since 2013 No options granted
Summary of Nonvested Share Activity	A summary of the options’ activity by plan for the years ended December 31, 2022 and December 31, 2021 is presented below: Year of grant Outstanding as of December 31, 2020 Exercised Expired / Cancelled Outstanding as of December 31, 2021 Exercised Expired / Cancelled Outstanding as of December 31, 2022 2011 7,500 (7,500 ) — — — — — 2012 50,000 (30,000 ) — 20,000 (5,000 ) (15,000 ) —
Employees [Member]
Summary of Grants Under Outstanding Stock Award Plans	The table below summarizes grants under the outstanding stock award plans in 2022, as authorized by the Compensation Committee: Date of grant Plan name Number of shares granted Number of shares waived Number of shares lost on performance conditions May 23, 2019 2019 CEO Special Bonus 34,960 — — July 24, 2019 2019 Employee Plan 7,752,940 — (1,161,966 ) December 26, 2019 2019 Employee Plan 246,750 — (17,013 ) June 17, 2020 2020 CEO Special Bonus 16,000 — — July 23, 2020 2020 Employee Plan 7,437,580 — — December 24, 2020 2020 Employee Plan 562,350 — — July 28, 2021 2021 Employee Plan 6,327,205 — (920,263 ) December 21, 2021 2021 Employee Plan 213,270 — (60,483 ) July 27, 2022 2022 Employee Plan 6,243,670 — (*) December 22, 2022 2022 Employee Plan 287,675 — (*) (*) As of the date of issuance of these consolidated financial statements, a final decision by the Compensation Committee of the Supervisory Board on the achievement of the performance conditions had not been made yet.
Summary of Nonvested Share Activity	A summary of the unvested share activity by plan for the year ended December 31, 2022 is presented below: Unvested Shares Unvested as at December 31, 2021 Granted Forfeited / waived Cancelled on failed vesting conditions Vested Unvested as at December 31, 2022 2019 CEO Special Bonus 11,652 — — — (11,652 ) — 2019 Employee Plan 2,356,399 — (10,988 ) — (2,345,411 ) — 2020 CEO Special Bonus 10,667 — — — (5,333 ) 5,334 2020 Employee Plan 5,325,666 — (52,350 ) — (2,492,520 ) 2,780,796 2021 Employee Plan 6,497,505 — (65,958 ) (980,746 ) (1,751,287 ) 3,699,514 2022 Employee Plan — 6,531,345 (34,820 ) — — 6,496,525 Total 14,201,889 6,531,345 (164,116 ) (980,746 ) (6,606,203 ) 12,982,169

Revenues (Tables)

Revenues (Tables)	12 Months Ended
	Dec. 31, 2022
Revenue From Contract With Customer [Abstract]
Summary of Consolidated Net Revenues Disaggregated by Reportable Segment, Geographical Region of Shipment, Nature and Market Channel	The following tables present the Company’s consolidated net revenues disaggregated by geographical region of shipment, nature and market channel: Year ended December 31, 2022 December 31, 2021 December 31, 2020 Net revenues by geographical region of shipment (1) EMEA 3,619 2,557 1,966 Americas 2,310 1,525 1,165 Asia Pacific 10,199 8,679 7,088 Total net revenues 16,128 12,761 10,219 Net revenues by nature Revenues from sale of products 15,953 12,560 10,049 Revenues from sale of services 130 169 132 Other revenues 45 32 38 Total net revenues 16,128 12,761 10,219 Net revenues by market channel (2) Original Equipment Manufacturers (“OEM”) 10,764 8,486 7,411 Distribution 5,364 4,275 2,808 Total net revenues 16,128 12,761 10,219 (1) Net revenues by geographical region of shipment are classified by location of customer invoiced or reclassified by shipment destination in line with customer demand. For example, products ordered by U.S.-based companies to be invoiced to Asia Pacific affiliates are classified as Asia Pacific revenues. Furthermore, the Company, among the different periods, may be affected by shifts in shipments from one location to another, as requested by customers. (2) Original Equipment Manufacturers (“OEM”) are the end-customers to which the Company provides direct marketing application engineering support, while Distribution refers to the distributors and representatives that the Company engages to distribute its products around the world.

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
Net Revenues by Product Segment and by Product Line	The following tables present the Company’s consolidated net revenues and consolidated operating income by reportable segment. Net revenues by reportable segment: December 31, 2022 December 31, 2021 December 31, 2020 ADG 5,969 4,350 3,284 AMS (1) 4,911 4,587 3,858 MDG (1) 5,228 3,802 3,064 Total net revenues of product segments 16,108 12,739 10,206 Others 20 22 13 Total consolidated net revenues 16,128 12,761 10,219 (1) Effective July 1, 2022, the Low Power RF business unit was transferred from AMS to MDG with no significant impact on segment reporting. Prior year periods have been adjusted accordingly.
Operating Income by Reportable Segment	Operating income by reportable segment: December 31, 2022 December 31, 2021 December 31, 2020 ADG 1,469 512 182 AMS (1) 1,237 1,022 816 MDG (1) 1,830 908 498 Total operating income of product segments 4,536 2,442 1,496 Others (2) (97 ) (23 ) (173 ) Total consolidated operating income 4,439 2,419 1,323 (1) Effective July 1, 2022, the Low Power RF business unit was transferred from AMS to MDG with no significant impact on segment reporting. Prior year periods have been adjusted accordingly. (2) Operating income (loss) of “Others” includes items such as unused capacity charges, including reduced manufacturing activity due to COVID-19 and incidents leading to power outage, impairment, restructuring charges and other related closure costs, management reorganization costs, phase-out and start-up costs of certain manufacturing facilities, and other unallocated income (expenses) such as: strategic or special R&D programs, certain corporate-level operating expenses, patent claims and litigations, and other costs that are not allocated to product groups, as well as operating earnings of other products.
Reconciliation of Operating Income of Reportable Segments to Total Consolidated Operating Income	The reconciliation of operating income of reportable segments to the total consolidated operating income is presented in the below table: December 31, 2022 December 31, 2021 December 31, 2020 Total operating income of reportable segments 4,536 2,442 1,496 Impairment, restructuring charges and other related closure costs — (2 ) (11 ) Start-up and phase-out costs (13 ) — — Unused capacity charges (22 ) (16 ) (153 ) Other unallocated manufacturing results (57 ) 1 (8 ) Gain on sale of non-current assets 2 3 11 Strategic and other research and development programs and other non-allocated provisions (1) (7 ) (9 ) (12 ) Total operating loss Others (97 ) (23 ) (173 ) Total consolidated operating income 4,439 2,419 1,323 (1) Includes unallocated income and expenses such as certain corporate-level operating expenses and other income (costs) that are not allocated to the product segments.
Net Revenues	Net revenues December 31, 2022 December 31, 2021 December 31, 2020 Switzerland 4,569 3,282 2,795 France 153 126 89 Italy 47 56 52 USA 1,981 1,253 976 Singapore 8,604 7,442 5,817 Japan 758 586 479 Other countries 16 16 11 Total net revenues 16,128 12,761 10,219
Property, Plant & Equipment	Property, plant and equipment, net December 31, 2022 December 31, 2021 Netherlands 2,753 1,476 France 1,774 1,154 Italy 1,683 1,469 Other European countries 161 136 USA 52 36 Singapore 880 671 Malaysia 365 221 Other countries 533 497 Total property, plant and equipment, net 8,201 5,660

Other Income and Expenses, Net

Other Income and Expenses, Net (Tables)	12 Months Ended
	Dec. 31, 2022
Other Income And Expenses [Abstract]
Other Income and Expenses, Net	Other income and expenses, net consisted of the following: Year ended December 31, 2022 Year ended December 31, 2021 Year ended December 31, 2020 Public funding 177 162 231 Start-up and phase-out costs (13 ) — (8 ) Exchange gain (loss), net 15 7 8 Patent costs (8 ) (10 ) (11 ) Gain on sale of non-current assets 2 5 14 COVID-19 incremental costs (10 ) (19 ) (32 ) Other, net (4 ) (4 ) — Total 159 141 202

Interest Income (Expense), Net

Interest Income (Expense), Net (Tables)	12 Months Ended
	Dec. 31, 2022
Banking And Thrift Interest [Abstract]
Summary of Interest Income (Expense), Net	Interest income (expense), net consisted of the following: Year ended December 31, 2022 Year ended December 31, 2021 Year ended December 31, 2020 Income 71 13 34 Expense (13 ) (42 ) (54 ) Total 58 (29 ) (20 )

Income Tax (Tables)

Income Tax (Tables)	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income (Loss) before Income Tax	Income (loss) before income tax is comprised of the following: Year ended December 31, 2022 Year ended December 31, 2021 Year ended December 31, 2020 Income (loss) recorded in the Netherlands (22 ) (20 ) (19 ) Income (loss) from foreign operations 4,508 2,357 1,286 Income (loss) before income tax benefit (expense) 4,486 2,337 1,267
Income Tax Benefit (Expense)	Income tax benefit (expense) is comprised of the following: Year ended December 31, 2022 Year ended December 31, 2021 Year ended December 31, 2020 The Netherlands taxes - current — — — Foreign taxes - current (510 ) (285 ) (171 ) Total current taxes (510 ) (285 ) (171 ) The Netherlands taxes - deferred — — — Foreign taxes - deferred (10 ) (46 ) 12 Total deferred taxes (10 ) (46 ) 12 Income tax expense (520 ) (331 ) (159 ) Effective tax rate 12 % 14 % 13 %
Differences in Income Taxes Computed at Netherlands Statutory Rate and Effective Income Tax Rate	The principal items comprising the differences in income taxes computed at the Netherlands statutory rate of 25.8% in 2022, 25% in 2021 and 25% in 2020, and the effective income tax rate are the following: Year ended December 31, 2022 Year ended December 31, 2021 Year ended December 31, 2020 Income tax benefit (expense) computed at statutory rate (1,158 ) (584 ) (316 ) Non-deductible and non-taxable permanent differences, net 22 4 (1 ) Valuation allowance adjustments 140 (2 ) 11 Effect on deferred taxes of changes in enacted tax rates 6 6 (5 ) Current year credits 30 39 40 Other tax and credits (51 ) (22 ) (40 ) Benefits from tax holidays 60 49 37 Net impact of changes to uncertain tax positions (12 ) (8 ) (1 ) Earnings of subsidiaries taxed at different rates 443 187 116 Income tax benefit (expense) (520 ) (331 ) (159 )
Deferred Tax Assets and Liabilities	Deferred tax assets and liabilities consisted of the following: December 31, 2022 December 31, 2021 Tax loss carryforwards and investment credits 520 707 Less unrecognized tax benefit (25 ) (81 ) Tax loss carryforwards net of unrecognized tax benefit 495 626 Inventory valuation 42 28 Impairment and restructuring charges 4 4 Fixed asset depreciation in arrears 55 52 Increased depreciation incentives 83 128 Capitalized development costs 79 121 Receivables for government funding 121 64 Tax credits granted on past capital investments 218 213 Pension service costs 62 82 Stock awards 17 14 Operating lease liabilities 50 39 Commercial accruals 27 12 Other temporary differences 23 25 Total deferred tax assets 1,276 1,408 Valuation allowances (416 ) (576 ) Deferred tax assets, net 860 832 Accelerated fixed asset depreciation (37 ) (32 ) Acquired intangible assets (23 ) (22 ) Advances of government funding (177 ) (115 ) Operating lease right-of-use assets (50 ) (39 ) Other temporary differences (31 ) (36 ) Deferred tax liabilities (318 ) (244 ) Net deferred income tax asset 542 588
Gross Deferred Tax Assets On Tax Loss Carryforwards And Investment Credits Expiration Table Text Block	As of December 31, 2022, the Company and its subsidiaries have gross deferred tax assets on tax loss carryforwards and investment credits that expire starting from 2023. December 31, Year 2022 2023 3 2024 2 2025 2 2026 2 2027 5 Thereafter 506 Total 520
Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits	A reconciliation of 2022, 2021 and 2020 beginning and ending amounts of unrecognized tax benefits is as follows: December 31, 2022 December 31, 2021 December 31, 2020 Balance at beginning of year 118 48 48 Additions based on tax positions related to the current year 4 72 1 Additions based on acquisitions related to the current year — — — Additions for tax positions of prior years 13 1 1 Reduction for tax positions of prior years (69 ) (1 ) (2 ) Settlements (2 ) — (1 ) Foreign currency translation (3 ) (2 ) 1 Balance at end of year 61 118 48

Earnings per Share (Tables)

Earnings per Share (Tables)	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Summary of Earnings per Share ("EPS")	For the years ended December 31, 2022, 2021 and 2020, earnings per share (“EPS”) was calculated as follows: Year ended December 31, 2022 Year ended December 31, 2021 Year ended December 31, 2020 Basic EPS Net income attributable to parent company as reported 3,960 2,000 1,106 Weighted average number of shares outstanding 905,606,885 904,332,429 894,578,477 Basic EPS 4.37 2.21 1.24 Diluted EPS Net income attributable to parent company as reported 3,960 2,000 1,106 add-back interest expense, net of income tax effect 2 — — Net income attributable to parent company as adjusted 3,962 2,000 1,106 Weighted average shares outstanding 905,606,885 904,332,429 894,578,477 Dilutive effect of stock awards 6,789,662 9,107,124 8,860,216 Dilutive effect of convertible bonds 33,825,000 11,402,645 16,291,279 Number of shares used in calculating diluted EPS 946,221,547 924,842,198 919,729,972 Diluted EPS 4.19 2.16 1.20

Commitments (Tables)

Commitments (Tables)	12 Months Ended
	Dec. 31, 2022
Commitments And Contingencies Disclosure [Abstract]
Company's Commitments	The Company’s commitments as of December 31, 2022 were as follows: In millions of U.S. dollars Total 2023 2024 2025 2026 2027 Thereafter Purchase obligations 5,554 4,556 424 287 101 62 124 of which: Equipment purchase 3,587 3,584 3 — — — — Foundry purchase 1,827 872 393 275 101 62 124 Software, design, technologies and licenses 140 100 28 12 — — — Other obligations 1,864 1,072 155 100 56 155 326 Total 7,418 5,628 579 387 157 217 450

Financial Instruments and Ris_2

Financial Instruments and Risk Management (Tables)	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Notional Amounts of Outstanding Derivative Instruments	As of December 31, 2022, the Company had the following outstanding derivative instruments that were entered into to hedge Euro-denominated and Singapore dollar-denominated forecasted transactions: In millions of Euros Notional amount for hedge on forecasted R&D and other operating expenses Notional amount for hedge on forecasted manufacturing costs Forward contracts 540 986 Currency collars 500 791 In millions of Singapore dollars Notional amount for hedge on forecasted R&D and other operating expenses Notional amount for hedge on forecasted manufacturing costs Forward contracts — 247
Fair Value of Derivative Instruments	Information on fair value of derivative instruments and their location in the consolidated balance sheets as of December 31, 2022 and December 31, 2021 is presented in the table below: As of December 31, 2022 As of December 31, 2021 Asset Derivatives Balance sheet classification Fair value Fair value Derivatives designated as a hedge: Foreign exchange forward contracts Other current assets 37 2 Foreign exchange forward contracts Other non-current assets 8 — Currency collars Other current assets 10 1 Currency collars Other non-current assets 5 — Total derivatives designated as a hedge: 60 3 Derivatives not designated as a hedge: Foreign exchange forward contracts Other current assets 9 3 Total derivatives not designated as a hedge: 9 3 Total Derivatives 69 6 As of December 31, 2022 As of December 31, 2021 Liability Derivatives Balance sheet classification Fair value Fair value Derivatives designated as a hedge: Foreign exchange forward contracts Other payables and accrued liabilities (23 ) (29 ) Foreign exchange forward contracts Other non-current liabilities (3 ) — Currency collars Other payables and accrued liabilities (9 ) (13 ) Currency collars Other non-current liabilities (1 ) — Total derivatives designated as a hedge: (36 ) (42 ) Derivatives not designated as a hedge: Foreign exchange forward contracts Other payables and accrued liabilities (3 ) (1 ) Total derivatives not designated as a hedge: (3 ) (1 ) Total Derivatives (39 ) (43 )
Effect on Consolidated Statements of Income of Derivative Instruments	The effect of derivative instruments designated as cashflow hedge on the consolidated statements of income for the year ended December 31, 2022 and December 31, 2021 and on the “Accumulated other comprehensive income (loss)” (“AOCI”) as reported in the consolidated statements of equity as of December 31, 2022 and December 31, 2021 is presented in the table below: Gain (loss) deferred in OCI on derivative Location of gain (loss) Gain (loss) reclassified from OCI into earnings December 31, 2022 December 31, 2021 reclassified from OCI into earnings December 31, 2022 December 31, 2021 Foreign exchange forward contracts 14 (20 ) Cost of sales (83 ) 11 Foreign exchange forward contracts 2 (2 ) Selling, general and administrative (9 ) — Foreign exchange forward contracts 4 (9 ) Research and development (32 ) 1 Currency collars 1 (11 ) Cost of sales (46 ) 4 Currency collars 1 (1 ) Selling, general and administrative (6 ) 1 Currency collars 1 (5 ) Research and development (21 ) 2 Total 23 (48 ) (197 ) 19
Effect on Consolidated Statements of Income of Derivative Instruments Not Designated as Hedge	The effect on the consolidated statements of income for the year ended December 31, 2022 and December 31, 2021 of derivative instruments not designated as a hedge is presented in the table below: Location of gain Gain (loss) recognized in earnings (loss) recognized in earnings December 31, 2022 December 31, 2021 Foreign exchange forward contracts Other income and expenses, net 24 9 Total 24 9
Schedule of Financial Assets (Liabilities) Measured at Fair Value on Recurring Basis	The table below details financial assets (liabilities) measured at fair value on a recurring basis as of December 31, 2022: Fair Value Measurements using December 31, 2022 Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Marketable securities – U.S. Treasury debt securities 679 679 — — Short-term deposits 581 581 — — Equity securities measured at fair value through earnings 26 26 — — Derivative assets designated as cash flow hedge 60 — 60 — Derivative assets not designated as cash flow hedge 9 — 9 — Derivative liabilities designated as cash flow hedge (36) — (36) — Derivative liabilities not designated as cash flow hedge (3) — (3) — Contingent consideration on business acquisitions (31) — — (31) Total 1,285 1,286 30 (31) The table below details financial assets (liabilities) measured at fair value on a recurring basis as of December 31, 2021: Fair Value Measurements using December 31, 2021 Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Short-term deposits 291 291 — — Equity securities measured at fair value through earnings 29 29 — — Derivative assets designated as cash flow hedge 3 — 3 — Derivative assets not designated as cash flow hedge 3 — 3 — Derivative liabilities designated as cash flow hedge (42) — (42) — Derivative liabilities not designated as cash flow hedge (1) — (1) — Contingent consideration on business acquisitions (77) — — (77) Total 206 320 (37) (77)
Schedule of Liabilities Measured at Fair Value on Recurring Basis Using Significant Unobservable Inputs (Level 3)	For liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3), the reconciliation between January 1, 2022 and December 31, 2022 is presented as follows: For liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3), the reconciliation between January 1, 2021 and December 31, 2021 is presented as follows: Fair Value Measurements using Significant Unobservable Inputs (Level 3) January 1, 2021 123 Changes in fair value measurement (38) Currency translation adjustment (8) December 31, 2021 77 Amount of total gains (losses) for the period included in earnings attributable to liabilities still held at the reporting date (2)
Fair Value Information on Other Financial Assets and Liabilities Recorded at Amortized Cost	The following table includes additional fair value information on financial assets and liabilities as of December 31, 2022 and 2021: 2022 2021 Level Carrying Amount Estimated Fair Value Carrying Amount Estimated Fair Value Cash equivalents (1) 1 2,996 2,996 2,883 2,883 Short-term, deposits 1 581 581 291 291 Long-term debt – Bank loans (including current portion) 2 1,165 1,165 1,152 1,152 – Finance leases (including current portion) 2 57 57 — — – Senior unsecured convertible bonds issued on August 4, 2020 (2) 1 1,495 1,561 1,387 1,975 (1) Cash equivalents primarily correspond to deposits at call with banks. ( 2 ) The carrying amount as of December 31, 2022, of the senior unsecured convertible bonds as reported above, corresponds to the nominal value of the bonds, net of $5 million unamortized debt issuance costs, in compliance with the new accounting guidance. The impact of the adoption is described in Note 2 and Note 15. The fair value represented the market price of the bonds trading on the Frankfurt Stock Exchange.
Schedule of Methodologies Used to Estimate Fair Value	The methodologies used to estimate fair value are as follows: Components Methodology used to estimate fair value Debt securities classified as available-for-sale Quoted market prices for identical instruments Foreign exchange forward contracts, currency options and collars Quoted market prices for similar instruments Equity securities measured at fair value through earnings Quoted market prices for identical instruments Equity securities carried at cost as a measurement alternative Valuation of the underlying investments on a new round of third-party financing or upon liquidation Long-term debt and current portion of long-term debt Future cash flows on a borrowing-by-borrowing basis and discounting these future cash flows using the Company's incremental borrowing rates for similar types of borrowing arrangements Cash and cash equivalents, short-term deposits, accounts receivable, short-term borrowings, and accounts payable The carrying amounts reflected in the consolidated financial statements are considered as reasonable estimates of fair value due to the relatively short period of time between the origination of the instruments and their expected realization.

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Transactions with Related Parties	The below table summarizes transactions incurred in 2022, 2021 and 2020 with companies for which certain members of the Company’s management perform similar policymaking functions. These include, but are not limited to: Orange and Idemia France. December 31, December 31, December 31, 2022 2021 2020 Sales & other services 13 8 5 Other purchases 25 19 21 Accounts receivable 5 2 1 Accounts payable 2 — —

Accounting Policies - Additiona

Accounting Policies - Additional Information (Detail) - USD ($)		12 Months Ended
	Jan. 01, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Summary Of Accounting Policies [Line Items]
Sustainability threshold for uncertain tax position		50%
Cumulative probability threshold for realization of income tax benefits		50%
Significant assets held for sale		$ 0	$ 0
Employees average service period to grant awards		3 years
Advertising expenses		$ 18,000,000	$ 14,000,000	$ 12,000,000
Debt securities		0
Change in accounting principle, accounting standards update, adoption date	Jan. 01, 2022
Increase in convertible debt	$ 107,000,000
Convertible debt	1,500,000,000
Unamortized debt issuance cost	6,000,000
Decrease in long term deferred tax liabilities	15,000,000	$ 22,000,000
Total decrease in equity	92,000,000
Decrease in additional paid in capital	117,000,000
Increase in retained earnings	$ 25,000,000
Dilutive effect of convertible bonds underlying number of shares	33,825,000
French [Member] | Research tax credits [Member]
Summary Of Accounting Policies [Line Items]
Tax credit carryforward expiration term		3 years
Leases [Member]
Summary Of Accounting Policies [Line Items]
Operating and financing option to extend		true
Minimum [Member]
Summary Of Accounting Policies [Line Items]
Revenue recognition expected payment terms		30 days
Maximum [Member]
Summary Of Accounting Policies [Line Items]
Revenue recognition expected payment terms		90 days
Maximum [Member] | Leases [Member]
Summary Of Accounting Policies [Line Items]
Short term lease payments excluding capitalization amount		$ 5,000
Trademarks and Licenses [Member] | Minimum [Member]
Summary Of Accounting Policies [Line Items]
Estimated useful lives of intangible assets		3 years
Trademarks and Licenses [Member] | Maximum [Member]
Summary Of Accounting Policies [Line Items]
Estimated useful lives of intangible assets		8 years
Purchased and Internally Developed Software [Member] | Maximum [Member]
Summary Of Accounting Policies [Line Items]
Estimated useful lives of intangible assets		4 years

Accounting Policies - Schedule

Accounting Policies - Schedule of Property, Plant and Equipment Useful Lives (Detail)	12 Months Ended
	Dec. 31, 2022
Buildings [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of Property, Plant and Equipment, Average	33 years
Facilities and Leasehold Improvements [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of Property, Plant and Equipment, Average	5 years
Facilities and Leasehold Improvements [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of Property, Plant and Equipment, Average	10 years
Machinery and Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of Property, Plant and Equipment, Average	2 years
Machinery and Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of Property, Plant and Equipment, Average	10 years
Computer and R&D Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of Property, Plant and Equipment, Average	3 years
Computer and R&D Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of Property, Plant and Equipment, Average	6 years
Other [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of Property, Plant and Equipment, Average	2 years
Other [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of Property, Plant and Equipment, Average	5 years

Short-Term Deposits and Marke_3

Short-Term Deposits and Marketable Securities - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Financing Receivable Recorded Investment [Line Items]
Short-term deposits	$ 581	$ 291
Marketable securities	679		$ 133
Marketable Securities, principal amount transferred to short-term securities lending transactions	750
U.S. Treasury Debt Securities [Member]
Financing Receivable Recorded Investment [Line Items]
Marketable securities	687	$ 0
Aggregate amortized cost basis of securities	$ 695
Weighted average maturity period	3 years 6 months

Short-Term Deposits and Marke_4

Short-Term Deposits and Marketable Securities - Changes in Value of Marketable Securities Reported in Current Assets on Consolidated Balance Sheets (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Marketable Securities [Line Items]
Beginning Balance		$ 133
Purchase	$ 687
Accretion	8
Proceeds at maturity		(132)
Change in fair value included in OCI	(16)	(1)
Ending Balance	679
U.S. Treasury Debt Securities [Member]
Marketable Securities [Line Items]
Beginning Balance		133
Purchase	687
Accretion	8
Proceeds at maturity		(132)
Change in fair value included in OCI	(16)	$ (1)
Ending Balance	$ 679

Trade Accounts Receivable, Ne_2

Trade Accounts Receivable, Net - Trade Accounts Receivable, Net (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Receivables [Abstract]
Trade accounts receivable	$ 1,991	$ 1,778
Current expected credit losses allowance (“CECLA”)	(21)	(19)
Total	$ 1,970	$ 1,759

Trade Accounts Receivable, Ne_3

Trade Accounts Receivable, Net - Schedule of Changes in Reported CECLA (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($)
Receivables [Abstract]
CECLA As of December 31, 2021	$ (19)
Current-period adjustment to CECLA	(2)
CECLA As of December 31, 2022	$ (21)

Inventories - Inventories (Deta

Inventories - Inventories (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Raw materials	$ 349	$ 223
Work-in-process	1,490	1,235
Finished products	744	514
Total	$ 2,583	$ 1,972

Other Current Assets - Other Cu

Other Current Assets - Other Current Assets (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Receivables [Abstract]
Public funding receivables	$ 190	$ 296
Taxes and other government receivables	270	119
Advances and prepayments	125	118
Loans and deposits	10	8
Interest receivable	22	1
Derivative instruments	56	6
Other current assets	61	33
Total	$ 734	$ 581

Public Funding - Additional Inf

Public Funding - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Government Assistance [Line Items]
Receivables related to public funding	$ 346
Receivables related to public funding, current	190	$ 296
Receivables related to public funding, noncurrent	156	$ 124
Liabilities related to public funding	88
Capital investment grants	95
Public funding related to R&D and innovation activities, recognized	$ 177
Government Assistance, Statement of Income or Comprehensive Income [Extensible Enumeration]	Other income and expenses, net
Cost of Sales [Member]
Government Assistance [Line Items]
Capital investment and industrialization funding amount	$ 59
Other Current Assets [Member]
Government Assistance [Line Items]
Receivables related to public funding, current	190
Other Noncurrent Assets [Member]
Government Assistance [Line Items]
Receivables related to public funding, noncurrent	156
Other Payables and Accrued Liabilities [Member]
Government Assistance [Line Items]
Liabilities related to public funding, current	37
Other Long-term Liabilities [Member]
Government Assistance [Line Items]
Liabilities related to public funding, noncurrent	51
Research tax credits [Member] | Other Noncurrent Assets [Member]
Government Assistance [Line Items]
Research tax credit receivables, noncurrent	294
French [Member] | Research and Development Expense [Member]
Government Assistance [Line Items]
Research tax credit received	106
French [Member] | Other Long-term Liabilities [Member]
Government Assistance [Line Items]
Liabilities related to public funding, noncurrent	$ 46
French [Member] | Research tax credits [Member]
Government Assistance [Line Items]
Tax credit carryforward expiration term	3 years

Goodwill - Changes in Carrying

Goodwill - Changes in Carrying Amount of Goodwill (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Goodwill [Line Items]
Goodwill, Beginning Balance	$ 313	$ 330
Measurement period adjustment		1
Foreign currency translation	(16)	(18)
Goodwill, Ending Balance	297	313
ADG [Member]
Goodwill [Line Items]
Goodwill, Beginning Balance	83	91
Foreign currency translation	(9)	(8)
Goodwill, Ending Balance	74	83
AMS [Member]
Goodwill [Line Items]
Goodwill, Beginning Balance	2	2
Goodwill, Ending Balance	2	2
MDG [Member]
Goodwill [Line Items]
Goodwill, Beginning Balance	228	237
Measurement period adjustment		1
Foreign currency translation	(7)	(10)
Goodwill, Ending Balance	$ 221	$ 228

Goodwill - Additional Informati

Goodwill - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Impairment loss of goodwill	$ 0	$ 0	$ 0

Other Intangible Assets, Net -

Other Intangible Assets, Net - Other Intangible Assets, Net (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Finite Lived Intangible Assets [Line Items]
Gross Amount	$ 1,714	$ 1,669
Accumulated Amortization	(1,309)	(1,231)
Net Amount	405	438
Technologies & Licenses [Member]
Finite Lived Intangible Assets [Line Items]
Gross Amount	1,064	1,050
Accumulated Amortization	(795)	(746)
Net Amount	269	304
Purchased and Internally Developed Software [Member]
Finite Lived Intangible Assets [Line Items]
Gross Amount	609	567
Accumulated Amortization	(514)	(485)
Net Amount	95	82
Technologies in Progress [Member]
Finite Lived Intangible Assets [Line Items]
Gross Amount	41	52
Net Amount	$ 41	$ 52

Other Intangible Assets, Net _2

Other Intangible Assets, Net - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Finite Lived Intangible Assets [Line Items]
Amortization expense	$ 103	$ 93	$ 79
Impairment loss of intangible assets	$ 38
Acquired Licenses and Technologies [Member]
Finite Lived Intangible Assets [Line Items]
Impairment loss of intangible assets		$ 1	$ 4

Other Intangible Assets, Net _3

Other Intangible Assets, Net - Estimated Future Amortization Expense Related to Intangible Assets (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
2023	$ 112
2024	98
2025	72
2026	42
2027	20
Thereafter	61
Net Amount	$ 405	$ 438

Property, Plant and Equipment_3

Property, Plant and Equipment, Net - Property, Plant and Equipment, Net (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Gross Amount	$ 26,216	$ 23,488
Accumulated Depreciation	(18,015)	(17,828)
Net Amount	8,201	5,660
Land [Member]
Property, Plant and Equipment [Line Items]
Gross Amount	83	84
Net Amount	83	84
Buildings [Member]
Property, Plant and Equipment [Line Items]
Gross Amount	1,116	951
Accumulated Depreciation	(563)	(562)
Net Amount	553	389
Facilities and Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Gross Amount	3,877	3,490
Accumulated Depreciation	(2,895)	(2,936)
Net Amount	982	554
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross Amount	18,751	17,085
Accumulated Depreciation	(14,023)	(13,786)
Net Amount	4,728	3,299
Computer and R&D Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross Amount	398	395
Accumulated Depreciation	(319)	(333)
Net Amount	79	62
Operating Lease Right-of-Use Assets [Member]
Property, Plant and Equipment [Line Items]
Gross Amount	311	314
Accumulated Depreciation	(118)	(114)
Net Amount	193	200
Finance lease right-of-use assets [Member]
Property, Plant and Equipment [Line Items]
Gross Amount	57
Accumulated Depreciation	(2)
Net Amount	55
Other Tangible Assets [Member]
Property, Plant and Equipment [Line Items]
Gross Amount	169	147
Accumulated Depreciation	(95)	(97)
Net Amount	74	50
Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Gross Amount	1,454	1,022
Net Amount	$ 1,454	$ 1,022

Property, Plant and Equipment_4

Property, Plant and Equipment, Net - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Depreciation charge	$ 1,113,000,000	$ 952,000,000	$ 844,000,000
Tax incentives and capital investment funding	25,000,000	13,000,000	10,000,000
Reduction in depreciation charges due to public funding	56,000,000	61,000,000	59,000,000
Cash proceeds from sale of property, plant and equipment	4,000,000	2,000,000	4,000,000
Impairment of long-lived assets	0	$ 0	$ 0
300mm fab [Member]
Property, Plant and Equipment [Line Items]
Definitive long-lived assets	$ 650,000,000

Leases - Additional Information

Leases - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2022
Maximum [Member]
Lessee Lease Description [Line Items]
Remaining lease term	47 years
Minimum [Member]
Lessee Lease Description [Line Items]
Remaining lease term	1 year

Leases - Schedule of Operating

Leases - Schedule of Operating and Finance Lease (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Lessee Disclosure [Abstract]
Operating leases	$ 193	$ 200
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, plant and equipment, net	Property, plant and equipment, net
Finance Leases	$ 55
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, plant and equipment, net	Property, plant and equipment, net
Total right-of-use assets	$ 248	$ 200
Current	59	55
Operating leases	$ 52	$ 55
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Other payables and accrued liabilities	Other payables and accrued liabilities
Finance Leases	$ 7
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Short-term debt	Short-term debt
Non-current	$ 191	$ 148
Operating leases	$ 141	$ 148
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other long-term liabilities	Other long-term liabilities
Finance Leases	$ 50
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Long-term debt	Long-term debt
Total lease liabilities	$ 250	$ 203

Leases - Schedule of Maturities

Leases - Schedule of Maturities of Operating and Finance Lease Liabilities (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Lessee Disclosure [Abstract]
2023	$ 57
2024	40
2025	27
2026	19
2027	12
Thereafter	86
Total future undiscounted cash outflows	241
Effect of discounting	(48)
Total operating lease liabilities	193
2023	8
2024	5
2025	5
2026	5
2027	28
Thereafter	23
Total future undiscounted cash outflows	74
Effect of discounting	(17)
Total finance lease liabilities	57
2023	65
2024	45
2025	32
2026	24
2027	40
Thereafter	109
Total future undiscounted cash outflows	315
Effect of discounting	(65)
Total operating and finance lease liabilities	$ 250	$ 203

Leases - Schedule of Operatin_2

Leases - Schedule of Operating and Finance Lease Term and Discount Rate (Detail)	Dec. 31, 2022	Dec. 31, 2021
Lessee Disclosure [Abstract]
Weighted average remaining lease term (in years) – operating leases	9 years 5 months 15 days	9 years 4 months 17 days
Weighted average remaining lease term (in years) – finance leases	9 years 10 months 20 days
Weighted average discount rate – operating lease	3.12%	2.69%
Weighted average discount rate – finance lease	3.86%

Leases - Schedule of Operatin_3

Leases - Schedule of Operating and Finance Lease Cost and Cash Paid (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Lessee Disclosure [Abstract]
Operating lease cost	$ 62	$ 68
Finance lease cost
Amortization of right-of-use assets	2
Interest	1
Operating lease cash paid	63	67
Finance lease cash paid

Leases - Schedule of Right-of-U

Leases - Schedule of Right-of-Use Assets Obtained in Exchange for New Operating and Finance Lease Liabilities (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Lessee Disclosure [Abstract]
Operating leases	$ 60	$ 80
Finance leases	$ 55

Long-Term Investments - Long-Te

Long-Term Investments - Long-Term Investments (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Statement Of Financial Position [Abstract]
Long-term investments	$ 11	$ 10

Other Non-Current Assets - Othe

Other Non-Current Assets - Other Non-Current Assets (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Statement Of Financial Position [Abstract]
Equity securities	$ 26	$ 29
Receivables from government agencies	156	124
French research tax credit receivable	294	376
Defined benefit plans	9	15
Prepayments and deposits to third parties	107	21
Derivative instruments	13
Other non-current assets	56	74
Total	$ 661	$ 639

Other Non-Current Assets - Addi

Other Non-Current Assets - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Non-current assets sold without recourse	$ 110,000,000	$ 118,000,000
Maximum [Member]
Non-current assets sold , cost	$ 1,000,000	$ 1,000,000

Other Payables and Accrued Li_3

Other Payables and Accrued Liabilities - Other Payables and Accrued Liabilities (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Payables And Accruals [Abstract]
Employee related liabilities	$ 599	$ 536
Employee compensated absences	196	181
Taxes other than income taxes	68	58
Advances from customers	225	25
Advances from grants	37	34
Derivative instruments	35	43
Defined benefit and contribution plans	39	34
Royalties	32	29
Current operating lease liabilities	52	55
Deferred and contingent consideration on business combinations		27
Others	102	79
Total	$ 1,385	$ 1,101

Other Payables and Accrued Li_4

Other Payables and Accrued Liabilities - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2022 USD ($)
Payables And Accruals [Abstract]
Deferred and contingent consideration paid	$ 25,000,000
Provision for penalties	$ 0

Long-Term Debt - Long-Term Debt

Long-Term Debt - Long-Term Debt (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Finance leases	$ 57
Total long-term debt	2,717	$ 2,539
Less current portion	(175)	(143)
Total long-term debt, less current portion	2,542	2,396
2.67% due 2028, floating interest rate at Euribor + 0.589% [Member]
Debt Instrument [Line Items]
Loans payable	163	202
1.20% due 2029, floating interest rate at Euribor + 0.564% [Member]
Debt Instrument [Line Items]
Loans payable	183	222
1.31% due 2031, floating interest rate at Euribor + 0.583% [Member]
Debt Instrument [Line Items]
Loans payable	322	379
0.89% due 2031, floating interest rate at Euribor + 0.660% [Member]
Debt Instrument [Line Items]
Loans payable	159	187
3.15% due 2027, floating interest rate at Euribor + 0.690% [Member] | Cassa Depositi e Prestiti SpA ("CDP") [Member]
Debt Instrument [Line Items]
Loans payable	120	156
1.85% due 2027, floating interest rate at Euribor + 0.550% [Member] | Cassa Depositi e Prestiti SpA ("CDP") [Member]
Debt Instrument [Line Items]
Loans payable	107	0
2.15% due 2027, floating interest rate at Euribor + 0.850% [Member] | Cassa Depositi e Prestiti SpA ("CDP") [Member]
Debt Instrument [Line Items]
Loans payable	107	0
Zero-coupon, due 2025 (Tranche A) [Member] | Senior Unsecured Convertible Bonds
Debt Instrument [Line Items]
Senior unsecured convertible bonds	748	713
Zero-coupon, due 2027 (Tranche B) [Member] | Senior Unsecured Convertible Bonds
Debt Instrument [Line Items]
Senior unsecured convertible bonds	747	674
3.86% due 2027, fixed interest rate
Debt Instrument [Line Items]
Finance leases	38	0
3.78% due 2042, fixed interest rate
Debt Instrument [Line Items]
Finance leases	19	0
0.32% (weighted average), due 2023-2028, fixed interest rate [Member]
Debt Instrument [Line Items]
Other Loans Payable	$ 4	$ 6

Long-Term Debt - Long-Term De_2

Long-Term Debt - Long-Term Debt (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
2.67% due 2028, floating interest rate at Euribor + 0.589% [Member]
Debt Instrument [Line Items]
Long-term debt maturity date	2028	2028
Interest rate	2.67%	2.67%
Description of floating rate basis	Euribor + 0.589%	Euribor + 0.589%
Basis spread on floating rate	0.589%	0.589%
1.20% due 2029, floating interest rate at Euribor + 0.564% [Member]
Debt Instrument [Line Items]
Long-term debt maturity date	2029	2029
Interest rate	1.20%	1.20%
Description of floating rate basis	Euribor + 0.564%	Euribor + 0.564%
Basis spread on floating rate	0.564%	0.564%
1.31% due 2031, floating interest rate at Euribor + 0.583% [Member]
Debt Instrument [Line Items]
Long-term debt maturity date	2031	2031
Interest rate	1.31%	1.31%
Description of floating rate basis	Euribor + 0.583%	Euribor + 0.583%
Basis spread on floating rate	0.583%	0.583%
0.89% due 2031, floating interest rate at Euribor + 0.660% [Member]
Debt Instrument [Line Items]
Long-term debt maturity date	2031	2031
Interest rate	0.89%	0.89%
Description of floating rate basis	Euribor + 0.660%	Euribor + 0.660%
Basis spread on floating rate	0.66%	0.66%
3.15% due 2027, floating interest rate at Euribor + 0.690% [Member]
Debt Instrument [Line Items]
Long-term debt maturity date	2027	2027
Interest rate	3.15%	3.15%
Description of floating rate basis	Euribor + 0.690%	Euribor + 0.690%
Basis spread on floating rate	0.69%	0.69%
1.85% due 2027, floating interest rate at Euribor + 0.550% [Member]
Debt Instrument [Line Items]
Long-term debt maturity date	2027	2027
Interest rate	1.85%	1.85%
Description of floating rate basis	Euribor + 0.550%	Euribor + 0.550%
Basis spread on floating rate	0.55%	0.55%
2.15% due 2027, floating interest rate at Euribor + 0.850% [Member] | Cassa Depositi e Prestiti SpA ("CDP") [Member]
Debt Instrument [Line Items]
Long-term debt maturity date	2027	2027
Interest rate	2.15%	2.15%
Description of floating rate basis	Euribor + 0.850%	Euribor + 0.850%
Basis spread on floating rate	0.85%	0.85%
Zero-coupon, due 2025 (Tranche A) [Member] | Senior Unsecured Convertible Bonds
Debt Instrument [Line Items]
Long-term debt maturity date	2025	2025	2025
Interest rate	0%	0%
Zero-coupon, due 2027 (Tranche B) [Member] | Senior Unsecured Convertible Bonds
Debt Instrument [Line Items]
Long-term debt maturity date	2027	2027	2027
Interest rate	0%	0%
3.86% due 2027, fixed interest rate
Debt Instrument [Line Items]
Long-term debt maturity date	2027	2027
Interest rate	3.86%	3.86%
3.78% due 2042, fixed interest rate
Debt Instrument [Line Items]
Long-term debt maturity date	2042	2042
Interest rate	3.78%	3.78%
0.32% (weighted average), due 2023-2028, fixed interest rate [Member]
Debt Instrument [Line Items]
Interest rate	0.32%	0.32%
0.32% (weighted average), due 2023-2028, fixed interest rate [Member] | Minimum [Member]
Debt Instrument [Line Items]
Long-term debt maturity date	2023	2023
0.32% (weighted average), due 2023-2028, fixed interest rate [Member] | Maximum [Member]
Debt Instrument [Line Items]
Long-term debt maturity date	2028	2028

Long-Term Debt - Long-Term De_3

Long-Term Debt - Long-Term Debt Denominated by Currencies (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Long-term debt	$ 2,717	$ 2,539
U.S. dollar [Member]
Debt Instrument [Line Items]
Long-term debt	1,495	1,387
Euro [Member]
Debt Instrument [Line Items]
Long-term debt	$ 1,222	$ 1,152

Long-Term Debt - Additional Inf

Long-Term Debt - Additional Information (Detail) $ / shares in Units, € in Millions

1 Months Ended

12 Months Ended

Jan. 01, 2022 USD ($)

Aug. 04, 2020 USD ($) $ / shares shares

Jul. 03, 2017 USD ($) $ / shares shares

Jul. 31, 2021 USD ($) Bond shares

Jul. 31, 2020 USD ($) shares

Dec. 31, 2022 USD ($)

Dec. 31, 2021 USD ($)

Dec. 31, 2020 USD ($)

Dec. 31, 2017

Dec. 31, 2022 EUR (€)

Jun. 01, 2021 EUR (€)

Dec. 31, 2020 EUR (€)

Aug. 01, 2017 EUR (€)

Debt Instrument [Line Items]

Senior unsecured convertible bonds conversion premium rate

37.50%

Conversion features of the instruments value

$ 215,000,000

$ 242,000,000

$ 184,000,000

Allocated debt issuance costs

1,000,000

1,000,000

Allocated debt deferred tax effect

30,000,000

Issuance of convertible bonds in equity and amount

77,000,000

Increase in convertible debt

$ 107,000,000

Convertible debt

1,500,000,000

Unamortized debt issuance cost

6,000,000

Decrease in long term deferred tax liabilities

15,000,000

$ 22,000,000

Total decrease in equity

92,000,000

Decrease in additional paid in capital

117,000,000

Increase in retained earnings

$ 25,000,000

Loss on financial instruments, net

$ (43,000,000)

$ (26,000,000)

Medium Term Credit Facilities [Member]

Debt Instrument [Line Items]

Unutilized committed medium term credit facilities

1,281,000,000

Support R&D and Capital Expenditure Programs [Member]

Debt Instrument [Line Items]

Line of credit outstanding amount | €

€ 600

Amount outstanding

0

Support R&D and Capital Expenditure Programs [Member] | Europe Union [Member]

Debt Instrument [Line Items]

Line of credit outstanding amount | €

€ 500

Amount outstanding

346,000,000

Support R&D and Capital Expenditure Programs [Member] | Italy and France [Member]

Debt Instrument [Line Items]

Line of credit outstanding amount | €

€ 500

Amount outstanding

481,000,000

New Facility Agreement with CDP Two [Member]

Debt Instrument [Line Items]

Line of credit outstanding amount | €

€ 200

Amount outstanding

214,000,000

New Facility Agreement with CDP One [Member]

Debt Instrument [Line Items]

Line of credit outstanding amount | €

€ 150

Amount outstanding

$ 120,000,000

Fair Value, Inputs, Level 3 [Member]

Debt Instrument [Line Items]

Fair value of liability component

1,362,000,000

1,266,000,000

Senior Unsecured Convertible Bonds

Debt Instrument [Line Items]

Net proceeds from issuance of senior unsecured convertible bonds

$ 1,567,000,000

1,502,000,000

Zero-coupon, due 2025 (Tranche A) [Member]

Debt Instrument [Line Items]

Senior unsecured convertible bonds conversion premium rate

47.50%

Debt Conversion, Converted Instrument, Shares Issued | shares

4,585

Debt conversion, bond par value

$ 200,000

Zero-coupon, due 2025 (Tranche A) [Member] | Senior Unsecured Convertible Bonds

Debt Instrument [Line Items]

Debt instrument principal amount

$ 750,000,000

Long-term debt maturity date

2025

2025

2025

Percentage at which bonds issued

105.80%

Senior unsecured convertible bonds conversion price | $ / shares

$ 43.62

Interest rate

0%

0%

0%

Zero-coupon, due 2027 (Tranche B) [Member]

Debt Instrument [Line Items]

Senior unsecured convertible bonds conversion price | $ / shares

$ 45.10

Senior unsecured convertible bonds conversion premium rate

52.50%

Debt Conversion, Converted Instrument, Shares Issued | shares

4,435

Debt conversion, bond par value

$ 200,000

Zero-coupon, due 2027 (Tranche B) [Member] | Senior Unsecured Convertible Bonds

Debt Instrument [Line Items]

Debt instrument principal amount

$ 750,000,000

Long-term debt maturity date

2027

2027

2027

Percentage at which bonds issued

104.50%

Interest rate

0%

0%

0%

Dual Tranche Senior Unsecured Convertible Bonds | Senior Unsecured Convertible Bonds

Debt Instrument [Line Items]

Debt instrument principal amount

$ 1,500,000,000

$ 1,500,000,000

Senior unsecured convertible bonds conversion price | $ / shares

$ 20,540,000

Zero-coupon, due 2022 (Tranche A) [Member]

Debt Instrument [Line Items]

Senior unsecured convertible bonds conversion premium rate

37.50%

Debt conversion, bond par value

$ 750,000,000

Conversion features of the instruments value

$ 0

Zero-coupon, due 2022 (Tranche A) [Member] | Treasury Stock [Member]

Debt Instrument [Line Items]

Debt Conversion, Converted Instrument, Shares Issued | shares

11,400,000

Zero-coupon, due 2022 (Tranche A) [Member] | Measurement Input, Discount Rate [Member]

Debt Instrument [Line Items]

Debt discount rate

0.0270

0.008

Zero-coupon, due 2022 (Tranche A) [Member] | Fair Value, Inputs, Level 3 [Member]

Debt Instrument [Line Items]

Fair value of liability component

$ 739,000,000

Loss on financial instruments, net

$ 25,000,000

Zero-coupon, due 2022 (Tranche A) [Member] | Senior Unsecured Convertible Bonds

Debt Instrument [Line Items]

Debt instrument principal amount

$ 750,000,000

0.25%, due 2024 (Tranche B) [Member]

Debt Instrument [Line Items]

Debt instrument periodic payment

semi-annually

0.25%, due 2024 (Tranche B) [Member] | Measurement Input, Discount Rate [Member]

Debt Instrument [Line Items]

Debt discount rate

0.0328

0.25%, due 2024 (Tranche B) [Member] | Senior Unsecured Convertible Bonds

Debt Instrument [Line Items]

Debt instrument principal amount

$ 750,000,000

Long-term debt maturity date

2024

Interest rate

0.25%

Zero-coupon, due 2022 (Tranche A) [Member] | Senior Unsecured Convertible Bonds

Debt Instrument [Line Items]

Long-term debt maturity date

2022

Zero Coupon Due Two Thousand Nineteen Tranche A | Senior Unsecured Convertible Bonds

Debt Instrument [Line Items]

Percentage at which bonds issued

101.265%

Tranche Two

Debt Instrument [Line Items]

Debt Conversion, Converted Instrument, Shares Issued | shares

9,737

Tranche One

Debt Instrument [Line Items]

Debt Conversion, Converted Instrument, Shares Issued | shares

9,737

Debt conversion, bond par value

$ 200,000

Zero Point Two Five Percentage Due Two Thousand And Twenty Four Trancheb

Debt Instrument [Line Items]

Interest rate

0.25%

Zero Coupon Due Two Thousand And Twenty Four Tranche B

Debt Instrument [Line Items]

Debt conversion, bond par value

$ 248,000,000

Conversion features of the instruments value

$ 0

Number of bonds settled | Bond

3,750

Number of bonds settled on net-share basis | Bond

1,238

Total consideration of bonds on net-share basis

$ 479,000,000

Number of bonds settled on full cash basis | Bond

2,512

Total consideration of bonds on full cash basis

$ 1,015,000,000

Write-off of unamortized debt issuance costs

$ 1,000,000

Zero Coupon Due Two Thousand And Twenty Four Tranche B | Treasury Stock [Member]

Debt Instrument [Line Items]

Debt Conversion, Converted Instrument, Shares Issued | shares

5,800,000

Zero Coupon Due Two Thousand And Twenty Four Tranche B | Measurement Input, Discount Rate [Member]

Debt Instrument [Line Items]

Debt discount rate

0.011

Zero Coupon Due Two Thousand And Twenty Four Tranche B | Fair Value, Inputs, Level 3 [Member]

Debt Instrument [Line Items]

Fair value of liability component

$ 689,000,000

Loss on financial instruments, net

$ 44,000,000

Long-Term Debt - Total Long-Ter

Long-Term Debt - Total Long-Term Debt Outstanding Maturities (Detail) $ in Millions	Dec. 31, 2022 USD ($)
Debt Disclosure [Abstract]
2023	$ 175
2024	172
2025	922
2026	172
2027	908
Thereafter	373
Total	$ 2,722

Post-Employment and Other Lon_3

Post-Employment and Other Long-Term Employees Benefits - Changes in Benefit Obligation and Plan Assets (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Change in plan assets:
Plan assets at fair value at beginning of year	$ 743
Plan assets at fair value at end of year	565	$ 743
Pension Benefits [Member]
Change in benefit obligation:
Benefit obligation at beginning of year	1,165	1,216
Service cost	33	36	$ 31
Interest cost	27	21	21
Employee contributions	4	4
Benefits paid	(22)	(25)
Effect of settlement	(14)	(8)
Business combination		3
Actuarial (gain) loss	(260)	(48)
Foreign currency translation and other adjustments	(47)	(34)
Benefit obligation at end of year	886	1,165	1,216
Change in plan assets:
Plan assets at fair value at beginning of year	743	718
Return on plan assets	(157)	32
Employer contributions	25	17
Employee contributions	4	4
Benefits paid	(9)	(12)
Effect of settlement	(14)	(8)
Business combination		2
Foreign currency translation and other adjustments	(25)	(10)
Plan assets at fair value at end of year	567	743	718
Funded status	(319)	(422)
Net amount recognized in the balance sheet consisted of the following:
Non-current assets	9	15
Current liabilities	(11)	(11)
Long-term liabilities	(317)	(426)
Net amount recognized	(319)	(422)
Other Long-Term Benefit [Member]
Change in benefit obligation:
Benefit obligation at beginning of year	94	101
Service cost	17	13	11
Interest cost	1	1	1
Benefits paid	(6)	(5)
Actuarial (gain) loss	(15)
Foreign currency translation and other adjustments	(5)	(16)
Benefit obligation at end of year	86	94	$ 101
Change in plan assets:
Funded status	(86)	(94)
Net amount recognized in the balance sheet consisted of the following:
Current liabilities	(5)	(4)
Long-term liabilities	(81)	(90)
Net amount recognized	$ (86)	$ (94)

Post-Employment and Other Lon_4

Post-Employment and Other Long-Term Employees Benefits - Accumulated Other Comprehensive Income (Loss) Before Tax Effects (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Compensation And Retirement Disclosure [Abstract]
Accumulated other comprehensive loss, actuarial (gains)/losses, beginning balance	$ 142	$ 216
Net amount generated/arising in current year, actuarial (gains)/losses	(84)	(56)
Amortization, actuarial (gains)/losses	(3)	(12)
Foreign currency translation, actuarial (gains)/losses before tax	(10)	(6)
Accumulated other comprehensive loss, actuarial (gains)/losses, ending balance	45	142
Accumulated other comprehensive loss, prior service cost, beginning balance	2	3
Amortization, prior service cost	(1)	(1)
Foreign currency translation adjustment	0	0
Accumulated other comprehensive loss, prior service cost, ending balance	1	2
Accumulated other comprehensive loss Total, beginning balance	144	219
Net amount generated/arising in current year, Total	(84)	(56)
Amortization, Total	(4)	(13)
Foreign currency translation adjustment, Total	(10)	(6)
Accumulated other comprehensive loss Total, ending balance	$ 46	$ 144

Post-Employment and Other Lon_5

Post-Employment and Other Long-Term Employees Benefits - Schedule of Accumulated Benefit Obligations (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Accumulated benefit obligations	$ 778	$ 1,004
Other Long-Term Benefit [Member]
Defined Benefit Plan Disclosure [Line Items]
Accumulated benefit obligations	$ 25	$ 79

Post-Employment and Other Lon_6

Post-Employment and Other Long-Term Employees Benefits - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Pension plans with accumulated benefit obligations in excess of plan assets, accumulated benefit obligation	$ 409	$ 528
Pension plans with accumulated benefit obligations in excess of plan assets, fair value of plan assets	139	134
Pension plans with expected projected benefit obligations in excess of plan assets, projected benefit obligation	427	499
Pension benefits components other than service cost,	11	10	$ 12
Accrued benefits related to defined contribution pension plans	24	23
Annual cost of defined contribution plans	100	101	$ 91
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Pension plans with benefit obligations in excess of plan assets, benefit obligation	839	1,030
Employer contributions	25	$ 17
Expected contribution in cash	$ 30

Post-Employment and Other Lon_7

Post-Employment and Other Long-Term Employees Benefits - Components of Net Periodic Benefit Cost (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 33	$ 36	$ 31
Interest cost	27	21	21
Expected return on plan assets	(23)	(24)	(23)
Amortization of actuarial net loss (gain)	6	12	12
Amortization of prior service cost	1	1	1
Effect of settlement			1
Net periodic benefit cost	44	46	43
Other Long-Term Benefit [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	17	13	11
Interest cost	1	1	1
Amortization of actuarial net loss (gain)	(14)		3
Net periodic benefit cost	$ 4	$ 14	$ 15

Post-Employment and Other Lon_8

Post-Employment and Other Long-Term Employees Benefits - Weighted Average Assumptions Used in Determination of Benefit Obligation and Plan Assets (Detail)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Compensation And Retirement Disclosure [Abstract]
Discount rate	4.18%	1.84%
Salary increase rate	2.31%	2.27%
Expected long-term rate of return on funds for the pension expense of the following year	2.66%	3.19%
Net periodic benefit cost, Discount rate	1.84%	1.45%	1.95%
Net periodic benefit cost, Salary increase rate	2.27%	2.43%	2.48%
Net periodic benefit cost, Expected long-term rate of return on funds for the pension expense of the year	3.19%	3.44%	4.04%

Post-Employment and Other Lon_9

Post-Employment and Other Long-Term Employees Benefits - Pension Plan Asset Allocation (Detail)	Dec. 31, 2022	Dec. 31, 2021
Allocation of pension plan assets	100%	100%
Cash and Cash Equivalents [Member]
Allocation of pension plan assets	1%	1%
Equity Securities [Member]
Allocation of pension plan assets	17%	17%
Government Debt Securities [Member]
Allocation of pension plan assets	10%	12%
Corporate Debt Securities [Member]
Allocation of pension plan assets	21%	22%
Investment Funds [Member]
Allocation of pension plan assets	16%	21%
Real Estate [Member]
Allocation of pension plan assets	1%	1%
Other (Mainly Insurance Assets - Contracts and Reserves) [Member]
Allocation of pension plan assets	34%	26%

Post-Employment and Other Lo_10

Post-Employment and Other Long-Term Employees Benefits - Pension Plan Asset Allocation (Parenthetical) (Detail) - Investment Funds [Member]	Dec. 31, 2022	Dec. 31, 2021
Time Deposits and Money Market
Defined benefit plan, plan assets target allocation percentage	11%
Corporate Bonds
Defined benefit plan, plan assets target allocation percentage	79%	73%
Equity
Defined benefit plan, plan assets target allocation percentage		15%
Other Instruments
Defined benefit plan, plan assets target allocation percentage	10%	12%

Post-Employment and Other Lo_11

Post-Employment and Other Long-Term Employees Benefits - Pension Plan Asset Allocation Including Fair-Value Measurements (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	$ 565	$ 743
Cash and Cash Equivalents [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	4	5
Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	95	130
Government Debt Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	59	87
Corporate Debt Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	120	164
Investment Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	87	156
Real Estate [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	6	10
Other (Mainly Insurance Assets - Contracts and Reserves) [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	194	191
Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	6	8
Fair Value, Inputs, Level 1 [Member] | Cash and Cash Equivalents [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	4	5
Fair Value, Inputs, Level 1 [Member] | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	1	2
Fair Value, Inputs, Level 1 [Member] | Investment Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	1	1
Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	381	568
Fair Value, Inputs, Level 2 [Member] | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	94	128
Fair Value, Inputs, Level 2 [Member] | Government Debt Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	59	87
Fair Value, Inputs, Level 2 [Member] | Corporate Debt Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	98	139
Fair Value, Inputs, Level 2 [Member] | Investment Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	86	155
Fair Value, Inputs, Level 2 [Member] | Real Estate [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	6	10
Fair Value, Inputs, Level 2 [Member] | Other (Mainly Insurance Assets - Contracts and Reserves) [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	38	49
Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	178	167	$ 162
Fair Value, Inputs, Level 3 [Member] | Corporate Debt Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	22	25
Fair Value, Inputs, Level 3 [Member] | Other (Mainly Insurance Assets - Contracts and Reserves) [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	$ 156	$ 142

Post-Employment and Other Lo_12

Post-Employment and Other Long-Term Employees Benefits - Reconciliation for Plan Assets Measured at Fair Value Using Unobservable Inputs (Level 3) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Plan assets at fair value at beginning of year	$ 743
Foreign currency translation adjustment	0	$ 0
Plan assets at fair value at end of year	565	743
Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Plan assets at fair value at beginning of year	167	162
Contributions (employer and employee)	21	15
Return on plan assets		2
Net benefit payments	9	1
Settlements	(14)	(8)
Foreign currency translation adjustment	(5)	(5)
Plan assets at fair value at end of year	$ 178	$ 167

Post-Employment and Other Lo_13

Post-Employment and Other Long-Term Employees Benefits - Estimated Future Benefit Payments (Detail) $ in Millions	Dec. 31, 2022 USD ($)
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
2023	$ 41
2024	46
2025	57
2026	70
2027	51
From 2028 to 2032	319
Other Long-Term Benefit [Member]
Defined Benefit Plan Disclosure [Line Items]
2023	5
2024	6
2025	9
2026	8
2027	9
From 2028 to 2032	$ 43

Other Long-Term Liabilities - S

Other Long-Term Liabilities - Summary of Other Long-Term Liabilities (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Other Liabilities Noncurrent [Abstract]
Non-current operating lease liabilities	$ 141	$ 148
Contingent consideration on business combinations	31	70
Other long-term employee benefits	81	90
Long-term liabilities related to public funding	51	44
Long-term advances from customers	73
Derivative instruments	4
Others	73	64
Total	$ 454	$ 416

Shareholders' Equity - Addition

Shareholders' Equity - Additional Information (Detail)							1 Months Ended	3 Months Ended																12 Months Ended
	May 25, 2022 $ / shares	Jul. 01, 2021 USD ($)	May 27, 2021 $ / shares	Jun. 17, 2020 $ / shares	May 31, 2019 $ / shares	Jan. 22, 2007	Oct. 31, 2016	Mar. 31, 2023 $ / shares	Dec. 31, 2022 USD ($) $ / shares shares	Sep. 30, 2022 $ / shares	Jun. 30, 2022 $ / shares	Mar. 31, 2022 $ / shares	Dec. 31, 2021 USD ($) $ / shares shares	Sep. 30, 2021 $ / shares	Jun. 30, 2021 $ / shares	Mar. 31, 2021 $ / shares	Dec. 31, 2020 USD ($) $ / shares	Sep. 30, 2020 $ / shares	Jun. 30, 2020 $ / shares	Mar. 31, 2020 $ / shares	Dec. 31, 2019 $ / shares	Sep. 30, 2019 $ / shares	Jun. 30, 2019 $ / shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2007	Dec. 31, 2022 EUR (€) € / shares shares	May 20, 2012	May 20, 2011	May 20, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Authorized share capital | €																													€ 1,810,000,000
Common stock, shares authorized									1,200,000,000															1,200,000,000					1,200,000,000
Preference stock, shares authorized									540,000,000															540,000,000					540,000,000
Common stock, nominal value | € / shares																													€ 1.04
Common stock, shares issued									911,281,920				911,276,920											911,281,920	911,276,920				911,281,920
Common stock, shares outstanding									903,865,763				906,518,057											903,865,763	906,518,057				903,865,763
Shares issued as a percentage of par value of the preference shares to be issued						25%
Preference shares outstanding maximum period																												2 years
Expiration period of options after date of grant, in years						10 years
Expiration extended period of options after date of grant,in years							10 years
Preference share issued									0				0											0	0				0
Company owned treasury stock									7,416,157				4,758,863											7,416,157	4,758,863				7,416,157
Transfer of treasury shares to employees under the Company's share based remuneration programs									74,520,215															74,520,215					74,520,215
Transfer of treasury shares to employees under the Company's share based remuneration during the year																								6,587,002
Total intrinsic value of options exercised | $													$ 2,000,000				$ 2,000,000								$ 2,000,000	$ 2,000,000
Total intrinsic value of options outstanding | $													1,000,000												1,000,000
Grant date fair value of shares vested | $																								$ 189,000,000	181,000,000	141,000,000
Stock-based compensation, excluding payroll tax and social contribution, capitalized as part of inventory | $									$ 11,000,000				$ 9,000,000				$ 6,000,000							11,000,000	9,000,000	6,000,000
Total unrecognized compensation cost related to the grant of unvested shares | $									$ 228,000,000															$ 228,000,000
Employee service share-based compensation, unvested awards, total compensation cost not yet recognized, period for recognition																								9 months
Deferred income tax benefit relating to unvested share based compensation expense | $																								$ 15,000,000	14,000,000	10,000,000
Dividends, per share | $ / shares	$ 0.24		$ 0.24	$ 0.168	$ 0.24				$ 0.06	$ 0.06	$ 0.06	$ 0.06	$ 0.06	$ 0.06	$ 0.06	$ 0.042	$ 0.042	$ 0.042	$ 0.042	$ 0.06	$ 0.06	$ 0.06	$ 0.06
Dividends payable to stockholders | $									$ 60,000,000				$ 55,000,000											60,000,000	55,000,000
Scenario Forecast [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividends, per share | $ / shares								$ 0.06
Dividend Distribution First Installment [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend paid | $																								55,000,000	54,000,000	37,000,000	$ 53,000,000
Dividend Distribution Second Installment [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend paid | $																								54,000,000	55,000,000	38,000,000	53,000,000
Dividend Distribution Third Installment [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend paid | $																								48,000,000	54,000,000	34,000,000	48,000,000
Dividend Distribution Remaining Portion of Third Installment [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend paid | $																								6,000,000		4,000,000	6,000,000
Dividend Distribution of Last Installment [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend paid | $																									$ 55,000,000	$ 38,000,000	$ 54,000,000
Dividends payable to stockholders | $									$ 54,000,000															$ 54,000,000
Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Transfer of treasury shares to employees under the Company's share based remuneration during the year																								6,606,203
Vesting period of awards																								3 years
Supervisory Board 2012 Plan [Member] | Supervisory Board [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards are granted at the nominal value of the share | € / shares																													€ 1.04
Vesting period of awards																								3 years
Vesting schedule for Supervisory Board																								one third every year
Employee Plan 2009 [Member] | Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sub plan for employees of Company's European subsidiaries for statutory payroll tax purposes nonvested shares vested over requisite service period																														32%	32%	36%
2019 CEO Special Bonus [Member] | Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Transfer of treasury shares to employees under the Company's share based remuneration during the year																								11,652
Weighted average grant-date fair value of nonvested shares granted to employees under Employee Plan | $ / shares																								$ 14.97
Employee Plan 2019 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant-date fair value of nonvested shares granted to employees under Employee Plan | $ / shares																								$ 19.28
Employee Plan 2019 [Member] | Performance Conditions [Member] | Share-based Payment Arrangement, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares to vest																								66.67%
Employee Plan 2019 [Member] | Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Transfer of treasury shares to employees under the Company's share based remuneration during the year																								2,345,411
2020 CEO Special Bonus [Member] | Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Transfer of treasury shares to employees under the Company's share based remuneration during the year																								5,333
Weighted average grant-date fair value of nonvested shares granted to employees under Employee Plan | $ / shares																								$ 26.64
Employee Plan 2020 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant-date fair value of nonvested shares granted to employees under Employee Plan | $ / shares																								$ 30.17
Employee Plan 2020 [Member] | Performance Conditions [Member] | Share-based Payment Arrangement, Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares to vest																								100%
Employee Plan 2020 [Member] | Performance Conditions [Member] | Share-based Payment Arrangement, Tranche Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares to vest																								100%
Employee Plan 2020 [Member] | Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Transfer of treasury shares to employees under the Company's share based remuneration during the year																								2,492,520
Employee Plan 2022 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant-date fair value of nonvested shares granted to employees under Employee Plan | $ / shares																								$ 35.92
Shares expected to vest									2,705,521															2,705,521					2,705,521
Employee Plan 2022 [Member] | Performance Conditions [Member] | Share-based Payment Arrangement, Tranche Six [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares to vest																								100%
Employee Plan 2022 [Member] | Performance Conditions [Member] | Share-based Payment Arrangement, Tranche Seven [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares to vest																								100%
Employee Plan 2021 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant-date fair value of nonvested shares granted to employees under Employee Plan | $ / shares																								$ 39.20
Employee Plan 2021 [Member] | Performance Conditions [Member] | Share-based Payment Arrangement, Tranche Five [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares to vest																								66.67%
Employee Plan 2021 [Member] | Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Transfer of treasury shares to employees under the Company's share based remuneration during the year																								1,751,287
Share Buy-Back Program Launched on July 1, 2021 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period of buy-back program		3 years
Stock Repurchase Program, Remaining Authorized Repurchase Amount | $		$ 1,040,000,000							$ 346,000,000															$ 346,000,000
Number of common shares authorized to repurchase									9,200,000															9,200,000					9,200,000

Shareholders' Equity - Summary

Shareholders' Equity - Summary of Grants under Outstanding Stock Award Plans (Detail)	12 Months Ended
	Dec. 31, 2022 shares
Employees [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options granted	6,531,345
Employees [Member] | Employee Plan 2022 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options granted	6,531,345
2011 [Member] | Supervisory Board [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Year of grant	2011
Options granted	172,500
Options waived at grant	(30,000)
2012 [Member] | Supervisory Board [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Year of grant	2012
Options granted	180,000
Options waived at grant	(22,500)
No Options Granted [Member] | Supervisory Board [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Year of grant	Since 2013
May 23, 2019 [Member] | Employees [Member] | 2019 CEO Special Bonus [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options granted	34,960
Grant date of Nonvested share	May 23, 2019
July 24, 2019 [Member] | Employees [Member] | Employee Plan 2019 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options granted	7,752,940
Grant date of Nonvested share	Jul. 24, 2019
Share based compensation arrangement by share based payment award, Number of shares lost on performance	(1,161,966)
December 26, 2019 [Member] | Employees [Member] | Employee Plan 2019 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options granted	246,750
Grant date of Nonvested share	Dec. 26, 2019
Share based compensation arrangement by share based payment award, Number of shares lost on performance	(17,013)
June 17, 2020 [Member] | Employees [Member] | 2020 CEO Special Bonus [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options granted	16,000
Grant date of Nonvested share	Jun. 17, 2020
July 23, 2020 [Member] | Employees [Member] | Employee Plan 2020 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options granted	7,437,580
Grant date of Nonvested share	Jul. 23, 2020
December 24, 2020 [Member] | Employees [Member] | Employee Plan 2020 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options granted	562,350
Grant date of Nonvested share	Dec. 24, 2020
July 28, 2021 [Member] | Employees [Member] | Employee Plan 2021 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options granted	6,327,205
Grant date of Nonvested share	Jul. 28, 2021
Share based compensation arrangement by share based payment award, Number of shares lost on performance	(920,263)
December 21, 2021 [Member] | Employees [Member] | Employee Plan 2021 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options granted	213,270
Grant date of Nonvested share	Dec. 21, 2021
Share based compensation arrangement by share based payment award, Number of shares lost on performance	(60,483)
July 27, 2022 [Member] | Employees [Member] | Employee Plan 2022 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options granted	6,243,670
Grant date of Nonvested share	Jul. 27, 2022
December 22, 2022 [Member] | Employees [Member] | Employee Plan 2022 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options granted	287,675
Grant date of Nonvested share	Dec. 22, 2022

Shareholders' Equity - Summar_2

Shareholders' Equity - Summary of Nonvested Share Activity (Detail) - shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards vested, Number of Shares	(6,587,002)
Supervisory Board [Member] | 2011 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Year of grant	2011
Beginning Balance, Number of Shares		7,500
Awards granted, Number of Shares	172,500
Exercised		(7,500)
Supervisory Board [Member] | 2012 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Year of grant	2012
Beginning Balance, Number of Shares	20,000	50,000
Awards granted, Number of Shares	180,000
Exercised	(5,000)	(30,000)
Expired / Cancelled	(15,000)
Ending Balance, Number of Shares		20,000
Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Beginning Balance, Number of Shares	14,201,889
Awards granted, Number of Shares	6,531,345
Awards forfeited/waived, Number of Shares	(164,116)
Awards cancelled on failed vesting conditions, Number of Shares	(980,746)
Awards vested, Number of Shares	(6,606,203)
Ending Balance, Number of Shares	12,982,169	14,201,889
Employees [Member] | Employee Plan 2019 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Beginning Balance, Number of Shares	2,356,399
Awards forfeited/waived, Number of Shares	(10,988)
Awards vested, Number of Shares	(2,345,411)
Ending Balance, Number of Shares		2,356,399
Employees [Member] | 2020 CEO Special Bonus [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Beginning Balance, Number of Shares	10,667
Awards vested, Number of Shares	(5,333)
Ending Balance, Number of Shares	5,334	10,667
Employees [Member] | Employee Plan 2020 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Beginning Balance, Number of Shares	5,325,666
Awards forfeited/waived, Number of Shares	(52,350)
Awards vested, Number of Shares	(2,492,520)
Ending Balance, Number of Shares	2,780,796	5,325,666
Employees [Member] | 2019 CEO Special Bonus [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Beginning Balance, Number of Shares	11,652
Awards vested, Number of Shares	(11,652)
Ending Balance, Number of Shares		11,652
Employees [Member] | Employee Plan 2021 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Beginning Balance, Number of Shares	6,497,505
Awards forfeited/waived, Number of Shares	(65,958)
Awards cancelled on failed vesting conditions, Number of Shares	(980,746)
Awards vested, Number of Shares	(1,751,287)
Ending Balance, Number of Shares	3,699,514	6,497,505
Employees [Member] | Employee Plan 2022 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted, Number of Shares	6,531,345
Awards forfeited/waived, Number of Shares	(34,820)
Ending Balance, Number of Shares	6,496,525

Shareholders' Equity - Classifi

Shareholders' Equity - Classification of Pre-Payroll Tax and Social Contribution Stock-Based Compensation Expense Included in Consolidated Statements of Income (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total pre-payroll tax and social contribution compensation	$ 215	$ 221	$ 155
Cost of Sales [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total pre-payroll tax and social contribution compensation	34	34	25
Research and Development Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total pre-payroll tax and social contribution compensation	69	70	51
SG&A [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total pre-payroll tax and social contribution compensation	$ 112	$ 117	$ 79

Shareholders' Equity - Changes

Shareholders' Equity - Changes in AOCI Attributable to Stockholders (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Balance	$ 440	$ 450	$ 680	$ 421
Cumulative tax impact	20	46	43	54
Balance, net of tax	460	496	723	475
OCI before reclassifications	(211)	(224)	245
Amounts reclassified from AOCI	201	(6)	14
OCI Balance	(10)	(230)	259
Cumulative tax impact	(26)	3	(11)
OCI Balance, net of tax	(36)	(227)	248
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]
Balance	23	(48)	61	(3)
Cumulative tax impact	(3)	6	(8)
Balance, net of tax	20	(42)	53	(3)
OCI before reclassifications	(126)	(90)	64
Amounts reclassified from AOCI	197	(19)
OCI Balance	71	(109)	64
Cumulative tax impact	(9)	14	(8)
OCI Balance, net of tax	62	(95)	56
Accumulated Net Gains (Losses) on Available-for-Sale Securities [Member]
Balance	(16)		1	1
Cumulative tax impact	2
Balance, net of tax	(14)		1	1
OCI before reclassifications	(16)	(1)
OCI Balance	(16)	(1)
Cumulative tax impact	2
OCI Balance, net of tax	(14)	(1)
Accumulated Defined Benefit Plan Items [Member]
Balance	(78)	(162)	(231)	(223)
Cumulative tax impact	21	40	51	54
Balance, net of tax	(57)	(122)	(180)	(169)
OCI before reclassifications	80	56	(22)
Amounts reclassified from AOCI	4	13	14
OCI Balance	84	69	(8)
Cumulative tax impact	(19)	(11)	(3)
OCI Balance, net of tax	65	58	(11)
Foreign Currency Translation Adjustments ("CTA") [Member]
Balance	511	660	849	646
Balance, net of tax	511	660	849	$ 646
OCI before reclassifications	(149)	(189)	203
OCI Balance	(149)	(189)	203
OCI Balance, net of tax	$ (149)	$ (189)	$ 203

Shareholders' Equity - Schedule

Shareholders' Equity - Schedule of Items Reclassified Out of Accumulated Other Comprehensive Income (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	$ 8,493	$ 7,435	$ 6,430
Selling, general and administrative	(1,454)	(1,323)	(1,109)
Other components of pension benefit costs	(1,901)	(1,723)	(1,548)
Other components of pension benefit costs	(11)	(10)	(12)
Income tax benefit (expense)	(520)	(331)	(159)
Net income	3,966	2,006	1,108
Attributable to noncontrolling interest	(6)	(6)	(2)
Attributable to the parent company stockholders	3,960	2,000	1,106
Reclassification Out of Accumulated Other Comprehensive Income [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net income	(173)	5	(11)
Attributable to noncontrolling interest	0	0	0
Attributable to the parent company stockholders	(173)	5	(11)
Reclassification Out of Accumulated Other Comprehensive Income [Member] | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income tax benefit (expense)	27	(3)
Net income	(170)	16
Reclassification Out of Accumulated Other Comprehensive Income [Member] | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Foreign Exchange Contract [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	(129)	15	(3)
Selling, general and administrative	(15)	1	1
Other components of pension benefit costs	(53)	3	2
Reclassification Out of Accumulated Other Comprehensive Income [Member] | Amortization of Actuarial Gains (Losses) [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other components of pension benefit costs	(3)	(12)	(13)
Reclassification Out of Accumulated Other Comprehensive Income [Member] | Amortization of Prior Service Cost [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other components of pension benefit costs	(1)	(1)	(1)
Income tax benefit (expense)	1	2	3
Net income	$ (3)	$ (11)	$ (11)

Revenues - Additional Informati

Revenues - Additional Information (Detail1)	Dec. 31, 2022
Maximum [Member] | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations term	1 year

Revenues - Additional Informa_2

Revenues - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Revenue recognition and disaggregation payment terms description	The payment terms typically range between 30 and 90 days.
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Apple [Member]
Disaggregation of Revenue [Line Items]
Share of companies in consolidated net revenues	16.80%	20.50%	23.90%
Minimum [Member]
Disaggregation of Revenue [Line Items]
Revenue recognition and disaggregation payment terms	30 days
Maximum [Member]
Disaggregation of Revenue [Line Items]
Revenue recognition and disaggregation payment terms	90 days

Revenues - Summary of Consolida

Revenues - Summary of Consolidated Net Revenues Disaggregated by Reportable Segment, Geographical Region of Shipment, Nature and Market Channel (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Total net revenues	$ 16,128	$ 12,761	$ 10,219
Sales Channel, Directly to Consumer [Member]
Disaggregation of Revenue [Line Items]
Total net revenues	10,764	8,486	7,411
Sales Channel, Through Intermediary [Member]
Disaggregation of Revenue [Line Items]
Total net revenues	5,364	4,275	2,808
Net Sales [Member]
Disaggregation of Revenue [Line Items]
Total net revenues	15,953	12,560	10,049
Service [Member]
Disaggregation of Revenue [Line Items]
Total net revenues	130	169	132
Other Revenues [Member]
Disaggregation of Revenue [Line Items]
Total net revenues	45	32	38
EMEA [Member]
Disaggregation of Revenue [Line Items]
Total net revenues	3,619	2,557	1,966
Americas [Member]
Disaggregation of Revenue [Line Items]
Total net revenues	2,310	1,525	1,165
Asia Pacific [Member]
Disaggregation of Revenue [Line Items]
Total net revenues	$ 10,199	$ 8,679	$ 7,088

Segment Information - Net Reven

Segment Information - Net Revenues by Product Segment and by Product Line (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Net revenues	$ 16,128	$ 12,761	$ 10,219
Product Segments [Member]
Segment Reporting Information [Line Items]
Net revenues	16,108	12,739	10,206
ADG [Member] | Product Segments [Member]
Segment Reporting Information [Line Items]
Net revenues	5,969	4,350	3,284
AMS [Member] | Product Segments [Member]
Segment Reporting Information [Line Items]
Net revenues	4,911	4,587	3,858
MDG [Member] | Product Segments [Member]
Segment Reporting Information [Line Items]
Net revenues	5,228	3,802	3,064
Others [Member]
Segment Reporting Information [Line Items]
Net revenues	$ 20	$ 22	$ 13

Segment Information - Operating

Segment Information - Operating Income by Reportable Segment (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income (loss)	$ 4,439	$ 2,419	$ 1,323
Product Segments [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income (loss)	4,536	2,442	1,496
AMS [Member] | Product Segments [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income (loss)	1,237	1,022	816
Operating Segments [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income (loss)	4,536	2,442	1,496
Operating Segments [Member] | ADG [Member] | Product Segments [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income (loss)	1,469	512	182
Operating Segments [Member] | MDG [Member] | Product Segments [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income (loss)	1,830	908	498
Segment Reconciling Items [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income (loss)	(97)	(23)	(173)
Segment Reconciling Items [Member] | Others [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income (loss)	$ (97)	$ (23)	$ (173)

Segment Information - Reconcili

Segment Information - Reconciliation of Operating Income of Reportable Segments to Total Consolidated Operating Income (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income	$ 4,439	$ 2,419	$ 1,323
Impairment, restructuring charges and other related closure costs		(2)	(11)
Start-up and phase-out costs	(13)		(8)
Gain on sale of non-current assets	2	5	14
Operating Segments [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income	4,536	2,442	1,496
Segment Reconciling Items [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income	(97)	(23)	(173)
Impairment, restructuring charges and other related closure costs		(2)	(11)
Start-up and phase-out costs	(13)
Unused capacity charges	(22)	(16)	(153)
Other unallocated manufacturing results	(57)	1	(8)
Gain on sale of non-current assets	2	3	11
Strategic and other research and development programs and other non-allocated provisions	$ (7)	$ (9)	$ (12)

Segment Information - Net Rev_2

Segment Information - Net Revenues (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenues	$ 16,128	$ 12,761	$ 10,219
Switzerland [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenues	4,569	3,282	2,795
France [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenues	153	126	89
Italy [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenues	47	56	52
USA [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenues	1,981	1,253	976
Singapore [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenues	8,604	7,442	5,817
Japan [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenues	758	586	479
Other Countries [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenues	$ 16	$ 16	$ 11

Segment Information - Property,

Segment Information - Property, Plant & Equipment (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	$ 8,201	$ 5,660
Netherlands [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	2,753	1,476
France [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	1,774	1,154
Italy [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	1,683	1,469
Other European Countries [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	161	136
USA [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	52	36
Singapore [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	880	671
Malaysia [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	365	221
Other Countries [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	$ 533	$ 497

Other Income and Expenses Net -

Other Income and Expenses Net - Other Income and Expenses Net (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Other Income And Expenses [Abstract]
Public funding	$ 177	$ 162	$ 231
Start-up and phase-out costs	(13)		(8)
Exchange gain (loss), net	15	7	8
Patent costs	(8)	(10)	(11)
Gain on sale of non-current assets	2	5	14
COVID-19 incremental costs	(10)	(19)	(32)
Other, net	(4)	(4)
Total	$ 159	$ 141	$ 202

Interest Income (Expense), Ne_2

Interest Income (Expense), Net - Summary of Interest Income (Expense), Net (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Investments Debt And Equity Securities [Abstract]
Income	$ 71	$ 13	$ 34
Expense	(13)	(42)	(54)
Total	$ 58	$ (29)	$ (20)

Interest Income (Expense), Ne_3

Interest Income (Expense), Net - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Net Investment Income [Line Items]
Income	$ 71,000,000	$ 13,000,000	$ 34,000,000
Interest expense on borrowings and banking fees	13,000,000	42,000,000	54,000,000
Capitalized borrowing cost	0	0	0
U.S. Treasury Bonds [Member]
Net Investment Income [Line Items]
Interest income (expense), net	$ 1,000,000	1,000,000	3,000,000
Senior Unsecured Convertible Bonds
Net Investment Income [Line Items]
Non-cash accretion expense		$ 34,000,000	$ 42,000,000

Income Tax - Income (Loss) befo

Income Tax - Income (Loss) before Income Tax (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income (loss) recorded in the Netherlands	$ (22)	$ (20)	$ (19)
Income (loss) from foreign operations	4,508	2,357	1,286
Income before income taxes and noncontrolling interest	$ 4,486	$ 2,337	$ 1,267

Income Tax - Income Tax Benefit

Income Tax - Income Tax Benefit (Expense) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Foreign taxes - current	$ (510)	$ (285)	$ (171)
Total current taxes	(510)	(285)	(171)
Foreign taxes - deferred	(10)	(46)	12
Total deferred taxes	(10)	(46)	12
Income tax expense	$ (520)	$ (331)	$ (159)
Effective tax rate	12%	14%	13%

Income Tax - Additional Informa

Income Tax - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Jan. 01, 2022
Operating Loss Carryforwards [Line Items]
Netherlands statutory income taxes rate	25.80%	25%	25%
Effect of the tax benefits on basic earnings per share	$ 0.07	$ 0.05	$ 0.04
Maximum percentage of tax reduction from tax holidays	100%	100%	100%
Income tax holiday expiration date	Dec. 31, 2029
Legal inflationary index	2.56%
Deferred tax expense recorded as component of other comprehensive income (loss)	$ (26)	$ 3
Cumulative amount of distributable earnings	7,140	4,148
Distributable earnings becoming taxable upon repatriation amount	528
Indefinitely reinvested by foreign subsidiaries	308
Decrease in long term deferred tax liabilities	22			$ 15
Unrecognized tax benefits	25	81
Accrued interest and penalties related to uncertain tax positions			$ 1
Interest and penalties of unrecognized tax benefits	$ 6	7
Earliest Tax Year [Member]
Operating Loss Carryforwards [Line Items]
Open tax year	1997
Latest Tax Year [Member]
Operating Loss Carryforwards [Line Items]
Open tax year	2022
Maximum [Member]
Operating Loss Carryforwards [Line Items]
Accrued interest and penalties related to uncertain tax positions	$ 1	$ 1
Netherlands [Member]
Operating Loss Carryforwards [Line Items]
Cumulative amount of distributable earnings	$ 6,612

Income Tax - Differences in Inc

Income Tax - Differences in Income Taxes Computed at Netherlands Statutory Rate and Effective Income Tax Rate (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income tax benefit (expense) computed at statutory rate	$ (1,158)	$ (584)	$ (316)
Non-deductible and non-taxable permanent differences, net	22	4	(1)
Valuation allowance adjustments	140	(2)	11
Effect on deferred taxes of changes in enacted tax rates	6	6	(5)
Current year credits	30	39	40
Other tax and credits	(51)	(22)	(40)
Benefits from tax holidays	60	49	37
Net impact of changes to uncertain tax positions	(12)	(8)	(1)
Earnings of subsidiaries taxed at different rates	443	187	116
Income tax expense	$ (520)	$ (331)	$ (159)

Income Tax - Deferred Tax Asset

Income Tax - Deferred Tax Assets and Liabilities (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Tax loss carryforwards and investment credits	$ 520	$ 707
Less unrecognized tax benefit	(25)	(81)
Tax loss carryforwards net of unrecognized tax benefit	495	626
Inventory valuation	42	28
Impairment and restructuring charges	4	4
Fixed asset depreciation in arrears	55	52
Increased depreciation incentives	83	128
Capitalized development costs	79	121
Receivables for government funding	121	64
Tax credits granted on past capital investments	218	213
Pension service costs	62	82
Stock awards	17	14
Operating lease liabilities	50	39
Commercial accruals	27	12
Other temporary differences	23	25
Total deferred tax assets	1,276	1,408
Valuation allowances	(416)	(576)
Deferred tax assets, net	860	832
Accelerated fixed asset depreciation	(37)	(32)
Acquired intangible assets	(23)	(22)
Advances of government funding	(177)	(115)
Operating lease right-of-use assets	(50)	(39)
Other temporary differences	(31)	(36)
Deferred tax liabilities	(318)	(244)
Net deferred income tax asset	$ 542	$ 588

Income Tax - Gross Deferred Tax

Income Tax - Gross Deferred Tax Assets on Tax Loss Carryforwards and Investment Credits Expiration (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
2023	$ 3
2024	2
2025	2
2026	2
2027	5
Thereafter	506
Total	$ 520	$ 707

Income Tax - Reconciliation of

Income Tax - Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Balance at beginning of year	$ 118	$ 48	$ 48
Additions based on tax positions related to the current year	4	72	1
Additions for tax positions of prior years	13	1	1
Reduction for tax positions of prior years	(69)	(1)	(2)
Settlements	(2)		(1)
Foreign currency translation	(3)	(2)	1
Balance at end of year	$ 61	$ 118	$ 48

Earnings per Share - Summary of

Earnings per Share - Summary of Earnings per Share ("EPS") (Detail) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Basic EPS
Net income attributable to parent company as reported	$ 3,960	$ 2,000	$ 1,106
Weighted average number of shares outstanding	905,606,885	904,332,429	894,578,477
Basic EPS	$ 4.37	$ 2.21	$ 1.24
Diluted EPS
Net income attributable to parent company as reported	$ 3,960	$ 2,000	$ 1,106
add-back interest expense, net of income tax effect	2
Net income attributable to parent company as adjusted	$ 3,962	$ 2,000	$ 1,106
Weighted average number of shares outstanding	905,606,885	904,332,429	894,578,477
Dilutive effect of stock awards	6,789,662	9,107,124	8,860,216
Dilutive effect of convertible bonds	33,825,000	11,402,645	16,291,279
Number of shares used in calculating diluted EPS	946,221,547	924,842,198	919,729,972
Diluted EPS	$ 4.19	$ 2.16	$ 1.20

Commitments - Company's Commitm

Commitments - Company's Commitments (Detail) $ in Millions	Dec. 31, 2022 USD ($)
Recorded Unconditional Purchase Obligation [Line Items]
Purchase obligations, Total	$ 5,554
Purchase obligations, 2023	4,556
Purchase obligations, 2024	424
Purchase obligations, 2025	287
Purchase obligations, 2026	101
Purchase obligations, 2027	62
Purchase obligations, Thereafter	124
Other obligations, Total	1,864
Other obligations, 2023	1,072
Other obligations, 2024	155
Other obligations, 2025	100
Other obligations, 2026	56
Other obligations, 2027	155
Other obligations, Thereafter	326
Company's commitments, Total	7,418
Company's commitments, 2023	5,628
Company's commitments, 2024	579
Company's commitments, 2025	387
Company's commitments, 2026	157
Company's commitments, 2027	217
Company's commitments, Thereafter	450
Equipment Purchase [Member]
Recorded Unconditional Purchase Obligation [Line Items]
Purchase obligations, Total	3,587
Purchase obligations, 2023	3,584
Purchase obligations, 2024	3
Foundry Purchase [Member]
Recorded Unconditional Purchase Obligation [Line Items]
Purchase obligations, Total	1,827
Purchase obligations, 2023	872
Purchase obligations, 2024	393
Purchase obligations, 2025	275
Purchase obligations, 2026	101
Purchase obligations, 2027	62
Purchase obligations, Thereafter	124
Software, Design, Technologies and Licenses [Member]
Recorded Unconditional Purchase Obligation [Line Items]
Purchase obligations, Total	140
Purchase obligations, 2023	100
Purchase obligations, 2024	28
Purchase obligations, 2025	$ 12

Financial Instruments and Ris_3

Financial Instruments and Risk Management - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2022 USD ($) Customer	Dec. 31, 2021 USD ($) Customer	Dec. 31, 2020 USD ($)
Derivative [Line Items]
Maximum percentage for Research and Development and Corporate costs of the total forecasted transactions	80%
Maximum percentage for manufacturing costs of forecasted transactions	70%
Maximum percentage for designated hedged item of forecasted transactions	100%
Hedge exposure to the variability of cash flows for forecasted transactions	24 months
Deferred gains on derivative instrument, net of tax	$ 14,000,000
Period of Accumulated other comprehensive income (loss)	12 months
Fair value of assets	$ 69,000,000	$ 6,000,000
Fair value of liabilities	$ 39,000,000	$ 43,000,000
Maximum outstanding amount per instrument with each Bank , as percentage of total	20%
Number of customer represented more than 10% of trade accounts receivable | Customer	0	0
Contingent consideration, liability	$ 31,000,000	$ 77,000,000
Fair value of gain (loss) included in earnings	35,000,000
Impairment charge on investments	0	0	$ 0
Fair value measurement with unobservable inputs reconciliation non-recurring basis asset liability value	0	0
Unrealized loss position	0	0
Other Payables and Accrued Liabilities [Member]
Derivative [Line Items]
Settlement amount related to contingent consideration	7,000,000
Other Long-term Liabilities [Member]
Derivative [Line Items]
Contingent consideration, liability	31,000,000	70,000,000
Cost of Sales [Member]
Derivative [Line Items]
Fair value of gain (loss) included in earnings	2,000,000
Research and Development Expense [Member]
Derivative [Line Items]
Fair value of gain (loss) included in earnings	33,000,000
Foreign Exchange Contract [Member] | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification Out of Accumulated Other Comprehensive Income [Member] | Cost of Sales [Member]
Derivative [Line Items]
Realized gain (loss) on reduction in operating expenses	129,000,000	(15,000,000)	3,000,000
Foreign Exchange Contract [Member] | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification Out of Accumulated Other Comprehensive Income [Member] | Operating Expense [Member]
Derivative [Line Items]
Realized gain (loss) on reduction in operating expenses	68,000,000	$ (4,000,000)	(3,000,000)
Currency Collars [Member] | Option One [Member]
Derivative [Line Items]
Fair value of net assets (liabilities)	15,000,000
Fair value of assets	19,000,000
Fair value of liabilities	5,000,000
Currency Collars [Member] | Option Two [Member]
Derivative [Line Items]
Fair value of net assets (liabilities)	10,000,000
Fair value of assets	5,000,000
Fair value of liabilities	15,000,000
Foreign Exchange Forward Contracts [Member]
Derivative [Line Items]
Fair value of assets	54,000,000
Fair value of liabilities	$ 29,000,000
Minimum [Member]
Derivative [Line Items]
Major customer percentage of trade accounts receivable	10%	10%
Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Notional amount of Derivative Instruments	$ 931,000,000	$ 505,000,000	897,000,000
Foreign currency forward contracts maturity term	29 days
Fair value of assets	$ 9,000,000	3,000,000
Fair value of liabilities	3,000,000	1,000,000
Not Designated as Hedging Instrument [Member] | Foreign Exchange Forward Contracts [Member] | Other Payables and Accrued Liabilities [Member]
Derivative [Line Items]
Fair value of liabilities	$ 3,000,000	1,000,000
Not Designated as Hedging Instrument [Member] | Minimum [Member]
Derivative [Line Items]
Foreign currency forward contracts remaining terms	4 days
Not Designated as Hedging Instrument [Member] | Maximum [Member]
Derivative [Line Items]
Foreign currency forward contracts remaining terms	188 days
Designated as Hedging Instrument [Member]
Derivative [Line Items]
Notional amount of Derivative Instruments	$ 3,192,000,000	2,165,000,000	$ 1,502,000,000
Foreign currency forward contracts maturity term	239 days
Fair value of assets	$ 60,000,000	3,000,000
Fair value of liabilities	36,000,000	42,000,000
Designated as Hedging Instrument [Member] | Currency Collars [Member]
Derivative [Line Items]
Fair value of liabilities	9,000,000	13,000,000
Designated as Hedging Instrument [Member] | Currency Collars [Member] | Other Long-term Liabilities [Member]
Derivative [Line Items]
Fair value of liabilities	1,000,000
Designated as Hedging Instrument [Member] | Foreign Exchange Forward Contracts [Member] | Other Payables and Accrued Liabilities [Member]
Derivative [Line Items]
Fair value of liabilities	23,000,000	$ 29,000,000
Designated as Hedging Instrument [Member] | Foreign Exchange Forward Contracts [Member] | Other Long-term Liabilities [Member]
Derivative [Line Items]
Fair value of liabilities	$ 3,000,000
Designated as Hedging Instrument [Member] | Minimum [Member]
Derivative [Line Items]
Foreign currency forward contracts remaining terms	4 days
Designated as Hedging Instrument [Member] | Maximum [Member]
Derivative [Line Items]
Foreign currency forward contracts remaining terms	20 months

Financial Instruments and Ris_4

Financial Instruments and Risk Management - Notional Amounts of Outstanding Derivative Instruments (Detail) - Dec. 31, 2022 - Designated as Hedging Instrument [Member]	EUR (€)	SGD ($)
Foreign Exchange Forward Contracts [Member]
Derivative [Line Items]
Notional amount of Derivative Instruments	€ 540,000,000
Notional amount of Derivative Instruments	986,000,000	$ 247,000,000
Currency Collars [Member]
Derivative [Line Items]
Notional amount of Derivative Instruments	500,000,000
Notional amount of Derivative Instruments	€ 791,000,000

Financial Instruments and Ris_5

Financial Instruments and Risk Management - Fair Value of Derivative Instruments (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Derivatives, Fair Value [Line Items]
Total Asset Derivatives	$ 69	$ 6
Total Liability Derivatives	(39)	(43)
Foreign Exchange Forward Contracts [Member]
Derivatives, Fair Value [Line Items]
Total Asset Derivatives	54
Total Liability Derivatives	(29)
Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Total Asset Derivatives	60	3
Total Liability Derivatives	(36)	(42)
Designated as Hedging Instrument [Member] | Foreign Exchange Forward Contracts [Member] | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Total Asset Derivatives	37	2
Designated as Hedging Instrument [Member] | Foreign Exchange Forward Contracts [Member] | Other Non-Current Assets [Member]
Derivatives, Fair Value [Line Items]
Total Asset Derivatives	8
Designated as Hedging Instrument [Member] | Foreign Exchange Forward Contracts [Member] | Other Payables and Accrued Liabilities [Member]
Derivatives, Fair Value [Line Items]
Total Liability Derivatives	(23)	(29)
Designated as Hedging Instrument [Member] | Foreign Exchange Forward Contracts [Member] | Other Non-Current Liabilities [Member]
Derivatives, Fair Value [Line Items]
Total Liability Derivatives	(3)
Designated as Hedging Instrument [Member] | Currency Collars [Member]
Derivatives, Fair Value [Line Items]
Total Liability Derivatives	(9)	(13)
Designated as Hedging Instrument [Member] | Currency Collars [Member] | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Total Asset Derivatives	10	1
Designated as Hedging Instrument [Member] | Currency Collars [Member] | Other Non-Current Assets [Member]
Derivatives, Fair Value [Line Items]
Total Asset Derivatives	5
Designated as Hedging Instrument [Member] | Currency Collars [Member] | Other Non-Current Liabilities [Member]
Derivatives, Fair Value [Line Items]
Total Liability Derivatives	(1)
Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Total Asset Derivatives	9	3
Total Liability Derivatives	(3)	(1)
Not Designated as Hedging Instrument [Member] | Foreign Exchange Forward Contracts [Member] | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Total Asset Derivatives	9	3
Not Designated as Hedging Instrument [Member] | Foreign Exchange Forward Contracts [Member] | Other Payables and Accrued Liabilities [Member]
Derivatives, Fair Value [Line Items]
Total Liability Derivatives	$ (3)	$ (1)

Financial Instruments and Ris_6

Financial Instruments and Risk Management - Effect on Consolidated Statements of Income of Derivative Instruments (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) deferred in OCI on derivative	$ 23	$ (48)
Gain (loss) reclassified from OCI into earnings	(197)	19
Foreign Exchange Forward Contracts [Member] | Cost of Sales [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) deferred in OCI on derivative	14	(20)
Gain (loss) reclassified from OCI into earnings	(83)	11
Foreign Exchange Forward Contracts [Member] | SG&A [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) deferred in OCI on derivative	2	(2)
Gain (loss) reclassified from OCI into earnings	(9)
Foreign Exchange Forward Contracts [Member] | Research and Development Expense [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) deferred in OCI on derivative	4	(9)
Gain (loss) reclassified from OCI into earnings	(32)	1
Currency Collars [Member] | Cost of Sales [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) deferred in OCI on derivative	1	(11)
Gain (loss) reclassified from OCI into earnings	(46)	4
Currency Collars [Member] | SG&A [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) deferred in OCI on derivative	1	(1)
Gain (loss) reclassified from OCI into earnings	(6)	1
Currency Collars [Member] | Research and Development Expense [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) deferred in OCI on derivative	1	(5)
Gain (loss) reclassified from OCI into earnings	$ (21)	$ 2

Financial Instruments and Ris_7

Financial Instruments and Risk Management - Effect on Consolidated Statements of Income of Derivative Instruments Not Designated as Hedge (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Foreign exchange forward contracts	$ 24	$ 9
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Other income and expenses, net	Other income and expenses, net
Foreign Exchange Forward Contracts [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Foreign exchange forward contracts	$ 24	$ 9
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Other income and expenses, net	Other income and expenses, net

Financial Instruments and Ris_8

Financial Instruments and Risk Management - Schedule of Financial Assets (Liabilities) Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	$ 26	$ 29
Derivative instruments	69	6
Derivative instruments	(39)	(43)
Contingent consideration on business acquisitions	(31)	(77)
Total	1,285	206
U.S. Treasury Bonds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	679
Fair Value Through Earnings [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	26	29
Short-Term Deposits [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	581	291
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	1,286	320
Fair Value, Inputs, Level 1 [Member] | U.S. Treasury Bonds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	679
Fair Value, Inputs, Level 1 [Member] | Fair Value Through Earnings [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	26	29
Fair Value, Inputs, Level 1 [Member] | Short-Term Deposits [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	581	291
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	30	(37)
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration on business acquisitions	(31)	(77)
Total	(31)	(77)
Designated as Hedging Instrument [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative instruments	60	3
Derivative instruments	(36)	(42)
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative instruments	60	3
Derivative instruments	(36)	(42)
Designated as Hedging Instrument [Member] | Fair Value, Inputs, Level 2 [Member] | Cash Flow Hedging [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative instruments	60	3
Derivative instruments	(36)	(42)
Not Designated as Hedging Instrument [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative instruments	9	3
Derivative instruments	(3)	(1)
Not Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative instruments	9	3
Derivative instruments	(3)	(1)
Not Designated as Hedging Instrument [Member] | Fair Value, Inputs, Level 2 [Member] | Cash Flow Hedging [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative instruments	9	3
Derivative instruments	$ (3)	$ (1)

Financial Instruments and Ris_9

Financial Instruments and Risk Management - Schedule of Liabilities Measured at Fair Value on Recurring Basis Using Significant Unobservable Inputs (Level 3) (Detail) - Fair Value, Inputs, Level 3 [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Opening position	$ 77	$ 123
Changes in fair value measurement	(35)	(38)
Currency translation adjustment	(4)	(8)
Payments made	(7)
Closing position	31	77
Amount of total gains (losses) for the period included in earnings attributable to liabilities still held at the reporting date	$ 35	$ (2)

Financial Instruments and Ri_10

Financial Instruments and Risk Management - Fair Value Information on Other Financial Assets and Liabilities Recorded at Amortized Cost (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 3,258	$ 3,225
Short-term, deposits	581	291
Long-term debt
Finance leases (including current portion)	57
Estimate Fair Value [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	2,996	2,883
Short-term, deposits	581	291
Estimate Fair Value [Member] | Fair Value, Inputs, Level 1 [Member] | Senior Unsecured Convertible Bonds Issued on August 4, 2020 [Member]
Long-term debt
Senior unsecured convertible bonds	1,561	1,975
Estimate Fair Value [Member] | Fair Value, Inputs, Level 2 [Member]
Long-term debt
Bank loans (including current portion)	1,165	$ 1,152
Finance leases (including current portion)	$ 57
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]	Liabilities	Liabilities
Carrying Amount [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 2,996	$ 2,883
Short-term, deposits	581	291
Carrying Amount [Member] | Fair Value, Inputs, Level 1 [Member] | Senior Unsecured Convertible Bonds Issued on August 4, 2020 [Member]
Long-term debt
Senior unsecured convertible bonds	1,495	1,387
Carrying Amount [Member] | Fair Value, Inputs, Level 2 [Member]
Long-term debt
Bank loans (including current portion)	1,165	$ 1,152
Finance leases (including current portion)	$ 57
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]	Liabilities	Liabilities

Financial Instruments and Ri_11

Financial Instruments and Risk Management - Fair Value Information on Other Financial Assets and Liabilities Recorded at Amortized Cost (Parenthetical) (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Jan. 01, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unamortized debt issuance costs		$ 6
Senior Unsecured Convertible Bonds Issued on August 4, 2020 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unamortized debt issuance costs	$ 5

Financial Instruments and Ri_12

Financial Instruments and Risk Management - Schedule of Methodologies Used to Estimate Fair Value (Detail)	12 Months Ended
	Dec. 31, 2022
Debt Securities Classified as Available for Sale [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Methodology used to estimate fair value	Quoted market prices for identical instruments
Foreign Exchange Forward Contracts Currency Options and Collars [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Methodology used to estimate fair value	Quoted market prices for similar instruments
Equity Securities Measured at Fair Value Through Earnings [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Methodology used to estimate fair value	Quoted market prices for identical instruments
Equity Securities Carried at Cost as a Measurement Alternative [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Methodology used to estimate fair value	Valuation of the underlying investments on a new round of third-party financing or upon liquidation
Long-term Debt and Current Portion of Long Term Debt [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Methodology used to estimate fair value	Future cash flows on a borrowing-by-borrowing basis and discounting these future cash flows using the Company's incremental borrowing rates for similar types of borrowing arrangements
Cash And Cash Equivalents, Short-Term Deposits, Accounts Receivable, Short-Term Borrowings, and Accounts Payable [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Methodology used to estimate fair value	The carrying amounts reflected in the consolidated financial statements are considered as reasonable estimates of fair value due to the relatively short period of time between the origination of the instruments and their expected realization.

Related Party Transactions - Tr

Related Party Transactions - Transactions with Related Parties (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Related Party Transactions [Abstract]
Sales & other services	$ 13	$ 8	$ 5
Other purchases	25	19	21
Accounts receivable	5	$ 2	$ 1
Accounts payable	$ 2

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
ST Foundation [Member]
Related Party Transaction [Line Items]
Cash contribution to ST Foundation	$ 1	$ 0.5	$ 0.5

Valuation and Qualifying Acco_2

Valuation and Qualifying Accounts (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Allowance for Trade Receivables [Member]
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at beginning of period	$ 19	$ 16	$ 16
Additions/ (Deductions)	2	3
Balance at end of period	21	19	16
Valuation Allowance of Deferred Tax Assets [Member]
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at beginning of period	576	638	1,534
Translation adjustment	(19)	(24)	28
Charged to costs and expenses	(140)	(2)	(11)
Additions/ (Deductions)	(1)	(36)	(913)
Balance at end of period	$ 416	$ 576	$ 638